Food interactions : effects on health, consumer perception and impact on agro-food industries “FOODINTER”. by Scippo, Marie-Louise et al.
  
FOOD INTERACTIONS: EFFECTS ON HEALTH, 
CONSUMER PERCEPTION AND IMPACT ON  
AGRO-FOOD INDUSTRIES 
“FOODINTER” 
M.L. Scippo, R. Blust, D. Boniver, F. Brose, F. Callebaut ,  
A. Covaci, B. Dannevoye, S. Danyi, S. De Saeger, S. De Voghel, 
J. Diana Di Mavungu, C. Douny, J. Hermesse, Y. Larondelle,  
G. Maghuin-Rogister, M. Mormont, M. Muller, I. Nobels,  
A.S. Remacle, L. Ribonnet, J. Robbens, Y.J. Schneider,  






















Guy Maghuin-Rogister & Marie-Louise Scippo 
Université de Liège (ULg) 
Laboratory of Food Analysis Department of Food Sciences 
Marc Mormont  
Université de Liège (Ulg) 
Unit of Socio-Economy, Environment and Development (SEED), Department of Environmental Sciences 
and Management,  
Marc Muller  
Université de Liège (Ulg) 
Department of Life Sciences, Laboratory of Biology and Molecular Genetic, Faculty of Sciences,  
Yvan Larondelle, Yves-Jacques Schneider 
Université Catholique de Louvain (UCL) 
Institut des Sciences de la Vie, 
Luc Pussemier, Alfons Callebaut 
Veterinary and Agrochemical Research Centre (CODA-CERVA-VAR) 
Ronny Blust, Wim De Coen, Johan Robbens 
Universiteit of Antwerpen (UA) 
Laboratory of Ecophysiology, Biochemistry and Toxicology 
Sarah De Saeger, Carlos Van Peteghem 
Universiteit of Gent (UGent) 
Laboratory of Food Analysis, Faculty of Pharmaceutical Sciences 
 
Authors  
M.L. Scippo, F. Brose, B. Dannevoye , S. Danyi, C. Douny,  J. Hermesse, G. Maghuin-Rogister,  
M. Mormont, M. Muller, A.S. Remacle & E. Van der Heiden (ULg) 
Y. Larondelle, L. Ribonnet & Y.J. Schneider (UCL) 
D. Boniver , F. Callebaut, S. De Voghel & L. Pussemier (CERVA-CODA) 
R. Blust, A. Covaci, I. Nobels & J. Robbens (UA)    
S. De Saeger, J. Diana Di Mavungu, C. Van Peteghem (UGent) 
  
SCIENCE FOR A SUSTAINABLE DEVELOPMENT 
(SSD) 
FINAL REPORT  
 
Food interactions : effects on health, consumer 































Published in 2011 by the Belgian Science Policy 




Tel: +32 (0)2 238 34 11 – Fax: +32 (0)2 230 59 12 
http://www.belspo.be 
 
Contact person : : Christine Mathieu 
+32 (0)2 238 34 93 
 
Neither the Belgian Science Policy nor any person acting on behalf of the Belgian Science Policy 
is responsible for the use which might be made of the following information. The authors are 
responsible for the content. 
No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any 
form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without 
indicating the reference : 
M.L. Scippo, R. Blust, D. Boniver, F. Brose, F. Callebaut, A. Covaci, B. Dannevoye, S. Danyi,  
S. De Saeger, S. De Voghel, J. Diana Di Mavungu, C. Douny, J. Hermesse, Y. Larondelle,  
G. Maghuin-Rogister, M. Mormont, M. Muller, I. Nobels, A.S. Remacle, L. Ribonnet, J. Robbens, 
Y.J. Schneider, E. Van der Heiden, C. Van Peteghem, L. Pussemier. Food interactions : effects 
on health, consumer perception and impact on agro-food industries “FOODINTER”. Final 
Report. Brussels : Belgian Science Policy 2011 – 143 p. (Research Programme Science for a 
Sustainable Development) 
 
Project SD/AF/04 - Food interactions : effects on health, consumer perception and impact on agro-food industries - 
“FOODINTER” 
SSD-Science for a Sustainable Development – Agro-Food 3 
ACRONYMS AND ABBREVIATIONS  
3-ADON : 3-acetyldeoxynivalenol  
5-MC :   5-Methylchrysene  
15-ADON :  15-acetyldeoxynivalenol  
ADI :  Acceptable daily intake  
AFB1 :  Aflatoxin B1  
AFB2 :  Aflatoxin B2  
AFG1 : Aflatoxin G1  
AFG2 : Aflatoxin G2  
AFSSA : Agence française de sécurité sanitaire des aliments   
AhR :  Aryl hydrocarbon receptor  
ALT :  Altenuen  
AOH :  Alternariol  
AME :  Alternariol methylether  
AMA    Advanced Mercury Analyzer  
ANSES : Agence nationale de sécurité sanitaire (former AFSSA : Agence française 
pour la séxurité sanitaire des aliments) 
As :  Arsenic  
Ba :  Baryum  
BaP :  Benzo[a]pyrene  
Bi :  Bismuth  
BEAU : Beauvericin  
BMDL : Benchmark dose lower confidence limit  
Bw :  body weight 
Cd :  Cadmium  
Co :  Cobalt  
Cr :  Chromium  
Cu :  Copper  
DAD :  Diode array detection  
DAS :  Diacetoxyscirpenol  
DHT :   Dehydrotestosterone 
DON :  Deoxynivalenol  
DRI :  Dietary reference intake  
EC :   European community 
EDI :  Estimated daily intake  
EMA :  European medicines agency  
EFSA : European food safety authority  
ESI-MS/MS : Electrospray ionization tandem mass spectrometry  
FAO :  Food and Agriculture organization  
FASFC : Federal agency for the safety of the food chain  
FB1 :  Fumonisin B1  
FB2 :  Fumonisin B2  
FB3 :  Fumonisin B3 
FF :   Functional food 
FS :   Food supplement 
FSA :  Food Standards Agency  
F-X :  Fusarenon-X 
GBE :  Gingko biloba extract  
GL :  Glucosinolates  
GRH :  Glucoraphasatin  
GTL :  Glucotropaeolin  
Hg :  Mercury  
HPLC/UV-FLD: High performance liquid chromatography/Ultra violet Fluorescence detection  
HT-2 :  HT-2 toxin  
IAEA :  Atomic Energy  
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IC50 :   Concentration at which 50% of the cell growth is inhibited 
ICP-MS : Inductively coupled plasma  
ISO :   International Organisation for Standardisation 
JECFA : Joint FAO/WHO Experts Committee on Food Addi  
LC50 :  Lethal concentration at which 50 % of the cells are dead  
LC-MS : Liquid chromatography tandem mass spectrometry  
LOQ :  Limit of quantification  
MB :   Moniteur belge 
Mn :  Manganese  
Mo :  Molybdenum  
MOA :  Mode of action  
MOE :  Margin of exposure  
MRM :  Multiple reaction monitoring 
MS :  Mass spectrometry  
MT :  Metallothionein  
NC :  Non compliant  
NEO :  Neosolaniol  
Ni :  Nickel  
NIST :  National institue for standardization  
NIV :  Nivalenol  
OCP :  Organochlorine pesticide 
OTA :  Ochratoxin A  
PAH :  Polycyclic aromatic hydrocarbon 
Pb :  Lead  
PBDE : Polybromodiphenylether 
PC :   Plausible concentration 
PCB :  Polychlorobiphenyls 
PTWI :  Provisional tolerable weekly intake 
RIVM :  National institute for public health (The Netherlands)  
RP-LC : reversed-phase liquid chromatography  
RRF :  relative response factor  
Sb :  Antimoine  
SCF :  Scientific Committee for Food (European Commission)  
Se :  Selenium  
SPE :  solid phase extraction  
STERIG : sterigmatocystin  
Sr :  Strontium  
T-2 :  T-2 toxin  
TCDD : Tetrachlorodibenzodioxin  
Ti :  Titanium  
Tl :  Thallium  
TMDI :  Tolerable maximal daily intake  
WHO :  World Health Organization  
ZEA :  zearalenone  
Zn :  Zinc 
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Food supplements (FS) are subject to an ever growing interest, as they are now 
consumed by an increasing number of people. According to the results of a 
consumption survey conducted in France by the CCAF (2004), (N=1361), 11% of the 
grown-up respondents were FS consumers and 59% are consumers of « extended 
health food/products »  (Gaigner, 2005). Botanical materials represent a large 
segment of this class of products (e.g. soy isoflavones, yam or hop extracts). The 
vast majority of plant based food supplements sold legally in the EU today is 
harmless under recommended conditions of use. However, plant extracts as such 
may not be harmless. 
Furthermore severe cases of drug-plant extracts interactions have been well 
documented on patients (Abad, 2010, Chavez et al., 2005, Colalto, 2010, Izzo & 
Ernst, 2009), and it is likely that many more cases are not declared because not 
considered as originating from these interactions. Because of their vegetal origin and, 
in some cases, the non application of legal manufacturing guidelines (especially for 
materials prepared in third countries), the raw material used in preparing plant-based 
food supplements might also carry toxic environmental contaminants such as heavy 
metals or polycyclic aromatic hydrocarbons. It is important that plant-based FS 
comply with the legislation.  Numerous legal requirements are in place in the EU to 
ascertain that food of vegetal origin does not contain potentially harmful amounts of 
residues or contaminants.  
 
B. OBJECTIVES 
The FOODINTER project aims to study selected food supplements (FS) sold on the 
Belgian market in terms of chemical contamination and the activity of their active 
ingredients. Six categories of plant derived products were chosen : gingko-biloba, St 
John‟s wort, soy isoflavones, maca, black radish and garlic.  
The objective of this project is thus to contribute to the risk assessment of 
chemicals, natural compounds and environmental contaminants, present in FS which 
could interact between each other or with micro- or macronutrients of normal human 
diet. Interaction studies have been performed using existing in vitro models (based 
on various cultured cell types, prokaryotes and eukaryotes) with mixtures of active 
substances at concentrations that are very close to the real situation in human 
nutrition.  
Furthermore, this project aims to promote the communication between scientists 
and stakeholders (authorities, producers and consumers). In the field of food 
consumption, this objective is important because food safety depends not only on 
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production and control, but also on consumption practices and good information must 
therefore be promoted. The objective is not only an educational planning, but also to 
promote a dialog between science and society in order to better identify the societal 
preoccupations and needs that research has to satisfy. 
 
C. CONCLUSIONS 
Our project was divided in 3 parts : 
1. Selection and chemical analysis of samples of food supplements found on the 
Belgian market, 
2. In vitro analysis of pure compounds identified as active ingredients of the 
selected food supplements, as well as food supplements extracts, 
3. Study of the consumer perception of food supplements using the techniques 
of surveys, at the beginning of the project, and focus groups, at the beginning 
and the end of the project. 
 
Selection and chemical analysis of samples of food supplements found 
on the Belgian market 
We have selected for this project six different FS all made from one specific plant 
material: 
- Ginkgo biloba: improve blood circulation and cerebral oxygenation 
- St-John‟s wort (Hypericum perforatum): for mild depression 
- Soy isoflavones (from Glycine max): reduce menopause effects  
- Maca (Lepidium meyenii): increase libido and limit sexual disorders 
- Black radish (Raphanus sativus): for bile secretion and intestine activity 
- Garlic (Allium sativum): decrease arterial tension 
 In order to have an idea of what the consumer can find on the Belgian market, 61 
samples were collected, purchased from 37 companies via internet (36 samples), 
pharmacies (18 samples) and specialized shops (7 samples). Twenty five FS were 
notified in Belgium whilst 36 were not notified (and generally available via the internet). 
This material was used to perform the analyses of chemical contaminants and active 
ingredients.  
 
Analysis of chemical contaminants 
Analysis of mineral éléments : Seventeen trace elements (As, Ba, Bi, Cd, Co, Cr, Cu, 
Mn, Mo, Ni, Pb, Sb, Se, Sr, Ti, Tl, Zn) were quantified by inductively coupled plasma 
with mass spectrometer (ICP-MS). Mercury (Hg) was quantified by Advanced Mercury 
Analyzer (AMA). 
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There were 10 non compliant (NC) samples with respect to the Belgian legislation 
in force in 2007, at the time the samples were bought, for toxic element in FS (7 NC for 
Pb and 4 NC for Cd; one sample exceeded the maximal limit for both elements ). Since 
2008, the Belgian legislation has been replaced by a European Regulation, with higher 
maximal limits for Pb and Cd, and only 4 samples, ut of thèse 10, would remain NC for 
their Pb content. 
Analysis of mycotoxins : The target mycotoxins included nivalenol (NIV), 
deoxynivalenol (DON), neosolaniol (NEO), fusarenon-X (F-X), 3-acetyldeoxynivalenol 
(3-ADON), 15-acetyldeoxynivalenol (15-ADON), diacetoxyscirpenol (DAS), HT-2 
toxin (HT-2), T-2 toxin (T-2), aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 
(AFG1), aflatoxin G2 (AFG2), ochratoxin A (OTA), altenuen (ALT), alternariol (AOH), 
alternariol methylether (AME), fumonisin B1 (FB1), fumonisin B2 (FB2),  fumonisin 
B3 (FB3), zearalenon (ZEA), beauvericin (BEAU), sterigmatocystin (STERIG). They 
were analyzed using gradient reversed-phase liquid chromatography (RP-LC) with 
electrospray ionization tandem mass spectrometry (ESI-MS/MS). 
The toxins FB1, FB2, FB3 and OTA were detected in some samples. In 2 
samples (one of Gingko Biloba and one of Maca), OTA was found at a level above 2 
µg/kg (EC maximal limit for wine and grape juice, Regulation 1881/2006/EC). The 
levels of FB1, FB2 and FB3 were largely below 800 µg/kg (EC norm for the sum of 
FB1 and FB2 in breakfast cereals, Regulation 1881/2006/EC) in all samples. 
Analysis of PAHs : High performance liquid chromatography coupled to an 
ultraviolet, diode array or fluorescence detector (HPLC/UV-FLD) has been used to 
detect the 15(+1) EU priority PAHs in the sixty food supplements selected in this 
project. The results have shown that St-John‟s wort and Ginkgo biloba extracts 
presented the most frequent contaminations and the highest average values for 
PAHs concentrations. The most contaminated samples with the sum of the 16 PAHs 
were generally detected in St-John‟s wort and ginkgo products, except one sample of 
soy isoflavones. However, in most cases, the PAH intake from FS is less than 5% the 
PAH intake from normal food. 
Analysis of organochlorine pesticides (OCPs), polychlorinated biphenyls 
(PCBs) and of polybrominated diphenyl ethers (PBDEs), and dioxins in oily FS : 
Low amounts of p,p‟-DDE or p,p‟-DDD (< 10 µg/Kg) were detected in 3 garlic 
samples, but far below the legal limit of 50 µg/Kg for the  sum of DDT. Dioxins, PCBs 
and PBDEs were below the limit of quantification of the assay. 
 
Identification and analysis of active ingredients 
Relevant active ingredients were identified from the literature in the 6 
categories of food supplements. 
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These active ingredients are listed below. 
 
For some of them, these active ingredients have been analyzed using 
chemical methods (HPLC or LC-MS) in order to determine the real content of the 
chosen FS in these active ingredients. 
Analysis of six maca products (3 notified, 3 not notified) by nano-LC-MS 
revealed one product containing no lepidilin A and no lepidilin B. From these data, it 
could be concluded that this sample does not resemble a maca-extract. 
Nevertheless, macaridin was detected in all maca supplements, with no correlation 
with the presence of lepidilins.  
The glucosinolate (GL) profile in black radish (Raphanus sativus) based 
dietary products was investigated. An analytical strategy combining the use of LC-
PDA, LC-ESI-MS/MS and LC-APCI-MS/MS systems was applied. The LC-ESI-
MS/MS system was used to detect and identify the naturally occurring intact GLs. 
The identified intact GLs were then desulfated and quantified on an LC-PDA system 
as desulfo-GLs. Prior to quantification, the desulfo-GLs were identified using an 
APCI-MS/MS system. In total, six glucosinolates were identified and determined 
(quantified) in the six analyzed products. The quantitative data revealed a great 
diversity in the individual GL which can be attributed to differences between species 
and subspecies of the different black radishes from which the products were derived. 
Different growing conditions could also have contributed to the differences in the 
glucosinolate content in the different samples. 
According to the literature, glucoraphenin was found the most abundant glucosinolate 
in all samples.  
The hypericin content specified on the packaging of thirteen different food 
supplements was registered. In five cases (not notified products), the announced 
content of hypericin leads to an intake higher than the legal limit of 700 mg/day in the 
“plant” Royal Decree of 1997 (MB, 1997). 
We also observed the lack of hypericin content information on two notified 
food supplements. 
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The analysis of active ingredients in the selected products shows that the 
content of the product is not always mentioned on the label.  This is mandatory, 
according to the European Directive 2002/46/CE, transposed in Belgian legislation in 
the “plant” Royal Decree of 1997. But, as this “plant” decree is not yet complete, 
because the active ingredients are not identified for each plant food supplement, this 
obligation is not applicable. 
This shows the need for more research to identify active ingredients in plant 
FS as well as a gap to fill in the European and Belgian legislation. 
 
In vitro analysis of pure compounds identified as active ingredients of 
the selected food supplements, as well as food supplements extracts 
 
For the in vitro study, we focused on 3 categories of products, on the basis of 
the frequency of their consumption : soy isoflavones, St John Wort and Ginkgo 
biloba. For these 3 categories of products, we have tested their active ingredients 
separately with our panel of in vitro tests, as pure standards. The complete study (in 
vitro testing of active ingredients separately, mixture of active ingredients and plant 
extract) has been performed only on Ginkgo biloba, using a reference material (from 
the National Institute of Standardization, NIST), with certified concentration of active 
ingredients of Ginkgo biloba. 
In order to work with plausible intestinal concentrations, we have estimated 
daily intake (EDI) of each selected compound, using FS content values either from 
literature or from packaging. For certain compounds, such as active ingredients from 
soy isoflavones, the EDI from the diet must be added to the EDI from food 
supplement consumption. This methodology provided us with an idea of plausible 
intestinal concentrations to use as reference concentrations in our in vitro intestinal 
barrier model.  
In all in vitro models, ranges of concentrations were tested, including the 
intestinal plausible concentration, as a reference. 
 
The in vitro models used where : 
- A model to study the general toxicity of the active ingredients in bacteria 
(E.coli) and eukaryotic cell lines (hepG2 and Caco2); 
- A model to study the possible toxic mode of action of active ingredients 
using bacterial reporter gene assays allowing to investigate four mode of 
action : oxidative damage, DNA damage, general cell lesions and 
membrane damage; 
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- A model to study the possible endocrine disrupting and dioxin-like activity 
of active ingredients using eukaryotic reporter gene assays (where the 
interactions with respectively, human steroid receptors and rat and human 
aryl hydrocarbon receptors, were studied); 
- A model to study the possible effects of active ingredients on human P450 
(CYP) 1A1 activity in human colon adenocarcinoma cells (Caco2 cells). 
 
The main results obtained with active ingredients at concentrations equal or 
below their calculated intestinal plausible level are indicated here below : 
In general toxicity assays, some cytotoxicity was observed with hyperforin, 
bilobalide, isorhamnetin, kaempferol, genistein, daidzein and glycitein. 
In mode of actions (MOA) assays, hypericin and hyperforin showed no 
effects, while an effect on DNA damage MOA was recorded for Gingkolide A, 
kaempferol and genistein, on cellular stress MOA for kampferol and on oxidative 
damage MOA for kaempferol, genistein and daidzein. 
In the Caco2 model to study the CYP1A1 activity, hypericin was able to 
slightly induce the CYP1A1 activity as well as to inhibit the CYP1A1 induction in 
presence of BaP, while hyperforin was only able to slightly induce CYP1A1 activity.  
The terpens from Ginkgo biloba (Gingkolides and bilobalide) as well as one 
flavonol (isorhamnetin) had no effect on the CYP1A1 activity, while the two other 
flavonols tested (kaempferol and quercetin) were able to induce as well as to inhibit 
the CYP1A1 activity. The whole Ginkgo biloba extract (NIST reference material) 
displayed the same kind of effect, but with a lower intensity. 
Soy isoflavones (genistein, daidzein and glycitein) were able to inhibit 
CYP1A1, but not to activate it. 
In the study of the interaction with the aryl hydrocarbon receptor (AhR), 
specific species effects were recorded. Both hypericin and hyperforin displayed the 
same effects : while they were unable to activate both the rat and human AhR, they 
potentiate the inductive effect of the reference ligand TCDD (tetrachlordibenzodioxin) 
in rat hepatoma cells (synergistic effect), but they inhibit this inductive effect in 
human hepatoma cells. 
For terpens active ingredients of Ginkgo biloba, only Gingkolide J displayed an 
effect (activation of human AhR), and for flavonols, only quercetin was able to 
activate the AhR (in human but not rat hepatoma cells), while the three flavonolos 
(isorhamnetin, kaempferol and quercetin) inhibited the AhR (in both rat and human 
cells for isorhamnetin and quercetin and only in human cells for kaempferol).  
The NIST Ginkgo biloba reference extract induced the AhR in both rat and 
human cells, acted in synergy with TCDD to induce AhR in rat cells (no inhibition 
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effect) and inhibit the TCDD induction of AhR in human cells. This last result is 
concordant with the observation made in Caco2 cells, where the NIST Ginkgo biloba 
extract both slightly induced the CYP1A1 (which is expressed in response of the 
activation of the Ah receptor, which is a transcription factor) and inhibited the 
CYP1A1 induction by BaP, another reference ligand for the Ah receptor.  
For soy isoflavones (genistein, daidzein and glycitein), the results obtained 
when studying their effect on the Ah receptor are less concordant with the 
observations made on the CYP1A1 activity: the three isoflavones were able to induce 
the rat AhR but not the human, while genistein and daidzein acted synergically with 
TCDD to induce AhR in rat cells and only genistein inhibited the TCDD induction of 
AhR in human cells. 
When studying the possible endocrine disrupting activity of selected 
active ingredients, hypericin and hyperforin were not able to activate steroid 
receptors (human estrogen, androgen, glucocorticoid and progesterone receptors), 
while hypericin inhibited the induction of the glucocorticoid receptor and both 
hypercin and hyperforin were able to inhibit the induction of the human estrogen 
receptor, showing a possible anti-estrogenic activity. 
Terpens showed no activity on steroid receptors, while the 3 flavonols were 
able to induce the human estrogen receptor (showing an estrogenic activity) but also 
to inhibit the induction of the progesterone receptor (anti-progestagen activity). 
The soy isoflavones, known to display an estrogenic activity, showed an 
expected activation effect on the estrogen receptor (showing that our model works), 
but also an inhibitory activity of the less studied progesterone and glucocorticoid 
receptors, showing a possible effect of these substance on other steroidal pathways 
than the estrogenic one. 
 
To summary the first two parts of the project, the results show that potential 
risks, for public health, are linked to 3 major areas: interactions with drugs that may 
modulate their efficiency (shown from the literature study), environmental 
contaminants, such as heavy metals and polycyclic aromatic hydrocarbons (shown 
from the analysis of 61 samples bought on the Belgian market in 2007), and 
biological effects of certain active compounds that might for example act as 
endocrine disruptors for specific target groups or modulate the activity of the 
metabolizing enzyme CYP1A1.  
 
Study of the consumer perception of food supplements using the techniques 
of surveys, at the beginning of the project, and focus groups, at the beginning 
and the end of the project. 
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From the consumers' encounter (third part of the project), we draw the 
following conclusions : the first is that consumers do not exactly know what can 
be categorised as FS and what can not. This raises the problem of a poor 
knowledge in the public of the exact definition and status of those products, even if 
paradoxically the categorization and definition of all health products seems heavily 
framed through regulation. 
The second is that FS (or products sold as FS) consumers are not a 
homogeneous group; they have very different profiles and may share very few 
characteristics from one to another. Food supplements consumption is widespread 
among the population, but the monthly expense on those products generally ranges 
between 20-50€. The four main profiles we identified are: performance profile ; well-
being profile ; deficiency profile ; prevention profile.  
 The third is that consumers have generally low risk awareness (even lower 
for interaction risks), lack a lot of information and of critical distance on those 
products, but want to be better informed. They also often make self-research on 
products, and can sometimes become hard to challenge (even by experts) as their 
main source of faith is themselves, the information they collected, their own 
experiences and feelings, or coming from trusted relatives. However, they can't be 
dismissed as "irrational" as they root their choices and judgements in personal 
history, values, “documented fears” (such as generalised low food quality), .... 
 The fourth is that the status to give to consumers in face of risk 
management should be clarified and reflected on ; indeed, consumers could play 
important roles regarding risk governance and should not simply be envisaged as 
passive receptors of information.  
 The fifth is that strategies of risk management that only rely on control 
show their limits in face of the new nature of risks, mainly complexity/systemic 
nature and uncertainty. Therefore, new strategies and new models of risk 
governance should be designed and experimented. 
Several actions could be envisaged in order to decrease possible negative 
health impacts. For example, the implementation of the HACCP-guide for food 
supplements that has been developed by the Belgian food supplement sector and 
has been approved by the Belgian authorities (guide G-011 approved on 9/08/2007). 
This guide is a guideline for producers on how to implement a quality control system 
covering all the steps: from growing conditions through transport to preparation and 
conservation, using the HACCP approach (for Hazard Analysis Critical Control 
Point). This is already mandatory in Belgium, following the “Autocontrol” Royal 
Decree of November 2003 (Moniteur Belge, 2003), which is an implementation of the 
European Food Law (Regulation (EC) n° 178/2002). In this HACCP plan, producers 
should reinforce their attention on chemical hazards, such as heavy metals 
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(included at the moment in the European Legislation, but not when the project 
started), as well as polycyclic hydrocarbons (not yet included in the European 
Legislation). Targeted chemical controls might be envisaged depending on the plant 
species.  
From the consumers' enquiry and the discussions in focus groups, we can 
make the following recommendations : the first is that the communication strategy 
should take into account the diversity in consumer profiles and consumption 
patterns. Therefore, a multifaceted communication strategy would be more suited 
than a too generalist and simplistic one. 
 The second is that an Internet platform (assembling competent 
authorities, representative of industry, scientists and consumer's 
organizations) on risks associated with FS (and products sold as FS) 
consumption would be a potentially very useful and powerful tool for consumers' 
information and empowerment, but also for risk governance, knowledge sharing with 
health professionals and mediators, and associated interdisciplinary research. 
 The third is that health professionals (practitioners, specialists of 
nutrition, dieteticians, pharmacists, etc.) should follow more training. Food 
supplements, alternative health products and nutrition (including problems of 
interactions between food and drugs) should be an essential part of their training. If 
those competences aren't mastered by practitioners (like patients complain about), 
then shouldn't the consultation of specialists of nutrition or FS be refunded by the 
healthcare system ?   
 The fourth is that producers should give even more (and better) 
information on products and processes, but also on theirs associated risks 
(including potential interactions with personal specificities, medicine and food). 
 The fifth is that FS management and associated regulation, procedures or 
product categories should be, if not reworked, at least clarified for consumers 
and allowing them to be more “responsible” actors in the risk management system.  
 
D. CONTRIBUTION OF THE PROJECT IN A CONTEXT OF SCIENTIFIC SUPPORT TO A 
SUSTAINABLE DEVELOPMENT POLICY  
 This project would like to draw the attention of the authorities and all 
stakeholders on the risks linked to the free consumption of certain categories of food 
supplements, especially derived from plants.  
 All the recommendations described above (to improve : - quality control 
systems in FS production plants, - the information to the consumers, - the training of 
health professionals, - the communication between stakeholders) would result in a 
better management of public health in Belgium. 
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1 INTRODUCTION 
This project deals with an important aspect of the evolution of our relationships 
with food. We have moved to an increasingly complex food chain and consumer 
habits have dramatically changed. It is thus necessary to focus on the study of how 
new consumption habits evolve and on aspects of information and communication to 
the authorities, agro-food companies, health professionals and consumers. 
Especially, food supplements  (e.g. nutrients, vitamins, hormone-like 
substances, amino acids, anti-oxidants,...) and functional foods (e.g. phytosterols or 
omega-3 fatty acids enriched food) need attention as they  are consumed by an 
increasing number of people. Food supplements do belong do to foodstuffs and are 
subjected to the European food law (EC, 2002), but the co-existence of botanical 
food supplements and herbal medicinal products, such as Ginkgo biloba or St John 
wort, which can belong to both categories, is confusing for the consumer.  
In many cases, there are still a number of unknowns such as the identification of 
specific active components and impurities, the effects of processing, the presence of 
toxic compounds, as well as their absorption and metabolism in the human body.  
Our project includes research in areas such as innovative analytical protocols 
and their validation, quick detection methods and predictive in vitro models pertaining 
to chemical safety (endocrine disruptors, toxins, plant protection products, dioxins, 
hormones, polycyclic aromatic hydrocarbons - PAHs, …). 
In the past, the attention of food toxicologists has been focused on the toxicity of 
single contaminating substances. The interactions between active and potentially 
toxic substances are poorly documented. Interactions can lead to additive or 
subtractive or even synergistic effects, which are being studied in FOODINTER. 
The objective of this project is to contribute to the risk assessment of chemicals, 
natural compounds and environmental contaminants, which could be present in food 
supplements and which could interact between each other or with micro or 
macronutrients of normal human diet.  
Interaction studies were performed using existing in vitro models (based on 
various cultured cell types, prokaryotes and eukaryotes) with mixture of active 
substances at concentrations not yet studied until now and very close to the real 
situation in human nutrition. Extrapolation from the in vitro observations to the real 
risks for human was attempted. Nevertheless, it must be noted that n vitro studies 
only give an idea of possible interactions and have to be confirmed by in vivo studies.  
From consumers surveys and discussion in focus groups, we also tried to 
analyze the place of food supplements in the diet and their impact on human health 
in order to increase the knowledge and fill some gaps regarding health claims and 
drawbacks that could be linked to these new habits in human nutrition. 
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Finally, the project also aimed at promoting better communication between 
scientists and stakeholders (authorities, producers and consumers). In the field of 
food consumption, this objective is important because food safety depends not only 
on production and control, but also on consumption practices and good information 
must therefore be promoted. It is not only an education plan, the objective is also to 
promote a dialog between science and society in order to better identify the societal 
preoccupations and needs that research has to satisfy.  
 
To reach the objectives, the following work packages were planned: 
WP1. Preliminary information collection 
WP2. Biochemical and chemical analyses of contaminants, active substances 
of food supplements  
WP3. Risk assessment and communication, recommendations. 
The results obtained from these 3 WP have been merged and are presented in the 
following section (“2. Methodology and results”) in 7 major points : 
2.1. Information collection and sociological investigation 
2.2. Collection of samples, labelling and notification status 
2.3. Analysis of environmental contaminants in selected food supplements 
2.4. Analysis of active ingredients in selected food supplements 
2.5. In vitro studies of pure active ingredients and food supplements extracts 
2.6. Review of the literature about in vitro and in vivo effect of food supplement 
active ingredients 
2.7. Risk assessment about selected food supplements categories 
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2 METHODOLOGY AND RESULTS 
2.1 Information collection and sociological investigation about 
food supplements 
The results that are presented here are a summary of the results we obtained 
through the six main “sociological” actions that we conducted in Foodinter (in both 
WP1 and WP3).  
 These tasks were :  
(1) a review of European and Belgian legislation ;  
(2) a review of social sciences literature dealing with risk (risk assessment, 
communication, management, …), consumer practices and representations 
about those products, marketing practices, etc. ;     
(3) exploratory focus groups on FS consumers general concerns about those 
products ;        
(4) surveys addressed to clients in FS retail places ;  
(5) interviews with producers ;                
(6) “risk focus groups” with consumers of FS. 
  
Let's slightly detail the methodology of the tasks ranging from (3) to (6) : 
 
(3)  The main objectives of exploratory focus groups were to examine social 
representations of FS, and opinions consumers wanted to express. We organized 
three focus groups, intended for both consumers and non-consumers, and carried 
out in three meetings of two hours each. The number of participants varied between 
6 and 12. Four outside participants also contributed as experts to these discussions 
through presentations. The groups were heterogeneous in terms of age, social 
situation but most of the participants were woman more or less interested in the 
question. Within both the interviewees and the focus groups participants, both 
working class strata and men were under represented categories, probably for 
cultural reasons that go beyond the scope of this research. This is an important point 
to consider, however, when discussing communication strategies from the results 
on.  
The first meeting was intended to give them basic scientific information and to 
identify points to be explored and discussed. The second meeting allowed the 
participants to acquire information on the legal and administrative aspects and to 
receive information from a producer. The last meeting consisted in an open and 
extensive discussion and was intended to formulate some proposals for policy-
making.  
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 (4)  Two identical surveys were then conducted by the teams of ULg (Socio 
Economy Environment and Development, Marc Mormont and co-workers) and 
CERVA-CODA (Luc Pussemier and co-workers). They consisted in 20 questions, 
both open and closed, addressed to clients in FS retail places.  
The first survey took place in Liège (167 respondents), addressed clients of 
drugstores, health food shops and organic food stores, herbalists, and 
supermarkets; the second was conducted in Ghent (276 respondents)1, and 
addressed only to clients of pharmacies.  
 The objectives of these questionnaires were to get a better understanding of : 
(a) knowledge and perceptions of food supplements, (b) consumption practices and 
frequency of FS consumption, (c) the budget allocated to their consumption, and (d) 
the perception of possible risks (See questionnaire in annex of the final report of 
phase I of the present project in Mormont et al., 2009).  The survey took place on 
food supplements retail outlets and was addressed more specifically to FS 
consumers ; it consequently induced a positive effect on the mean knowledge of 
respondents about those products, as well as the percentage of FS consumers 
among them.  
 
(5) Consultation of FS producers has been made through individual interviews with 
company officers. Four different producers' were interviewed (semi-directive 
interviews) to explore the way producers manage the risk aspects of food in this 
specific context.  
 The objectives of these interviews were to grasp : (a) the level of information 
companies have about contaminants and problems of possible interactions, as well 
as the importance of “interaction risks” or “systemic risks” in the firms' research 
activities ; (b) the importance of food safety in the company‟s strategies or research 
pools (traceability systems, contaminants and interaction-related risk management 
systems, opinions on product regulation, …) ; (c) the place of consumer‟s 
preoccupations and practices in this strategy.  
 
(6) Two sessions of three hours each were organized in Liège, each with the same 
group of participants (9 people). They were all FS consumers, and wanted to know 
more about FS or give their opinion. The proposed approach doesn't aim at 
representing exhaustively citizens' opinions, but rather at exploring what would be an 
informed citizen‟s or consumer‟s framing of the central questions behind the 
Foodinter project, that is in general risk issues regarding FS. The process was the 
following : 
                                                 
1 
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Sequence 1 : citizens are called to express their preoccupations about food 
safety and risks in FS production, marketing or consumption. 
Sequence 2 : citizens are provided with scientific information on the results of the 
FOODINTER research ; they are invited to formulate any questions or remarks. 
Sequence 3 : citizens are slightly provided with information, web links to food-
chain security or risk management agencies, and collective reflexions on what 
are risk communication actions stakeholders implement nowadays about FS 
(consumer associations, industry, health professionals, etc), what could be their 
practices and strategies or attitudes towards risk. 
Sequence 4 : (4a) Citizens are called to formulate remarks or concerns regarding 
risks associated with FS, discuss those remarks altogether, and then (4b) 
formulate remarks, proposals or recommendations on the communication of the 
results, as well as extensively on general risk communication, and/or risk 
management regarding FS. 
 
 This process induced a “progressive informed framing” that helped 
researchers to shape the scientific recommendations on risk communication. 
 
2.1.1 Legislation review 
 European regulations 
 
On European level, food supplements are regulated by the directive 
2002/46/EC. This directive is a first step towards harmonization of the different 
national legislations. 
Therefore this Directive helps gathering better conditions for free circulation of 
FS, equal competition conditions in Europe, and protection of consumers. Indeed, 
each country has its own regulation or notification scheme regarding food 
supplements, which can show differences (though they tend to decrease with 
2002/46/EC, as European directives have to be transposed in national legislation).   
This directive defined food supplements (FS) as “foodstuffs the purpose of which 
is to supplement the normal diet and which are concentrated sources of nutrients or 
other substances with a nutritional or physiological effect, alone or in combination, 
marketed in dose form, namely forms such as capsules, pastilles, tablets, pills and 
other similar forms, sachets of powder, ampoules of liquids, drop dispensing bottles, 
and other similar forms of liquids and powders designed to be taken in measured small 
unit quantities”. Examples of FS are ampoules of omega-3, tablets of vitamin A, multi-
vitamin and multi-mineral tablets or capsules or capsules of plant extracts such as 
valerian, garlic,… 
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It results from this definition that FS are foods and therefore are also the subject 
of the Regulation (EC) 178/2002 of the European Parliament and of the Council of 
28th January 2002, establishes the general principles and prescriptions of food 
legislation, instituting the European food security Authority and determining 
procedures for foodstuff safety. This regulation is the basis of food safety regulation 
at European and national levels, as is directly applicable.  In the definition of food in 
this regulation, medical products are excluded. Consequently the Directive 
2002/46/EC doesn't apply to medicinal products defined in Directive 2001/83/EC 
(EC, 2001), enforcing a communitarian code for medicinal products for human use 
nor to traditional herbal medicinal products as defined in Directive (EC) N° 
2004/24/EC of the European Parliament and of the Council of 31 March 2004 
amends Directive 2001/83/EC on the Community code relating to medicinal products 
for human use (EC, 2001). 
Regulation N° 852/2004 deals with food hygiene. 
General labelling provisions and definitions are contained in Directive 
2000/13/EC (EC, 2000). 
 European Regulation (EC) N° 1924/2006 concerns nutrition and health 
claims made on foods, that applies to FS as they are food according to the regulator. 
 The Confederation of the Food and Drink Industries of the EU (CIAA), 
European Responsible Nutrition Alliance (ERNA), European Federation of Health 
Products Manufacturers (EHPM) and European Botanical Forum (EBF) have jointly 
contributed to the « Food industry‟s contribution to the list of claims according to 
Article 13 of the regulation 1924/2006 » which aims at compiling a list of health 
relationships for nutrients or substances to be evaluated by EFSA in accordance with 
Article 13 of this Regulation, with corresponding scientific references. It can be 
considered as the first part of the claims that have been submitted for evaluation in 
the so-called “Article 13 list”. It covers several sections: vitamins, minerals, 
carbohydrates, protein, fats, fiber, probiotics, foods and beverages, diets, other 
substances and botanicals.  
 We could underline that this regulation has made emerge critics and blur on its 
application.  According to the CIAA (Confederation of the Food and Drink Industries), 
and despite the consequent work undertaken by the European Food Safety Agency 
(EFSA) on regulation 1924/2006 guidance (EFSA, 2010), « there is still much 
uncertainty as to what is required by way of the scientific substantiation of such 
claims. The consequence of this is that there is still insufficient clarity for industry 
applicants and a need, therefore, to re-examine the process for dealing with claims in 
this and other areas of new and emerging science » (CIAA, 2010). 
 The European Commission announced in a communication (27/09/2010) 
(Europa, 2010) the delaying of health claims regarding « botanicals » from the 
procedure of the progressive review by EFSA of the huge quantity of health claims 
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known as « Article 13 ». The reasons are insufficient time to evaluate all claims 
(more than 5000!), but also divergences in opinions and conflicts about the way 
plants are « treated » in the regulation, and in the « Traditional Herbal Medicine 
Products Directive » (THMPD) that have to be resolved first.  
 Regulations (EC) N° 396/2005 and 1881/2006 of the European Commission of 
19 December 2006, sets maximum levels of pesticides and of certain contaminants 
in foodstuff respectively. 
 Finally, let's quote Regulation (EC) N° 1925/2006 (EC, 2006) concerning the 
addition of vitamins, minerals and some other substances to foodstuff. 
 Obviously, all horizontal and vertical legislation applying to food or to specific 
substances also applies to food supplements when justified. 
 We can remark in this review cases of the European Court of Justice that 
show that the legislation surrounding “new health products” and especially « foood 
supplements », often qualified as “border” products, can be subject to divergent 
interpretations (see for instance cases C-140/07 and C-88/07). 
 
 Belgian regulations : In Belgium, there a  three Royal Decrees, and two 
Ministerial Orders, that apply to food supplements and that have been modified in 
order to transpose the European directive 2002/46/EC. 
In the three Royal Decrees, FS are defined as “pre-dosed foodstuffs 
containing one or several nutrients, plants or plant preparations, or any other 
substance having a physiological or nutritive effect and which goal is to supplement 
normal diet.”, whereas nutrients are “nutritive substances needed by the human 
organism”. Since the human organism is unable to produce these nutrients, adequate 
uptakes have to rely on foodstuff consumption. They are namely vitamins, minerals, 
amino acids, and fatty acids. Different dose forms in which dietary supplements can 
be available are also cited.  
These Royal Decrees mention the notification process through which a FS has 
to go in order to be marketed in Belgium. There are indeed three relatively similar 
notification processes for the three categories of products created through law 
(Nutrients (NUT), Plants (PL) and Other Substances (AS)) covered by each of the 
three Royal Decrees described here (the notification process will be detailed below).  
In these three Decrees, it is mentioned that “in the labeling, displaying and 
advertising for food supplements, it is banned : 1° to give the product preventive, 
curative or therapeutic properties or evoke similar properties ; and 2° to state or 
suggest that a balanced and diversified diet is not a sufficient source of Nutrients in 
general”.  
The first Royal Decree tackles the issue of Nutrients and their use into food 
supplements (AR 3/03/92). The first Ministerial Order (AM 21/05/2003) (Moniteur 
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Belge, 2003) relates to AR/3/03/92 and determines which are the chemical forms of 
vitamins and minerals that can be used in FS. 
 The second Royal Decree (AR 29/08/1997) concerns plants and plant 
preparations. In the appendix to this decree, there are three lists:  
(1) a list of dangerous plants whose use for direct consumption or as 
ingredient of preparation is strictly prohibited.  
(2) a list of eatable mushrooms. 
(3) a list of plants that may be used in food supplements which have to be 
notified.  For some of those plants, maximum amounts are laid down per daily 
portion, for which a list of recommended analysis methods has been drawn up  
 
 The third Royal Decree (AR 12/02/2009) (Moniteur Belge, 2009a) regards 
manufacturing and marketing of food supplements containing substances other than 
nutrients and plants or plant preparations.  
 The second Ministerial Order (AM 19/02/2009) (Moniteur Belge, 2009b) 
relates to AR 12/02/2009 and also regards manufacturing and marketing of food 
supplements containing substances other than Nutrients and plants or plant 
preparations. 
 The label of FS shall bear all mandatory indications, as for ordinary foods, as 
described in the royal decree of 13/09/1999 (Moniteur Belge, 1999) about pre-packed 
foodstuff labelling. Besides this, the label of food supplements shall bear a series of 
additional indications:  
(1) the name "food supplement"; 
(2) the recommended daily intake (RDI);  
(3) a warning not to exceed the recommended daily intake;  
(4) a statement that the products should be stored out of the reach of 
young children; 
(5) a statement that food supplements should not be used as a substitute 
for a varied diet; 
(6) the amounts of nutrients present in the product per recommended daily 
portion (this may also be given in graphical form);  
(7) the name of the plant(s) in the language of the region (when available), 
as well as the scientific name (for food supplements containing plants).  
 During the notification process, every notification file (of products falling in one 
of the three categories cited above (NUT ; PL ; AS)) is examined by the Belgian 
authorities (Federal Public Service “Health, Food Chain Safety and Environment”).  
 The notification file shall contain, among others, the following items :  
(1) the nature of the product; 
(2) the complete list of the ingredients of the product (qualitative and 
quantitative);  
Project SD/AF/04 - Food interactions : effects on health, consumer perception and impact on agro-food industries - 
“FOODINTER” 
SSD-Science for a Sustainable Development – Agro-Food 25 
(3) if applicable, the nutritional composition (or analysis) of the product ;  
(4) the labelling of the product;  
(5) data required to appreciate the nutritional value of the product;  
(6) the commitment of producers to realize frequent analysis of the 
product, at various moments, and to let the results at the availability of 
the Service;  
(7) the evidence of payment of a fee to the public authorities for every 
notified product. 
 Maximal and minimal limits in terms of % of the Dietary Reference Intake 
(DRI) are fixed for different nutrients used in FS. Guidelines are detailing the labelling 
and the advertising of these FS. The DRI for vitamins and minerals, foodstuff 
consumption data and forbidden product are cited in three annexes accompanying 
the Decree.  
In case of any breach of the foodstuffs legislation, the product will not receive 
a notification number (NUT), will not be allowed on the market. These products will 
be named in this report “non-notified product” to distinguish it from notified food 
supplements. Examples of a breach of the legislation are: excessive maximum 
amounts, too high doses or use of prohibited additives. All notified products are 
stated in a list updated regularly, published on Federal Public Service “Health, Food 
Chain Safety and Environment” website : 
(http://www.health.belgium.be/eportal/foodsafety/foodstuffs/foodsupplements/index.ht
m?fodnlang=fr) 
 The  Superior Health council (SHC) and the Commission for advice on plant 
preparations play an important role in the legislation process. The SHC expresses 
recommendation on specific matters (such as lately, recommendations on maximum 
concentration of lycopene and luteine in FS), and on  general Belgian health and 
food security.  
The commission for advice on plant preparations  is responsible  , among 
other, for updating the lists of forbidden and permitted plants, the determination 
which parts of plants can or cannot be used, the determination of maximal 
dosages,…. 
Both these scientific organizations can also be asked for advice for specific 
dossiers when the applicant asks for a derogation of the legislation (for example to 
exceed the maximum levels of nutrients or to use non-harmful plant preparations 
from plants that are mentioned on the first list in the annex of the decree on plants). 
 The report “Nutritional recommendations for Belgium 2009” (SHC-8309), mentions 
that  FS and FF can be used to compensate for deficiencies, or in particular physio-
pathological situations, what indeed corresponds to only a small part of FS 
consumers as we will see. 
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For another version of legislation review, the European Botanical Forum published a guiding 
document. This can be downloaded from EBF web site :   
http://www.botanicalforum.eu/uploads/ebf_factsheets.pdf  
 
2.1.2 Review of the social sciences literature on risk 
communication, risk management, and food supplements 
consumers' practices or representations about those 
products  
 We summarized this review into three main study fields : 
 A first study field investigates the consumption practices of FS consumers, as 
well as their representations and “needs” or demands. Example in this field are : the 
BfR (German Federal Institute for Risk Assessment) research project aiming at 
understanding which information do consumers need about FS, entitled “Target 
group-driven risk communication on food supplements” (BfR, 2008). 
We can also cite the work of Touvier & al. (2003), or of Gaigner and Hebel (2005), 
trying to know who are the consumers of FS and understand consumption practices. 
 In this field, we could also underline studies on the evolution of consumers' 
relation with, definition or perception of “risk”. Let's remark that we can find in studies 
a tendency to split, on one side “citizen's views”, that are often tainted with fear or 
irrationality, and on the other “experts' views”, that are presented as rational and 
even uncontroversial.  
 A second study field aims at understanding the evolving nature of risks along 
with “modernity” and the way risk communication, management (through policy, or 
governance) should adapt to this deep shift. This field can also examine food 
“quality”, standards, control and certification processes, as well as their evolution. 
 A first example is to be found through the interesting work of Beck G. and 
Kropp (2010), who analysed the problems and failures in conventional expert-based 
risk communication in face of uncertainty, precisely in the case of FS ; their study, 
appealing for new management frames and practices, is based on Ulrich Beck's 
theoretical frame of “risk society” or “risks of Second Modernity” (Beck, 1986 ; 1991).   
 Renn and Klinke (2004) presented new concepts for risk management and 
communication, in face of new, complex and “systemic” risks. 
 Let's also cite Brown (2009), who explores the evolution of the models of risk 
communication. First step is a well-spread “deficit model” in which consumers' “bad” 
practices or “misunderstandings” should be fixed through expert-based assessment 
and advice. The second step is a “new deficit model”, in which science, asked to 
remove all current uncertainties, gets “paralysed” by the need of analysing 
everything, what is hardly feasible in a context of complexity. The more you know, 
the more you realize that you need additional information. Pace of evolution is quick 
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(with new products or processes), and finally uncertainty is (and will probably always 
be) a fundamental compound of risk. “Although an enormous amount of research is 
needed, I believe that the argument for more research (…) provides an illusion that 
the deficit can be fixed (…) [and] fails to deal with the real issue, which is how to 
regulate in face of uncertainty” (Brown, 2009).  Brown tries then to describe an ideal, 
adaptive governance regime, where these failures can be addressed, mainly by 
being more transparent for consumers and allowing two-sided transmission, 
cooperation and reflexivity between the three pillars or risk governance (namely risk 
assessment, risk communication and risk management). This governance regime 
would have the four following characteristics: (1) informed for “governors” ; (2) 
transparent for consumers ; (3) prospective (as opposed to reactive), providing 
mechanisms to anticipate future, yet unknown harm ; and (4) adaptive and reflexive 
(as it can never be finished nor perfect, but has to be continuously built “on the 
move”, from its experiences). 
 In this field, we could also cite the work of Callon, Latour, Lascoumes and 
Barthe (2001) around the question of “how to act in uncertainty ?”. 
 Finally, the third study field we identified aims at understanding the evolution 
of the roles and missions of science in face of risk in this “context”, as well as the 
potential of development of new, interesting collaboration between disciplines or 
between “social categories” : between professionals, researchers and experts, policy, 
agencies, as well as citizens or organised consumers.  
 Let's here cite Weingart (2004) or Gago (2004), who details the evolution of 
scientific activity in face of the challenges of public trust and risk governance. 
  
2.1.3 Summary of the results obtained through the surveys and 
“risk focus groups” with food supplements consumers2 
 Unclear definition of “food supplements” and low understanding of the 
management system of food supplements    
Respondents to surveys do not exactly know what kind of preparations can be 
categorized as food supplements, showing for example a lot of hesitation for vitamins 
and plant extracts or oils.  
This is to be linked with the “blurry” and hardly shared status of FS – be it 
among consumers or between them and the law, networks of scientists or experts, 
professionals, … . This status is see-sawing between food and medicine, and makes 
the “category” of FS appear as a very heterogeneous one, even for some a “non-
category” or a marketing invention (as the products sold under this appellation 
                                                 
2 The detailed results of the survey (including the questionnaire) and focus groups can be found in a 
separate and comprehensive publication, is available on demand or will be published on the 
website of the project. 
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existed far before their large scale marketing, and often in different forms or 
processed differently).  
So do FS give the beneficial effects of both medicinal products and food 
without being any, stricto sensu ? Moreover, how could the product be more 
precisely defined than by a literal definition, such as “FS complete nutrition”, what 
indeed doesn't mean anything as we are supposed to feed “well”. In the same sense, 
to what products sends the expression “alternative health products”? We could 
observe that it's impossible to have clear, consensual answers to these questions. 
 This « blurry vision » seems to be exacerbated as a lot of actors, from the 
producers to the private, family-member or relative adviser perpetrate this blur and 
“convince” with arguments crossing the fields of prevention, treatment, performances 
or well-being.  
 The way that regulation and administration have chosen is to try to stabilize 
categories, and to examine each product in turn. Products are to be sorted in “FS” 
category (regulated as food) or medicinal products ; but this seems very complex3 
and unknown or misunderstood by the public ! Consumers didn't understand well the 
categories of law (“medicinal product”, “food supplement”, “herbal medicinal product”, 
“other”, ...) and what they trustfully assess, while the same seems true for quality 
controls. This unveils the important question of the trust of consumers in production 
and risk management actors, as well as in the risk management system and 
procedures themselves. We can see the risk of  a gap growing between consumers 
and all other actors of products or risk management if trust would come to diminish 
again. 
 It is hard to believe that consumers frame or define these “categories” of 
products similarly than regulation, when stating for instance that “food is the first 
medicine”. They then surely don't frame similarly the interconnections of these 
categories following their naming : if we eat always properly, will we need medicine 
or FS anymore ? This raises also consumers' concerns about their feeling of a 
globally degrading quality of food in “modern” societies, that they fail to address when 
compensating with FS...but which is at the same time a potentially big motivation for 
other consumers to take FS ! 
 Indeed, for consumers, FS (or assimilated products) consumption isn‟t rooted 
in a « cold and closed definition », and is neither a mechanical act, but a living, a 
personal experience, rooted in their history, habits, thoughts, representations and 
values, and mixing the field of food or nutrition with the one of medicine or medical 
treatment. Food and medicine are possessed by a symbolic dimension that shouldn't 
be underestimated when assessing social representations of FS. Food and medicine 
are two very different pools of images and representations that are both activated 
and mixed in complex, sometimes paradoxical ways when consumers are put in front 
                                                 
3 See for instance cases of the European Court of Justice C-140/07 and C-88/07. 
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of FS (and the “wave” of all other “health products”). This underlines the potential of 
those products to make consumers “loose their marks”, failing to put their 
consumption of FS in perspective.  
 
 A high heterogeneity in consumer “profiles” and consumption patterns 
 There is no “mean consumer” of FS, such as there is no “typical” FS but a 
wide range of products and applications. 
 This heterogeneity can be detailed though the following dimensions : we could 
first observe a high heterogeneity in  the motivations or in the objectives consumers 
pursue through FS consumption (see Figure 1). This was noticeable through the 
surveys,  and was verified through focus groups with consumers, though these 
profiles should be refined (and eventually new ones added) with a more detailed and 
representative survey. This first level of heterogeneity is according to us the most 
prominent to understand consumers‟ practices and to design a suited communication 
strategy. Thus, other levels of heterogeneity detailed afterwards should be linked to 
this first heterogeneity in consumer profiles or consumption patterns.  
 
Figure 1 : Consumers' motivations to consume FS.  
REM : In this graph and following, percentages are means of the two surveys, and overtake 100% 
since multiple answers were allowed. 
 
 This diversity (and diversity in the products used) can also be based upon 
gender : women seem to be relatively more interested in « well-being », alternative 
health and therapies, or diet ; male consumers seem from their side to be more 
interested in the boosting of performances (especially true for sport or fitness). But it 
depends of course of a lot of other factors, such as age or health situation (if one has 
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chronicle diseases, deficiencies, etc.), and upon other « subjective criteria » such as 
the degree of conviction in the products used and its effects, the mode of relation to a 
product regarded as « natural »,  the origin of the decision to consume FS (see 
Figure 2), the values, knowledge or tips transmitted from relatives (as well as 
practitioners, articles, ...),... 
 
Figure 2 : How are influenced consumers' decision to consume FS ? 
 
 
  We identified four main profiles or patterns , drawn as ideal-types : 
 “Performance” profile (sport, studying/working), where FS consumption is 
motivated by (or “makes possible”) the improvement of one's physical or mental 
capacities and performance. Performance seems rooted in a kind of functional 
“problem-solution” approach (the problem being to be not powerful enough, or to 
perceive that its physical or mental limits are too low compared to what is 
expected or “possible” thanks to new substances).   
 We could also widen the range of this “performance” category to include products 
used to improve anything, be it appearance, aesthetic, outline, hair or nails 
resistance, etc. 
 The link to “natural” or “health” seems to be the weakest in this profile, but would 
tends to reinforce when including aesthetic or outline purposes. 
 
 “Well-being” profile (or “smartening up”, “healthy life”, ... profiles), where FS 
consumption is motivated by the reaching of a balanced diet, long-lasting and 
“healthy” life. 
 A first problem here is to acknowledge on the impossibility  to define these 
qualificatives (“healthy”, balanced”, ...) (1) differently than by the negative (“the 
absence of troubles”) and (2) in an objective, measurable way (as troubles are 
always “perceived” and are to be assessed through medical assessment). The 
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problem here is then the absence of marks by which a state of “good health” 
could be judged by consumers, who bare the diffuse risk not to be able to escape 
from a too narrow, subjective and idealistic view about their state of health, or in 
other words, to engage an “endless quest”. 
In this profile, “natural” qualities (though unclearly defined or assessed) of the 
product are central for consumers and even makes FS prevail on conventional 
medicine, which seems often perceived as very criticized and untrusted 
“chemical crap”, that they want to avoid as much as possible. This relation to the 
“natural” in this profile is also central as unhealthy or “unnatural” diets and 
“modern lifestyles [are] threatening and should be challenged”. This appears 
rather paradoxical, as for other consumers, FS consumption isn't considered as a 
solution as it can inherently give breath to “unnecessary” health products 
consumption, containing the risk to ingest “(chemical) crap” as well, when the 
look for a balanced and healthier food would be required at the root.  But FS, we 
can say, hold more promises than “normal food”, may it be healthy, organic one : 
they are sold as acting quickly, being relatively cheap, not very harmful (thought 
sometime encouraged by relatives, articles, or the for the “reason” that FS are 
sold over-the-counter and can allow “self-treatment”), etc. … arguments that 
some consumers would want to be banned or dismantled by public health 
authorities as it stimulates FS consumption, and particularly unnecessary FS 
consumption.  
For important this challenge of “having a healthy life” can be nowadays (what we 
don't judge here), we can ask where would the limits be, talking about ideals 
such as “well-being” or “harmony” ? How could  they be defined ? How could this 
reasoning be empowered, be put in perspective in face of manipulation or 
propaganda risks from the industry,  letting this ideal or “purity” model be pushed 
too far in order to boost consumption ?  
 
 Deficiency profile ; consumers are here more “forced to” take FS, as they may 
have a chronic illness (for instance digestion troubles) or particular deficiencies 
(for instance a mineral deficiency or temporary blood circulation troubles). We 
could therefore draw two sub-categories in the deficiency profile, or more likely 
continuum based on the length or frequency of the treatment, and its character of 
necessity towards the trouble. 
The “curative”, “problem-solving” dimension  in this consumption profile is 
central, and could obviously hardly be addressed in the same manner the 
“performance” or “well-being” categories. “Problems” have to be objectified 
through medical assessment. What will also differ from those profiles is that this 
call for performance or “well-being” is virtually unlimited, and comes from a mix of 
psychological and social pressures, from society's increasing pace as well as 
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from one's personal wills, myths and “dreams” about his body (pushing the limits 
further, reach “physical harmony”, cope with tiredness, ...).  
We could add that it can be sometimes very difficult to judge if one's troubles are 
“real” or perceived/exaggerated. They could also be caused by multiple and 
sustained auto-treatments consumers can do on their own, as some could also 
be some kind of “hypochondriac” ; in a lot of cases, it's also hard to say if the 
perceived “treatment” doesn't give breath to problems, or at least to their ongoing 
perception. Anyway, our role couldn't be to judge consumers on this very 
sensitive issue, and this would be more dependent on the competence of doctors 
and nutrition specialists. But we could also make the hypothesis, comforted by 
consumer‟s sharing of experiences, that practitioners lack competences, 
professional conscience, or simply time to overcome this task (such as 
interdisciplinary, long-term, complex and deep studies or analysis about nutrition 
and practices, in relation with mind and thoughts, patient's relation to illness, … ).  
We could rise the question of competition between cheap, but poor advice 
everyone can find on internet, and costly (to very costly for specialists) but good 
advice one has to ask his practitioner (and engage those complex, expensive, 
long-term analysis). Moreover, it can be sometimes very difficult to find a “good” 
practitioner, one who “gives real, useful tips”, “is objective and doesn't look to 
manipulate you”, or simply “one who listens to you”, “one that takes the time to 
(…)”. 
Relation to the “natural” could also be important in the deficiency profile, but it's 
not very clear here (depends on consumer's trajectory). 
 
Prevention profile ; typical examples would be the autumn vitamins and 
minerals treatment, or omega-3 and -6 fatty acids consumption. We have to warn 
that it can be sometimes hard to distinguish between “performance” and 
“prevention” profiles, as they may both be rooted in the same “improvement” 
logic, that insists for instance on the strengthening of natural defences and of 
“tonus” as well to remain healthy.  
It's important to underline that this pattern is the more widespread among FS 
consumers, as shown through the surveys (about half of the respondents). They 
want to reinforce their immune system and fight against tiredness (what 
obviously corresponds to the widespread vitamins and mineral cures) and stress. 
This consumption is recommended by practitioners for a long time on, and is 
rooted in “traditional” or “familial” medical practices. 
 
 This heterogeneity is connected to networks of advice, and of advisers or 
“mediators”, that are people or information sources that influence FS consumption : 
they can be formal networks, such as for practitioners or specialists, but also more 
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informal such for web sites (often partial or uncontrolled), but also sport trainers or 
“natural therapists”, friends or relatives and their experiences (“uniniated” 
knowledge), …  
 Labels and description of products are also important sources of information, 
as most of the interviewed consumers read labels and are convinced of the beneficial 
effects of the products as producers describe them.  
 We can also point out various levels of information of consumers (or of 
“access to information”) ; some are real “information-hunter” (and deplore huge lacks 
in “good information), while others will never look for any. This is also to be linked 
with different degrees in perception of risk by consumers. 
 A large part of questioned people (around 50%) do consume food 
supplements from their own initiative (without any medical advice), while around 50% 
took the decision on medical advice and 30% following relatives' advices (multiple 
answers). Consumers don't share the same relation with their practitioner or 
specialists (or extensively with medicine) : some can be disappointed by conventional 
medicine and its range of questionable products, some won't, … It's another 
dimension that should be studied more in detail when designing the risk 
communication. 
 The frequency of consumption and the budget allocated to them is also 
variable ; a lot of consumers are regular customers (37% of interviewees consume 
FS on a daily or weekly basis ; 30% “regularly” (at least one month every year) ; 35% 
“incidentally”).  
 The monthly expense on FS is generally less than 40-50€ per month. 
 In order to better understand how FS consumption is qualified and defined by 
consumers, we propose to analyse those patterns of consumption with two models : 
the “medicine-intake model”, and the “food-consumption  model”. Those are 
completely different in terms of practices of consumers, collective norms and 
representations, motivations, knowledge-building and networks of advice or 
“prescription” chains, etc. 
 Going on building the models, we could then break down the various patterns 
of consumption of “alternative health products” (FS or assimilated), that fall in those 
two categories, “medicine” and “food”, along three dimensions :  
 (1) The relation with body : 
- For medicine-view, it cures a sickness or an ache (that has to be previously 
felt by the ill person, through physical or physiological manifestations) 
-  For food-view, it nourishes a body that feels hunger, and that also has 
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 (2) The prescription : 
 - Strong and imperative for medicine, assessed by practitioners 
 - Weak for food, let at personal appreciation 
 (3) The relation with knowledge : 
 -  Expert knowledge for medicine 
- Common or unitiated knowledge for food (i.e. situated in natural categories 
or references such as family and personal history, traditions, etc.) 
 
 The notification process, as well as the known biological activity of some plant 
based food supplements, seem to implicitly treat FS consumption and related risk 
management along the “medicine” model, with the consequence (among others) of 
fearing risky auto-medication of consumers, their potentially challenging attitude 
against scientific recommendations, or their lack of will to listen to scientific advice. In 
other words, the underlying model or reference is ordered on expert knowledge, that 
has to define and teach “good practice”, as opposed to a model based on 
preferences and taste, underlying food consumption. 
 On the other hand, we find the model (implicit as well) of food consumption, 
that we suppose is based on taste and “spontaneous appreciation” from consumers, 
of what fits them or what is a “healthy food”. 
 For consumers, the vision of FS along either “medicine” or “food” doesn't 
seem as clear nor socially shared, even if the reference to “health” or physiological 
effects is strong in discussions (indeed, reference to health is also strong in the “food 
model”). Indeed, we can see that FS consumers, depending on their “profile” or 
“pattern of consumption”, make original combinations of the three compounds 
detailed above. This is especially true for the profiles “well-being” and “performance”. 
  
Figure 3 : Interpretation of the four profiles through the model of food and medicine 
qualification. 
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 These “in between”, hybrid combinations consequently seem to escape the 
management schemes, both of food and of medicine. The example of the consumer 
that  is prescribed FS by his practitioner is at the opposite of the consumer who 
wants to improve his sport performances, after a sport-friend suggested him to do so. 
What is more complicated, is the example of a patient taking FS as medicine, that 
chooses to consume FS to cure a disease despite advice from his doctor, that may 
for instance follow advices of other patients that have the same symptoms. 
 
 We could consequently make two hypothesis :  
 one on the heterogeneity of mode of consumption, or “consumption 
patterns”, which justifies different policies adapted to them. 
 the second on the emergence of a new type of consumption, that can't be 
qualified in a precise way, mixing compounds of the two models drawn. 
This is of course to be linked to the blurred, unshared definition and 
categorization of “health products” in general (may they be qualified as 
“alternative” or not). This would also justify the elaboration of specific 
policies. 
 
 A consequence of this is that it seems less important for risk management to 
distinguish between product types (or definitions), misunderstood by consumers, 
than between modes and patterns of consumption. (This will be discussed in section 
3.2). 
 
 Low risk awareness from consumers, but who want to be better informed 
 It can be noticed that most of the FS consumers seem very cautious regarding 
food and health, probably more than non consumers on the average. There is a sort 
of ambiguity in these attitudes, or a sort of unveiling of the various compromises 
consumers do, since they are at the same time interested in « natural », healthy and 
well-balanced diet, seem aware of risk concerns and « money » or lobby pressures 
from industry, but are nevertheless users of these products since they can alleviate 
problems they experience.  
 Risks associated with FS consumption  are generally not spontaneously 
evoked by consumers, what lets us think that they are largely not aware that there 
simply are risks, but deplore what they perceive as weaknesses in the control. Some 
consumers seem to treat FS as “natural” products, that aren't seen very risky 
(between 30 and 50% of the respondents don't think there are risks associated with 
FS consumption, while the majority of other respondents think there are some (but 
don't necessarily know which risks, or how to act in face of them) ; see Figure 4).  
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Figure 4 : Risk perception  
 
 FS are generally described positively, for example as “healthy” products or 
products that allow smartening up or improvement of one's performances ; they are 
sold over-the-counter, without prescription (can even be ordered on the Internet), 
allowing “self management” and allowing to save seeing the doctor ; etc. The main 
risk mentioned by consumers is overuse (“excess is always bad”). This observation 
underlines that a communication on risks associated with FS should be “positive” 
rather than “negative” (only pointing out risks, disqualifying consumers attitudes and 
knowledge), in order to avoid a gap between communicators and “targets”, the last 
seeing FS with such a “positive aura”. 
 On the other hand, a large part of interviewees don't seem to be aware that 
simultaneous intake of drug or food could pose a health risk (around one out of four 
think that FS are always compatible with drug intake ; see Figure 5). We can though 
say that there  is a kind of underestimation of danger concerns among our sample, 
for “inner” risks (environmental contaminants, ...),  as well as for interaction risks.  
Figure 5 : Perception of interaction risks 
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 About FS, people can trust relatives or sports friends as much as general 
practitioners. The latter are criticized to generally show a lack of knowledge, will and 
time to consider seriously FS consumption (considering all the available products and 
moreover potential interactions). It was remarkable to notice that every of the 
consumers that attended the focus groups have had problems to talk of their FS 
consumption with their practitioner, and raised the difficulty to find a competent 
specialist that is at the same time open to those “alternative health products”.  
 During focus groups, consumers deplored the lack of knowledge on the long-
term side-effects of FS, revealing lacks in risk management and call for expert 
assessment. 
 Though there doesn't really appear to be a strong demand for more control or 
direct protection (excepted from more “active” consumers), the demand for trusted 
expert assessment and information on risk is quite strong and seems better accepted 
than formulation of “good practice” or bans. This demand for more information 
regards concentrations in active compounds, precise composition, quality tests 
passed (certification, …), notice of use, origin of raw materials and place of 
manufacture, … This demand for more information is supported by the results, which 
show that a majority of consumers read the available information (leaflets, when 
there is one)(see Figure 6). 
Figure 6 : reading of labels or leaflets provided with FS  
 
  Concerning the Foodinter research project, they felt rather dubious about the 
expected results of laboratory research and asked for a good communication of 
these results to the public. 
 From all these results we can conclude on a hypothetical way that, even if FS 
consumption is growing, consumers do not entirely trust commercial food nor 
medicine. FS are rather clearly distinguished from drugs and from food, even if 
consumers don't seem to know clearly how to treat them (as medicine, as 
« complements » or « supplements », as convenient « boosters », ...). As far as 
consumers of supplements are concerned, they are suspicious and they try, with a 
good reflexivity, to find solutions to chronic health problems that seem to be linked 
with their way of life. They consider supplements as improvements, keeping in mind 
Project SD/AF/04 - Food interactions : effects on health, consumer perception and impact on agro-food industries - 
“FOODINTER” 
SSD-Science for a Sustainable Development – Agro-Food 38 
a good idea of well balanced diet. Information and better control are the main 
preoccupations they formulate, with an emphasis on independence of control, of 
research and of public information.  
 
 Which status to give to consumers in face of risk ? 
 What should be discussed by the public authorities is the status of consumers 
in face of risks. Are they only “passive receptors”, to inform or “educate” through 
expert advice ? (like in Brown's deficit model (Brown, 2009)). This model and 
presuppositions, such as the idea of direct change from the “targets” (even if the 
message comes from a trusted and independent source), appears to be invalidated 
through our discussion groups : “even if there are risks, I don't know if I will stop 
directly, I can still choose...”  
 ...Or shall we take their practices, representations and reflexivity (opinion, 
recommendations, …) into account, in a risk governance regime that is more 
symmetric (as opposed to the unilateralism of Brown's “deficit” and the “new deficit” 
models) ? 
 Consumers don't just have perceptions and passive reactions ; they make 
reorganizations and arrangements. 
 Consequently, what about thinking on this “adaptive risk governance regime”, 
that Brown pointed out ? This should be built on the features of risks of “Second 
Modernity” rather than being overtaken by them ? 
 This of course doesn't exclude the need for expert assessment and 
recommendations, but the limits of this assessment should be made explicit and 
communicated, while the modalities of interactions between consumers and experts 
should be redefined in order to rebuild trust and avoid gaps between them. 
 Moreover, we think that such an “ideal” communication process (which, to 
caricature, supposes exhaustive and uncontroversial assessment, ideal and clear 
message, ideal comprehension and application from the “public”, leading directly to 
behaviour change) could hardly find grip on consumers as long as they are seen as 
“mean consumers”, or “consumers to educate”, “whose practices are wrong and to 
be changed”...  And thus risks to remain a pious hope. Moreover, this struggle is 
supposed to occur every time a new risk concern will appear, what is clearly 
unpractical and increases each time the risk of defiance ! 
 Consumers are not “mean”, nor “passive”, nor stupid ! They mostly have a 
reflexivity on their FS consumption, which can sometimes take them a lot of their 
daily time. They want to “master their consumption”, and can not blindly trust any one 
(who ever it can be, even the practitioner himself !)...excepted maybe their own body 
and feelings. They can have an active attitude, or a critical attitude against a 
communication that would target “mean” consumers in which they would not 
recognize themselves, or inversely would feel stereotyped. We can also formulate 
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the hypothesis that FS consumers have a “culture of health” superior to the average, 
as they can be more reflexive and critical, are active and accumulate knowledge, are 
getting used to listen to their bodies and draw conclusions from their consumptions, 
… If this happened to be proven, it would imply that a simplistic or paternalist 
communication strategy would be quickly dismissed by those consumers ! 
 All this call for taking consumers' specificity into account is globally positive for 
science, as consumers don't show a global mistrust in science (this is indeed the 
opposite, as scientists were given a lot of credit during our focus groups), but the 
main question behind this trust is to know in whose name they speak ! This raises the 
important need for more independent, quality assessment and advice. 
 
 Which type of risk management could fit the complexity of FS risks issues ? 
 Presently, risks associated with FS are managed by a system of “auto-
control”, inherited from quality and standards systems of “past” era. We qualify this 
era as “past” in reference to Ulrich Beck (Beck, 1986 ; 1991) since the nature of risks 
feared by consumers (in particular, long-term effects and interaction risks) and 
studied in the Foodinter research largely overtake the usual framing of risks applied 
from decades on, which focused on precise, bounded and “simple” risks. These risks 
were “simple” since it was easy to identify their causes and their effects or 
consequences, objectified through scientific assessment, and allowing to assign 
responsibilities to actors without doubt.  
 In contrast, the “new era” we entered into is characterised by uncertainty. It 
bares a renewed nature and way of qualification of the risks having to be managed, 
such as the interaction risks studied in Foodinter (but the same is true for long-term 
effects of FS consumption, not studied here) : risks are complex or multi-factorial, 
“systemic” and retroactive as for interactions, fast-evolving and depending on a huge 
range of products or substances, …. It has become nearly impossible to clearly 
determine and isolate causes or factors of risks, while the same is true for 
consequences which depend on a potential infinity of particular cases (here, of 
consumers, practices, nutritional regimes, ...). In this context, it appears clearly that 
the regime of responsibility can't be that simple than in the “past”. Responsibilities 
are shared, impossible to isolate. 
 These considerations are also perceptible from the discussion groups 
conducted with consumers, which showed they were far from being all dupe of the 
inherent limits of the actual risk management model.They can even become more 
aware of these limits when scientists, public actors or enterprises try to present only 
certitudes to them... and make silence on everything that remains unclear or 
uncertain. 
 Moreover, we can add to these the following facts : first is that FS are sold 
over-the-counter, and that this status seems hardly modifiable ; and secondly, that 
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there is absolutely no control of the Internet (advice and sale), and it is clearly 
impractical to prevent consumers from buying FS on this platform that offers them 
numerous advantages. 
 What consequently seems to become unavoidable is that we have to 
reconsider the ideal model of “total control” of risks, which clearly shows its limits in 
the era of “Second Modernity” (Beck, 1986 ; 1991) and in face of corresponding 
characteristics of risks. We can't however say that we have to definitely turn away 
from it (it's not our responsibility, and would mean that everything can be thrown 
away in it, which is not the case ; control would still be an important dimension of an 
innovative, adaptive and multi-dimensional risk management system). 
 The question of trust from consumers is a central point to consider when we 
make the assumption for the need of an adaptive, symmetrical risk governance 
regime, as it seems that critics directed to the actual risk management system can 
only go growing with future occurrences of unanticipated risks. To rebuild this trust, 
we propose a risk management approach that makes its limits explicit, that implies 
citizens and consumers through dialogue, and that is fundamentally more anticipative 
and adaptive (especially of what's yet uncertain and even unknown !).  
 The place of each category of actor concerned by risks associated with FS 
(consumers, but also health professionals, producers, and scientists as well) could 
be redefined in face of the new nature of risks having to be managed. 
 The communication associated with this system shouldn't aim one “mean” 
target, but specific profiles, and should also be done at various levels to reach the 
expectancies of very different consumers, it should be multiple. It should be 
complete, deep and simple at the same time, should allow consumer empowerment, 
by allowing them to put risk in perspective and to increase their reflexivity (on risks as 
well as on risk management system), but also give them simple, conventional 
practical tips or examples. 
 
2.2 Collection of samples, labelling and notification status  
 
 The selection, for further studies, of products sold on the Belgian market as 
« food supplements » was carried out by taking into consideration the following criteria: 
1) Active ingredients potentially susceptible to interact with some key enzymatic 
systems such as those involved in phase 1 en 2 metabolism. According to this criterion, 
it was obvious that several plant-based products will rank high due to the nature of their 
biologically active ingredients.    
2) Frequently used products (i.e. distributed by many producers and traders, 
mentioned by consumers during the surveys or mentioned in many commercial 
advertisements) 
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3) Products more prone to be contaminated by several kinds of contaminants 
(plant toxins, mycotoxins, heavy metals, PAH, dioxins and PCB, pesticides). Following 
this criterion, plant based products obtained by extensive cultivation methods will rank 
high (exposure to environmental pollution, non professional drying and extraction 
processes, etc). 
4) Exotic products susceptible to contain active ingredients that are less studied 
up to now (emerging risk potential) 
 Despite the fact that vitamin and mineral based FS are the most frequently used 
according to the information gathered, they were discarded from the selection because, 
in the framework of this project, the potential interactive effects with key enzyme 
systems were considered as a top priority for selection. The final selection was made of 
six different products all made from one specific plant material and complying with 
criterion 1. In addition, four of them were in accordance with criterion 2.  
The final selection was made of six different categories of specific plant material: 
- Garlic (G): Decreases arterial tension; very common botanical product, interactions 
with drugs 
- Ginkgo biloba (B): Improves blood circulation and cerebral oxygenation; very 
common botanical product, interactions with drugs 
- Saint-John’s Wort (W): Against mild depressions; very common botanical product, 
interactions with drugs 
- Soy isoflavones (I): Reduces menopause effects; frequently used; hormonal 
activity  
- Maca (M): Said to increase libido and limits sexual disorders; plant toxins 
(alkaloids); less studied  
-  Black radish (R): Stimulation of bile secretion and of intestinal activity; plant toxins 
(glucosinolates); less studied 
During the first trimester 2007, 61 samples were purchased via internet (36 
samples), pharmacies (18 samples) and specialized shops (7 samples). Eighteen 
were notified in Belgium while 43 were not. Forty-two were obtained as capsules 
containing solid plant material or extract, 13 were tablets and 6 were available as oily 
capsules. 
The complete list of the 61 samples is presented in the final report of phase I 
of this project (Mormont et al, 2009). 
We know that this selection of products is not statistically representative of the 
Belgian market of food supplements, but it allowed us to take a picture of what the 
Belgian consumer was able to find on the market in 2007.  It is important to note that 
the conclusions drawned from the study of these 61 samples can therefore not be 
extrapolated as such to the whole field of botanical food supplements, at the present 
time (2011). 
 
Project SD/AF/04 - Food interactions : effects on health, consumer perception and impact on agro-food industries - 
“FOODINTER” 
SSD-Science for a Sustainable Development – Agro-Food 42 
Notifications status 
Taking into consideration the available information on the notification, the 
products under study have been classified into 3 groups, in agreement with Pascale 
Degrijse, from the Federal Public Service Health, Food chain safety and 
Environment, Animal, Plant and food directorate-general, DG: 
1. The actual food supplements (FS), which are notified products that comply 
legislation, 
2. The not notified products (NNP), for which no notification file has been accepted 
by the Belgian authorities, and thus cannot be named food supplements,  
3. The medicinal products (MP), which are notified products that cannot stricto 
sensu be named food supplements because of one or a combination of the 
following reasons:  
 medicinal claims: the product is presented as having curative or preventive 
properties for human diseases,  
  the product exceeds the maximum permitted contents of active ingredients, 
 
The MP, as well as the NNP, are not legal on the market, unless they were registered 
as drug. None of the products bought in the framework of FOODINTER was 
registered as drug. 
Two preliminary results of our shopping are interesting: 
 Out of 25 products bought in pharmacies and specialized shops, 11 were not 
authorized to be on the Belgian market at that moment (3 NNP, 8 MP). This 
means that some products pass the barriers and reach the market‟s stands. 
The argument of the long period required to have the notification is sometimes 
evoked. The FASFC performed the same kind of sampling at the end of 2007; 
they found approximately 30% of not notified products, consistent with our 
observation.  
 On the other hand, only 4 of the products bought through the internet were 
notified (out of 36), and thus may not be sold in Belgium.  
 
Labelling 
From the 61 chosen products, the presence/absence of several indications on 
the label was analyzed: 
 Is the denomination “food supplement” indicated? 
 Are the name and scientific name of the plant provided? 
 Is the advised consumption (frequency) indicated? 
 Is the net weight provided? 
 Are the active ingredients concentrations indicated? 
 Is the list of ingredients present? 
 Are nutrition facts mentioned ? ** 
 Is there any expiration date? 
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 Are there recommendations for a good conservation? 
 Is there information about keeping out of reach of children? 
 Is the NUT/ Lot number/ charge number present? 
 Is the name and address of the furnisher/seller present? 
 Is it mentioned that the food supplement cannot replace a normal diet? 
 Is there a phone number / e-mail / website provided for more information ? ** 
 Does the packaging provide information about the necessity to not exceed the 
advised dose, to consult a doctor *, to be aware of the drug interactions*, or to 
warn the persons who are more subject to health issues *? 
* Not requested but seems important for us in the specific frame of this project 
** Not requested, but might be interesting information    
 
Some questions arose from the large variability of the information on the 
package: Is a postal box a sufficient address? Is the notation “complement” similar to 
“food supplement”? Is “60*500mg” sufficient as a net weight? 
The situation about the labelling of products sold as food supplements on the 
Belgian market can be considered as reassuring information for the notified food 
supplements. Nevertheless, two of those FS have insufficient labelling, lacking 3 
mandatory information. It has to be stressed that indications on active ingredients 
concentration is difficult to judge since the active ingredients are sometimes even not 
known. As an example, none of the Maca plant extracts provides any concentration 
of potentially active ingredients. 
For some FS, NNP and MP, the advice to consult or to speak to the doctor is 
not mentioned on the label. We stress in this project that this is a matter of concern, 
since interactions with drugs are widely known by the professionals of the medical 
sector. Those interactions will be approached in the following chapters. Nevertheless 
in the Belgian legislation (RD 27/08/1997), safety warnings are mandatory for certain 
foods and food supplements containing plant preparations. 
 the labeling of food supplements containing the leaf of Ginkgo biloba L. must 
include the following warning: “Consult your doctor if you take anticoagulant 
medication.” 
 the labeling of food supplements containing the flowering aerial parts of 
Hypericum perforatum L. must include the following warning: “Inform your 
doctor and/or pharmacist if you are taking medicine simultaneously.”. 
This Belgian legislation also limits the presence of certain plant constituents in FS. 
For example : 
 Food supplements to which the seed or the seedling of Glycine max. (L.) 
Merrill have been added, may only be marketed under the following condition: 
the intake of the daily dose as recommended in the labelling or in advertising 
may not result in an intake quantity of isoflavones exceeding 40 mg 
(expressed as glycoside of the main component). 
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 Food supplements to which the leaf of Ginkgo biloba L. has been added may 
only be marketed under the following condition: the intake of the daily dose as 
recommended in the labelling or in advertising may not result in an intake 
quantity of flavonol glycosides exceeding 21.6 mg and an intake quantity of 
terpene lactones exceeding 5.4 mg. 
 Food supplements to which flowering aerial parts of Hypericum perforatum L. 
have been added may only be marketed under the following condition: the 
intake of the daily dose as recommended in the labelling or in advertising may 
not result in an intake quantity of hypericine exceeding 700 µg. 
 Maca can be in food supplements if analysis reports prove that the plants in 
question are free of alkaloids 
 
2.3 Analysis of environmental contaminants in selected food 
supplements 
2.3.1 Trace elements 
Metals and minerals are integral parts of the food chain, and, even if they have 
different origins (natural, artificial), they reach the lasts steps of such chains, thus 
becoming in several cases very dangerous with irreversible effects for animal and 
human life (Locatelli, 2008). The toxicity depends on the doses ingested by the 
human being.  For heavy metals, chronic diseases occur when the consumer is 
exposed during a long period. Those metals are mainly found in our food, in plants, 
meat, fish and water. The risks have decreased thanks to the environmental actions 
taken by the authorities during the last decades (unleaded gas, collection of worn 
batteries, unleaded paints,…).  
Nevertheless, even if our food can be considered as safe, any other intake 
should be avoided as far as possible. 
2.3.1.1 Analysis of trace elements 
Seventeen trace elements (As, Ba, Bi, Cd, Co, Cr, Cu, Mn, Mo, Ni, Pb, Sb, Se, 
Sr, Ti, Tl, Zn) were quantified by inductively coupled plasma with mass spectrometer 
(ICP-MS). Mercury (Hg) was quantified by Advanced Mercury Analyzer (AMA). The 
detailed methodology and results are available in the final report of phase I of 
FOODINTER (Mormont et al., 2009). 
The results reveal that there were 10 non compliant (NC) samples with 
respect to the Belgian legislation for toxic elements in FS, in force in 2007 (7 NC 
samples for Pb and 4 NC for Cd; one sample exceeded the maximal limit for both 
elements). See the results in TABLE I. 
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TABLE I: Heavy metal concentration (µg/kg) in non compliant samples, according to the 
Belgian maximal limit in force in 2007. FS : Food supplements (notified products), MP: 
medicinal products, NNP: not notified products. - : not detected. 
 
It has to be stressed that one particular case of non-compliancy was very 
dramatic (74 fold the Pb maximal limit for one St John‟s wort based NNP) and that 
the Belgian Food Agency has been informed about the NC samples according to 
Belgian regulations. 
In July 2008, maximal limits for heavy metals in food supplements have been 
included in the European Regulation (Regulation (EC) n° 1881/2006), and are the 
following : 
Hg : 100 g/kg 
Pb : 3 000 g/kg 
Cd : 1 000 g/kg (except FS derived from seaweed and from dried bivalve molluscs : 
3 000 g/kg) 
According to this new legislation, only 4 products would remain non compliant 
out of 10. 
2.3.1.2 Cadmium in FS: health outcomes 
- Because of its high rate of soil to plant transfer, cadmium is a contaminant 
found in most human foodstuff, which makes diet the primary source of exposure 
among non smoking, nonoccupationally exposed populations (Clemens, 2006). In the 
human body, cadmium has no known physiological function, and no mechanism is 
expected to have evolved for its selective transport and homeostasis. Most of the 
cadmium is absorbed through intestinal transit. Following the literature, from 3 to 7% 
of the cadmium present in foodstuff is absorbed (Satarug et al.,2010). The food 
groups that contributed to the major part of the dietary cadmium exposure, primarily 
because of the high consumption, were cereals and cereal products, vegetables, 
nuts and pulses, starchy roots or potatoes, and meat and meat products (EFSA, 
2009). In Belgium, Vromman and co-workers showed that Cereal products and 
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potatoes are the main food groups that contribute to Cd exposure in Belgium, while 
offal (which are not regularly consumed) only contributed to 0.57 % of the exposure 
and crustaceans and bivalves to 4.01 % (Vromman et al., 2010). 
The other way to absorb cadmium is the inhalation of industrial smokes, 
cigarette smoke, and urban air. Cadmium exposure is well studied and documented, 
considering both high and normal exposure levels. In their review, Satarug and co-
workers cited different consequences of exposure to cadmium such as osteoporosis, 
renal injuries, diabetes, hypertension, cancer, etc. (Satarug et al., 2010) (FASFC, 
2009a). 
The European Food Safety Authorities (EFSA) defined in 2009 a new safe 
provisional tolerable weekly intake (PTWI) of 2,5 µg cadmium/week/kg body weight. 
This health based guidance value has been discussed several times in the past, 
arguing that the past safe intake level does not provide sufficient health protection 
and that it should be lowered.  
The results observed for the products analyzed in this study were converted to 
µg cadmium per week per kg body weight, considering a body weight of 70kg (see 
TABLE II). The maximum intake following the recommendations provided on the 
label is far from being negligible (up to 14% of the maximal intake).  
 
TABLE II: Cadmium intake from the ingestion of non compliant samples for Cadmium. FS: 
Food supplements (notified products), NNP: not notified products, Cd=Cadmium, 
PTWI=provisional tolerable weekly intake. 
 
 
Even if the cadmium levels measured in the products of this study are too low 
to cause injuries, they should be added to the amount taken up with the normal diet, 
which has been calculated to be 1,27 µg/kg bw/week (FASFC, 2009a). Moreover, 
because of the high variability in the conditions of plant cultivation and the lack of 
systematic control at the production site, high doses of cadmium could occur.  
2.3.1.3 Lead in FS: health outcomes 
Lead contamination of the human body results from various sources such as 
lead dust, lead-containing objects such as paints and lead pipes, through the 
gastrointestinal tract from contaminated water or vegetal food contaminated after 
atmospheric deposition (some plants are capable of taking up lead from soil through 
their root systems, but this uptake does not appear to be appreciable (EFSA, 2010), 
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and from several industrial processes such as glazing or manufacture of lead 
accumulators (Rosin, 2009). 
In the body, 95–99% of ingested lead is sequestered in erythrocytes and 
dispersed through soft tissues and bone and is also found in hair and nails. The 
metabolism of lead stored in bone parallels that of calcium and the resorption of 
calcium during osteoporosis is accompanied by passage of lead from bone into 
blood. In blood, its half-life is up to 30 days and it is excreted in the urine; its storage 
in bone can remain for more than 20 years (Rosin, 2009). 
Based on consumption data from the Belgian food survey from 2004 and 
results from the Pb analyses control in the framework of the control program from the 
FASFC for 2006, 2007 and 2008, the median and the 95th percentile dietary 
exposure to lead in the Belgian adult population was estimated at 0,9 µg/kg bw/week 
and 2,5 µg/kg bw/week, respectively. The median and the 95th percentile dietary 
exposure of children was estimated at 2,9 µg/kg bw/week and 7,5 µg/kg bw/week. 
The Pb dietary exposure for consumers that follow the food recommendations for the 
consumption of vegetables and fish was estimated at 0,98 μg/kg bw/week and 1,02 
μg/kg bw/week, respectively (FAFSC, 2009b). 
Considering the multiple diseases correlated with lead ingestion, the World 
Health Organization (WHO) defined a safe provisional tolerable weekly intake (PTWI) 
of 25 μg lead/week/kg body weight (WHO, 2000). More recently, the EFSA (EFSA, 
2010), as well as the JECFA (2011) considered the PTWI as no longer appropriate, 
because, based on the dose–response analyses, the JECFA estimated that the 
previously established PTWI of 25 µg/kg bw was associated with a decrease of at 
least 3 IQ points in children and an increase in systolic blood pressure of 
approximately 3 mmHg (0.4 kPa) in adults. The approach is to use the Benchmark 
Dose Lower Confidence Limit (BMDL) calculated on the basis of the modelization of 
a dose/response curve in animal experiments, or from human epidemiology studies 
(which was the case in the EFSA and JECFA avices on heavy metals), as suggested 
by the International Programme on Chemical Safety (ICPS, 2009a,b). The BMDL 
varies according to the endpoint that has been considered in toxicological studies. To 
evaluate the risk, a margin of exposure (MOE) is calculated, which is the ratio 
between the BMDL and the intake. The EFSA concluded that the risk of clinically 
important effects on either the cardiovascular system or kidneys of adult consumers 
is low to negligible at current levels of lead exposure. In infants, children and 
pregnant women, there is potential concern at current levels of exposure to lead for 
effects on neurodevelopment. Protection of children and women of child-bearing age 
against the potential risk of neurodevelopmental effects should be protective for all 
other adverse effects of lead, in all populations (EFSA, 2010).  
The seven non compliant products according to the Belgian regulation in force 
in 2007 are presented in Table III . Except for one garlic sample, lead was detected 
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only in samples prepared from the leaves, fruits or barks of the plants cultivated 
outside (St John‟s wort and Ginkgo biloba), consistent with the fact that lead in plants 
is due mainly to atmospheric deposition or absorption by their external parts 
(Albertine, Oetterer, & Prado Filho, 1997). 
The weekly intake has been calculated following the recommended 
consumption on the labelling (the worst case has been chosen). 
Let‟s note that the Belgian adult median dietary exposure to lead via 
normal food has been estimated to 0.9 µg/kg bw/week (Vromman et al, 
2010). 
 
TABLE III: Lead intake from the ingestion of non compliant (NC) samples for Lead 
(according to the Belgian legislation in force in 2007). FS: Food supplements (notified 
products), MP: medicinal products, NNP: not notified products, Pb=Lead, PTWI=provisional 
tolerable weekly intake; BMDL=Benchmark dose lower confidence limit (4,4 µg/week*kg bw); 




The St John‟s wort DIETI NATURA exceeds 2,5 folds the BMDL, giving a margin 
of exposure (MOE) of 0,4, which is too low, according the safe MOE proposed by 
EFSA, of a minimum of 1 (EFSA, 2010), and contributing to nearly half of the PTWI. 
The other products seem to contribute less severely to the weekly intake.  
Considering the contribution of other lead sources (air, water and food), which 
for an adult is estimated from 0,9 µg/kg bw/week to 2,5 µg/kg bw/week (thus from 4 
to 10 % of the PTWI), all the products mentioned in Table III do cause a significant 
contribution to the lead exposure.  
The intake considered here is far from the historically excessive exposures to 
lead among the upper class of the Roman society, or in the 19th century with the 
extensive use of lead in many industrial processes in Britain, nevertheless the long 
term consequences of exposure to lead are still major: degenerative brain disease, 
degenerative vascular disease, hypertension and vascular disease (Rosin, 2009).  
Considering those results, the lead and cadmium content in products 
presented as food supplements for the consumer could be a matter of concern. 
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These results show that it is important to not forget the food supplements 
consumption in lead and cadmium risk assessments studies. 
2.3.2 Mycotoxins 
A mycotoxin is a toxic secondary metabolite produced by molds. The reason 
for the production of mycotoxins is not completely understood. Because mycotoxins 
weaken the receiving host, the mold may use them as a strategy to better prepare 
the environment for further fungal proliferation. The production of toxins depends on 
the surrounding intrinsic and extrinsic environments. The presence of mycotoxins in 
food (mostly cereals and plant based products) is due to multicausal factors including 
environmental conditions (climate and insects as fungal spore vectors for example), 
improper agricultural practices, wrong post-harvest handling, no specific HACCP 
(Hazard Analysis of Critical Control Points) and scarce implementation of 
decontamination procedures (Brera et al. 2008). Temperature treatments, such as 
cooking and freezing, do not destroy mycotoxins (Cahagnier, 1998). 
Around a thousand mycotoxins have been described, but only some families 
are of concern for humans and animals (e.g. aflatoxins, fumonisins, trichothecenes, 
ochratoxins). They may have various effects as for example carcinogenic, provoking 
acute hepatitis, poisoning and renal pathologies (Cahagnier, 1998).  
 
Mycotoxins: possible health concerns 
The occurrence of mycotoxins in the products under study was investigated 
using gradient reversed-phase liquid chromatography (RP-LC) with electrospray 
ionization tandem mass spectrometry (ESI-MS/MS). Detection of the mycotoxins was 
carried out in the multiple reaction monitoring (MRM) mode. Mycotoxins were 
extracted using acidified ethyl acetate as extraction solvent. Sample clean-up 
involved an n-hexane defatting step followed by a solid phase extraction (SPE) step 
on an Oasis SPE cartridge. The different samples were screened for the presence of 
23 mycotoxins (See below). For positive samples, the mycotoxins were quantified by 
the standard addition approach. A detailed description of the analytical method can 
be found in Diana Di Mavungu et al. (2009).  
The target mycotoxins included nivalenol (NIV), deoxynivalenol (DON), 
neosolaniol (NEO), fusarenon-X (F-X), 3-acetyldeoxynivalenol (3-ADON), 15-
acetyldeoxynivalenol (15-ADON), diacetoxyscirpenol (DAS), HT-2 toxin (HT-2), T-2 
toxin (T-2), aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 (AFG1), aflatoxin 
G2 (AFG2), ochratoxin A (OTA), altenuen (ALT), alternariol (AOH), alternariol 
methylether (AME), fumonisin B1 (FB1), fumonisin B2 (FB2),  fumonisin B3 (FB3), 
zearalenon (ZEA), beauvericin (BEAU), sterigmatocystin (STERIG).   
In 54 out of 61 products analyzed, none of the 23 mycotoxins was detected. 
The toxins FB1, FB2, FB3 and OTA were detected in some samples (Table IV). 
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Nevertheless, the levels of FB1, FB2 and FB3 were largely below 800 µg/kg (EC 
maximal limit for the sum of FB1 and FB2 in breakfast cereals, Regulation (EC) n° 
1881/2006) in all samples. In 2 samples, OTA was found at a level above 2 µg/kg 
(EC maximal limit for wine and grape juice, Regulation (EC) n°1881/2006). 
 
TABLE IV: Mycotoxin contamination (g/kg) in samples. FS: Food supplements 
(notified products), MP: medicinal products, NNP: not notified products 
 
The fact that the maximal limit set by the European authorities is not exceeded 
in the foodstuffs may not be considered as a sufficient guarantee for food safety, 
because there are still a lot of uncertainties linked to the toxicological assessment of 
the contaminants. Among these, it is frequently argued that the possible additive and, 
worse, synergistic effects of different contaminants are not taken into consideration. 
This is the case here as at plausible intestinal concentrations, some polyphenols and 
dietary contaminants, such as captan (pesticide) or cadmium (heavy metal), 
markedly increase the mycotoxin ochratoxin A absorption (Larondelle et al., 2006). 
Nevertheless, interactions with the bolus in the digestive system (stomach, intestine) 
would probably change the mycotoxin concentration in contact with the intestinal 
cells. 
Recently, the EFSA evaluated the daily intake of OTA from food, in Europe. 
This mean intake was evaluated to 2-3 ng/kg b.w./day for adults (15 years old and 
more) and 6-8 ng/kg b.w./day for high consumers (EFSA, 2006). In the same study, 
the EFSA proposed a maximal tolerable intake set to 120 ng/kg b.w./week. At 
present the weekly exposure ranges from 15 to 60 ng OTA per kg bodyweight per 
week, including high consumers of foods containing OTA, which is below the TWI 
value of 120 ng/kg b.w. Nevertheless, more data would be needed to assess 
exposure rates of infants and children. 
In opposition with what is observed for the heavy metals cadmium and lead, 
the products presented as food supplements for the consumer considered in this 
study do not significantly contribute to human exposure to individual mycotoxins.  
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2.3.3 Polycyclic Aromatic Hydrocarbons (PAHs) 
2.3.3.1 Definition and health outcomes of PAHs 
Polycyclic aromatic hydrocarbons (PAHs) are a large group of more than 200 
different chemicals containing two or more fused aromatic rings made up of carbon 
and hydrogen atoms. PAHs are formed during the incomplete burning of organic 
substances and pyrolysis processes (Mc Grath et al., 2001) such as: forest fires, 
processing of coal and crude oil, vehicle traffic, residential heating, industrial power 
generating, cooking, smoking (Tamakawa, 2008). They are widely present in the 
environment due to their lipophilic properties allowing their adsorption on 
atmospheric particles and their deposition in sediments, soils and plants.  The 
primary routes for human exposure to PAHs are inhalation of polluted air, foods 
normally containing microgram quantities of PAHs (smoked foods for example), and 
foods whose contamination is due to the environment and/or production practices, 
such as a drying step before grinding of a plant. Among several routes, diet is 
estimated to be the major pathway for human exposure (Tamakawa, 2008). 
In the European Union, 16 PAHs have been selected as priority substances 
for food monitoring. These PAHs were selected on the basis of their classification as 
having „probable‟ or „possible‟ carcinogenicity to humans (European Commission, 
2005).  
Products presented as food supplements for the consumer may contain large 
contaminations with PAHs. The risk associated with PAHs in those kinds of products 
was recognized by the Scientific Committee on Food (SCF, 2002) but further 
investigation is needed to fix maximum tolerable levels. The critical effect of PAHs is 
their carcinogenicity. Because some of them are genotoxic, it is impossible to 
determine threshold concentration. There is currently no legislation in place 
controlling the maximum levels of B[a]P or other PAHs in food supplements. In the 
meantime, maximum tolerable levels are defined for benzo[a]pyrene (B[a]P) and 
benzo[a]anthracene (B[a]A) in smoke condensates (Regulations (EC) N° 2065/2003) 
and for B[a]P in various foodstuff categories (Regulation (EC) N° 1881/2006). 
Presently, B[a]P is used as a marker for the occurrence of carcinogenic PAHs. For 
example, the maximum levels for B[a]P in oils and fats are fixed to 2 µg kg-1. Maximal 
limits are also set for smoked fish and meat, as well as for babyfood and bivalve 
molluscs, for which the maximal limit is the highest : 10 µg kg-1. 
The main problem in evaluating carcinogenicity of PAHs in food and 
environment is that they are not present as individual compounds but as complex 
mixtures. This could be solved by summing PAH concentrations and expressing 
them as B[a]P equivalents after application of a toxic equivalent factor, similar to the 
procedure for dioxins. However, this is not possible for PAHS, because not all PAHs 
are acting through the same pathway.  
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In a recent advice, the EFSA (EFSA, 2008) came to the conclusion that BaP is 
not a suitable indicator for the occurrence of PAHs in food.  Based on the currently 
available data relating to occurrence and toxicity, the CONTAM Panel concluded that 
PAH4 (B[a]P + benz[a]antracene + benzo[b]fluoranthene +chrysene) and PAH8 are 
the most suitable indicators of PAHs in food, with PAH8 (B[a]P + benz[a]antracene + 
benzo[b]fluoranthene + benzo[k]fluoranthene + benzo[ghi]perylene + chrysene + 
dibenz[a, h]antracene + indeno[1,2,3-cd]pyrene) not providing much added value 
compared to PAH4.  
Based on this EFSA advice, the European Commission has drafted an 
amendment to regulation (EC) No. 1881/2006 with revised limits for benzo-a-pyrene 
and certain food stuffs and with additional limits for the PAH4 (European 
Commission, 2010). However no limits for food supplements will be included in the 
next change of regulation (EC) n°1881/2006.   
 
2.3.3.2 Analysis of PAHs 
During phase 1 of this project, 16 PAHs were quantified in the 61 products 
bought, using high performance liquid chromatography coupled to an ultraviolet, 
diode array or fluorescent detector as described in Danyi, et al. (2009). Detailed 
results are available in the final report of the phase I of the present project (Mormont 
et al, 2009). 
The results showed that St-John‟s wort and Ginkgo biloba extracts presented 
the most frequent contaminations and the highest average values for PAHs 
concentrations. Generally, not notified products bought through internet showed 
higher contaminations. 
In order to perform a risk assessment, in phase 1 of this project (Mormont et 
al., 2009), we calculated the daily intake of the sum of the 16 PAHs from the products 
taking into account their PAH concentrations and the recommended ingestion per 
day of each analyzed product, and compared it to the current margin of exposure 
(MOE) used by the JECFA (2005). The MOE has been calculated by dividing the 
PAH BMDL level by the PAH intake from each product. According to EFSA (2005), 
an MOE of 10,000 or higher, if it is based on the BMDL10 from an animal study, 
would be of low concern from a public health point of view and might be considered 
as a low priority for risk management actions.  Two of them were measured with a 
MOE lower than the safety limit of 10 000. In our study, the PAHs intake from two 
products would lead to an MOE below 10 000. 
As an exercice, the MOE has been calculated based on the daily mean intake 
of B[a]P and PAH8 (one of the most suitable indicators according to EFSA (2008)) in 
a normal diet plus the intake from each product, and taking into account the specific 
BMDLs for B[a]P and PAH8. The respective daily intakes from a normal diet are 
estimated at 315 ng/day for B[a]P, and 2405 ng/day for the PAH8.  
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For each of the 61 products, the calculated MOE was higher than 10.000 
(Results not shown).  
However, it is interesting to note that the daily intake of B[a]P and/or HAP8 
from the products varies from 0 to 35% of the average intake from a normal diet. The 
majority of samples (55 out of 61) contribute for less than 5% to the daily intake of 
B[a]P and/or HAP8, while 1 and 2 samples only contribute to more than 20% of the 
B[a]P and HAP8 daily intake respectively (see Figure 7).  
  
Figure 7 : Number of samples per categories of percentage of the daily intake of B[a]P and 
PAH8. “Percent BaP (PAH8) FSI/BaP (PAH8) normal intake” : ratio between the BaP (PAH8) 
daily intake from FS and the BaP (PAH8) daily intake from normal diet. 
 
We see in Figure 7 that the probability to reach more than 5 % of the average 
intake of a normal diet is not negligible for both BaP and PAH8, which makes the 
PAH content a possible matter of concern. 
 
2.3.4 Organochlorine pesticides (OCPs), polychlorobiphenyls 
(PCB’s), polybromodiphenylethers (PBDEs) and dioxins 
2.3.4.1 Definition and health outcomes 
Persistent organic pollutants (POPs) are chemical substances that have long 
half-lives in air, soil, sediments or biota and thus persist in the environment. Because 
of their high lipophilicity, they can contaminate all food chain levels. They are toxic 
and cause adverse health effects to humans and wild life. This group includes in 
particular OCPs (organochlorine pesticides), PCBs, (polychlorobiphenyls) PBDEs 
(polybromodiphenylethers) and dioxin. They have different origins: released as 
agrochemicals and industrial substances, or accidentally as by-products from 
combustion processes (Scippo et al., 2008). Except for occasional occupational 
exposures, the main intake road of POPs for humans remains the food. Foodstuffs of 
animal origin account for more than 90% of the human exposure. 
Numerous adverse health effects are attributed to POPs. Several 
organochlorine pesticides are suspected to act as endocrine-disrupting compounds 
(EDC). Like those measured in this study, they might contribute to numerous human 
female reproductive disorders and emphasize the sensitivity of early life-stage 
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exposures (Crain et al., 2008). Crain & co-workers suggested that interference with 
hormonal regulation of the menstrual cycle resulting in long and irregular cycles will 
reduce fecundability (the ability to conceive in a menstrual cycle). Several POPs and 
PCBs are also suspected to be human carcinogens. For example, it is well known 
that dioxins are carcinogenic in several animal species and humans (Scippo et al., 
2008). 
 
2.3.4.2 Analysis of organochlorine pesticides (OCPs), polychlorinated 
biphenyls (PCB’s), polybromodiphenylethers (PBDEs) and dioxin 
For the analysis of OCPs, PCBs and PBDEs in food samples, only the six oily 
samples were selected for analysis: four Garlics, one Ginkgo biloba, and one St 
John‟s wort. The analytical method for the simultaneous determination of various 
groups of persistent organic pollutants (organochlorine pesticides, polychlorinated 
biphenyls and polybrominated diphenyl ethers) was previously described by Jacobs 
et al., (2004), using gas chromatography coupled to mass spectrometry (GC-MS).  
Methodology for detection and detailed results of the analysis of OCPs, PCBs 
and PBDEs are described in details in the final report of phase I of the present 
project (Mormont et al, 2009). 
Dioxins were measured in the same oily samples using the CALUX method, 
according to Focant et al. (2005). 
None of the OCPs and PBDEs was detected above the limit of quantification 
(LOQ). Concerning the dioxins, all the samples were below the LOQ. This appears 
like reassuring results, and is consistent with the fact that POPs are known to 
bioaccumulate mostly in fatty tissues of animals and to a lesser extent, in plants. 
 
2.3.5 Food contaminants and secondary plant components: 
interactions at the intestinal level 
The intestinal mucosa cell monolayer is also the first barrier that either allows 
or prevents the entry of food antigens including food proteins, commensal gut 
microorganisms and pathogens, into the underlying tissues. It becomes increasingly 
evident that mucosal cells are much more than a simple „passive filter‟ and, through 
highly complex interactions, play a major role in regulating bioavailability of nutrients, 
drugs, and food contaminants. It is now clear that nutrients and contaminants present 
in the GIT influence expression and/or activity of some key proteins involved in 
regulation of cell growth, differentiation and apoptosis, with clear relations to 
pathologies such as cancer or intestinal inflammation.   
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Intestinal targets of food contaminants are cytochromes P450 (CYPs), 
conjugation enzymes and efflux pumps.  
Interactions of CYPs with active ingredients of food supplements are 
developed later in this study. The activity of CYPs, which are proteins involved in 
metabolism of various drugs, may be modulated also by different food contaminants, 
such as those we have analyzed in the previous chapters. For example, some 
mycotoxins undergo metabolism by CYPs. In liver, CYP3A and CYP1A subfamilies 
have been shown to be involved in activation of mycotoxins, particularly AFB1 and 
ochratoxin A (OTA) related carcinogenesis (Sergent, et al., 2008), whereas few data 
relate to the interactions between mycotoxins and intestinal CYPs. Heavy metals 
such as lead, cadmium and mercury, and other toxic elements such as arsenic have 
been shown to be involved in CYP function and regulation (Sergent, et al., 2008). 
Combined effects of AhR ligands (PAHs) and heavy metals, frequently environmental 
co-contaminants, have been reported: studies in cell lines from humans, rodents, 
chicken and fish generally indicate that heavy metals diminish the inductive potency 
of PAHs for the CYP1A1, 1A2 and 1B1 and, therefore, could diminish the 
carcinogenicity of PAHs (Sergent, et al., 2008).  
Efflux transporters play a key role in disposition and excretion of many 
substances, including endogenous metabolites, pharmacological drugs, as well as 
dietary compounds and various contaminants. Intestinal P-glycoprotein (Pgp) is a 
versatile multi-substrate pump, which can expel compounds out of the cells in order 
to return them to the luminal side of the intestinal barrier and maintain intracellular 
concentrations at low levels.  The role of Pgp in drug interactions and bioavailability 
has been highlighted. Environmental contaminants such as pesticides, mycotoxins, 
antifungals and PAHs may modify the activity and expression of efflux pumps, such 
as the P-glycoprotein (Sergent, et al., 2008). 
 
2.4 Analysis of active ingredients in selected food supplements 
2.4.1 Identification of active ingredients in herbal food supplements 
The six herbal plants categories chosen for our study all have well studied biological 
effects that were observed in the past. 
- Ginkgo biloba: improve blood circulation and cerebral oxygenation 
- St-John‟s wort (Hypericum perforatum): for mild depression 
- Soy isoflavones (from Glycine max): reduce menopause effects  
- Maca (Lepidium meyenii): increase libido and limit sexual disorders 
- Black radish (Raphanus sativus): for bile secretion and intestine activity 
Project SD/AF/04 - Food interactions : effects on health, consumer perception and impact on agro-food industries - 
“FOODINTER” 
SSD-Science for a Sustainable Development – Agro-Food 56 
- Garlic (Allium sativum): decrease arterial tension 
It is important to note that natural products, unlike conventional drugs, contain 
a complex mixture of bioactive entities which may not all provide therapeutic 
activities. Often, a complete characterization of all the chemical constituents from a 
natural product is not available.  
Additionally, chemical makeup of a natural product may vary depending on the 
part of the plant processed (stems, leaves, roots), seasonality and growing conditions 
(Chavez et al. 2005). Combination products composed of multiple natural products 
complicate matters further. In this study, we decided to only select products made 
from one plant species. 
The active ingredients were measured for three categories of food 
supplements: Ginkgo biloba, Black radish and Maca. 
 
2.4.2 Maca (Lepidium meyenii) active ingredients 
Active ingredients: Lepidilin A, lepidilin B, macaridin and MTCA.  
Important remark: In Maca, those alkaloïds may be considered as important 
specific active ingredients, but there is still no consensus. Nevertheless, they can be 
used as markers of authenticity. It seems, however, that some of the alkaloids are 
characterized by deleterious biological properties, such as carcinogenicity.  
Some countries considers that consumption of MACA presents a risk for the 
consumer. For example (cited in AFSSA, 2004) :  
The Danish authorities have considered that Maca root extracts present a risk for 
the consumers, they suspended it’s commercialization in food supplements 
because of the following reasons: 
- The dried root powder cannot be considered as a common consumed plant in 
Europe; 
- The presence of alkaloids in the Maca root; 
- The doses inducing effects on the sexual behavior of rats (0,15 to 75 mg/kg 
body weight) are in the range of those advised by the providers of the food 
supplements (around 67 mg/kg bw). 
Detailed methodology and results of the analysis of MACA are available in the final 
report of phase I of the present project (Mormont et al, 2009). 
Analysis of six maca products (3 notified, 3 not notified) by nano-LC-MS revealed 
one product containing no lepidilin A and no lepidilin B (see Table V). From these 
data, it could be concluded that this sample does not resemble a maca-extract. 
Nevertheless, macaridin was detected in all maca supplements, with no correlation 
with the presence of lepidilins. A small amount of MTCA ((1R,3S)-1-methyltetrahydro-
ß-carboline-3-carboxylic acid) has been detected in a notified sample. This alkaloid is 
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considered as a mutagenic precursor responsible for neuronal death by the AFSSA 
(AFSSA, 2004). Nevertheless it must be noted that MTCA is found in many foods 
and that the mutagenicity appears to be largely linked to concomitant factors within 
the chosen experimental settings (Gonzales et al 2008). 
 
TABLE V: Active ingredients of the six Maca products 
 
 
None of the six maca products announced the concentration of any potentially 
active ingredients on the label. 
 
2.4.3 Black radish (Raphanus sativus) active ingredients 
Active ingredients: glucosinolates (GL) 
The glucosinolate (GL) profile in black radish (Raphanus sativus) based 
dietary products was investigated. An analytical strategy combining the use of LC-
PDA, LC-ESI-MS/MS and LC-APCI-MS/MS systems was applied. The LC-ESI-
MS/MS system was used to detect and identify the naturally occurring intact GLs. 
The identified intact GLs were then desulfated and quantified on an LC-PDA system 
as desulfo-GLs. Prior to quantification, the desulfo-GLs were identified using an 
APCI-MS/MS system. A detailed description of the analytical method can be found in 
Njumbe Ediage et al. (2011). In total, six glucosinolates were identified and 
determined (quantified) in the dietary products (see TABLE VI). The quantitative data 
revealed a great diversity in the individual GL content in the six dietary products. This 
variation of the total GL content can be attributed to differences between species and 
subspecies of the different black radishes from which the products were derived. 
Different growing conditions could also have contributed to the differences in the 
glucosinolate content in the different samples (Ciska et al. 2000).  
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TABLE VI: Glucosinolates content in the black radish products. rRF: response factors (ISO 
9167−1−1992). The calculation of the intake/day took into account the recommended 
number of capsules, the amount of plant material per capsule and the total GL per capsule. 
 
 
Glucoraphenin was the most abundant glucosinolate in all samples. 
Glucoraphasatin and glucoraphenin have been reported as the main GLs in radish 
roots (Montaut et al. 2010). These GLs were also confirmed in all six black radish 
based dietary products. Since glucoraphasatin and glucoraphenin differ only in the 
degree of oxidation of the sulfur atom in the side chain, direct biological reduction of 
glucoraphenin to glucoraphasatin during sprouting could explain the possible 
co−existence of both glucosinolates in radishes. 
The daily intake of total GLs when following the advised intake varies from 
1.31 -> 4.45 mg, which can be considered as a considerable variation. 
None of the six black radish products presented as food supplements for the 
consumer announced on the label the concentration of any potentially active 
ingredients. 
 
2.4.4 St John’s wort (Hypericum perforatum) active ingredients 
Active ingredients: hyperforin, hypericin 
Initially, hypericin was considered to be the antidepressant constituent of St 
John‟s wort (SJW). This is the reason why only the hypericin content is obligatory to 
mention on the label. In the last decade, experimental and clinical evidence has 
shown that hyperforin is a major constituent required for the antidepressant activity. 
Many products containing extracts of SJW are still standardized on hypericin content 
because hyperforin is thought to be unstable (Barnes, 2002). None of the products 
bought refers to hyperforin content. 
Moreover, recent interest in St John‟s wort concerns mounting evidence that 
the component hypericin may be associated with cataractogenesis. Some details 
about this hypothesis are given in chapter 2.6.1. 
Project SD/AF/04 - Food interactions : effects on health, consumer perception and impact on agro-food industries - 
“FOODINTER” 
SSD-Science for a Sustainable Development – Agro-Food 59 
The Royal Decree of 1997 (MB, 1997) mentions that “the daily absorption 
recommended on the packaging or in the advertisement can‟t have the consequence 
of hypericin consumption higher than 700 µg per day”. Nevertheless, for the majority 
of the products, when the hypericin concentration was available, we observed that 
the consumption of only one pill was sufficient to exceed those 700 µg. Those five 
products are not notified (see right column in TABLE VII).  
We also observed the lack of hypericin content information on two notified 
food supplements. 
 
TABLE VII: Hypericin content specified on the packaging. FS: Food supplements (notified 
products), MP: medicinal products, NNP: not notified products. Cells in red=issues. 
 
Brand name Product name Type 
Hypericin content on the 
label 
Hypericyn/cap Hypericyn/day 






pseudohypericin: 0.3 mg/243 




Kira® Sint Janskruid 
LI 160 MP Not found     -     - 
SPRINGFIELD 
ST JANSKRUID 
500MG NNP hypericin (0,3%)= 1.5 mg/caps 1,50 2,25 
SOLGAR VITAMINS 
St John's Wort Herb 
300 mg Extract NNP 
hypericin 0,3% of extract 
(300mg) 1,00 1,00 
VITAMIN HEALTH 
Goed Gemoed, Sint 
Jans Kruid     NNP 
hypericin 0,3% of extract 
(300mg) 1,00 1,00 
SOURCE NATURALS 
St. Johns Wort, st 
Jans Kruid  NNP 
hypericin 0,3% of extract 
(300mg) 1,00 3,00 
HAGOR BIOSERVICE 
NV 
Bakanasan Huile de 








FORT FS Not found     -     - 
DIETI NATURA Millepertuis NNP Not found     -     - 
MAXIMUM NUTRIENTS St John's Wort 60  NNP 
hypericin 0,3% of extract 
(300mg) 1,00 2,00 
NATROL Millepertuis NNP 
Not visible (package 
damaged) N/A - 
VITADYNE Millepertuis MP 
hypericin standardized (mcg)= 
233µg/caps 0,23 0,69 
 
The determination of the active ingredients hyperforin and hypericin in St 
John‟s wort based food supplements was performed using high performance liquid 
chromatography coupled to an ultraviolet, diode array and fluorescence detector 
(HPLC-UV/FLD). The analytical method was developed using commercial hyperforin 
and hypericin standard solutions and applied to the selected St John‟s wort samples 
for the determination and quantification of these active compounds. 
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The results for the determination of hyperforin and hypericin in 12 St. John‟s 
Wort food supplements can be found in Table VIII. 
In the literature, some authors developed different methods of liquid 
chromatography for the determination of the active compounds of St. John‟s Wort 
dietary supplements. The concentration for hypericin ranged between 0.1 and 0.9 
mg/g dry powder (Liu et al., 2000; Ganzera et al. 2002). The concentration detected 
for hyperforin ranged between 2.4 and 9.3 mg/g of product (Liu et al., 2000) or 
between 0.4 and 13 mg/g (Ganzera et al. 2002). Studies of St. John‟s Wort products 
(tablets and capsules containing Hypericum perforatum extract or plant material) 
showed significant differences in their qualitative and quantitative composition. This 
variation was explained by the instability of hyperforin (thermolabile and 
photosensitive). 
Our results are in accordance with those results found in the literature: 
hypericin concentration ranged between 0.02 and 0.8 mg/g and was detected in all 
the samples The concentrations detected for hyperforin were between 1.3 and 36 
mg/g. 
 
Table VIII: Results of the hypericin/hyperforin analysis in St. John‟s Wort food supplements.  
 
Name 
Amount of substance 
per caps/weight of 
tablet (mg) 
Recommended 
ingestion per day 
(Caps/Tablets) 
Hyperforin Hypericin Hyperforin Hypericin 






STERK 410 2 caps  1.30  0.02 0.53 0.01 
Kira® Sint Janskruid 
LI 160 750 1-2 tablets 36.17 0.32 27.12 0.24 
ST JANSKRUID 
500MG 500 1-2 caps 36.59 0.34 18.29 0.17 
St John's Wort Herb 
300 mg Extract 460 1 caps 22.19 0.05 10.21 0.02 
Goed Gemoed, Sint 
Jans Kruid     515 1 caps 16.91 0.43 8.71 0.22 
St. Johns Wort, st 
Jans Kruid  480 3 tablets 28.09 0.74 13.48 0.35 
Arkogélules 
Millepertuis 345 1 caps 13.13 0.44 4.53 0.15 
MILLEPERTUIS 
FORT 190 3-6 caps 4.48 0.27 0.85 0.05 
Millepertuis 260 4-6 caps 12.62 0.78 3.28 0.20 
St John's Wort 60  470 1-3 caps  13.35 0.33 6.27 0.16 
Millepertuis 1050 Not found  12.88 0.20 13.53 0.21 
Millepertuis 440 3 caps  5.28 0.02 2.32 0.01 
 
ND: not detected
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2.4.5 Ginkgo biloba active ingredients 
Active ingredients: Bilobalide, ginkgolide, flavonols (kaempferol, quercetin, 
isorhamnetin). 
Only three products were analyzed in order to quantify their flavonol 
glycosides (1 FS, 1 NNP, and 1 MP). Results are compared to the expected 
concentrations (see TABLE IX), and show some discrepancies, which are difficult to 
explain because of the limited number of samples analyzed. 
 
TABLE IX : Expected and measured concentrations of flavonol glycosides in three Ginkgo 
biloba products. FS: Food supplements (notified products), MP: medicinal products, NNP: 














mg/tab (mg/tab) mg mg/100mg mg/tab 
Ginkgo NNP 40 10 316 17 53 
Bio-
Biloba MP 
100 24 427 26 82 
Ginkgo 
biloba FS 




Conclusions from the analysis of active ingredients 
 
 
The analysis of active ingredients in the selected products shows that the 
content of the product is not always mentioned on the label.  This is 
mandatory, according to the European Directive 2002/46/CE, transposed in 
Belgian legislation in the “plant” Royal Decree of 1997. But, as this “plant” 
decree is not yet complete, because the active ingredients are not identified for 
each plant food supplement, this obligation is not applicable. 
This shows the need for more research to identify active ingredients in plant 
FS as well as a gap to fill in the European and Belgian legislation. 
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2.5 In vitro studies of active ingredients and food supplements 
extracts 
2.5.1 General approach 
In phase I and II of this project, several relevant in vitro studies were 
performed by the different partners. The different in vitro techniques were applied to 
obtain information on: 
 The individual food supplement active ingredients. Therefore in vitro 
studies were performed with the individual active ingredients obtained 
as pure standards; 
 Possible interactions between the active ingredients. Mixtures of active 
ingredients from one food supplement were analyzed at concentrations 
similar to those present in a standardized extract (reference material 
from NIST);  
 Food supplement extracts. The same in vitro tests were performed with 
a standardized extract (reference material from NIST). 
The constraints were already mentioned during the first phase of the project: 
standards molecules are not available for all the active ingredients concerned, some 
ingredients are unstable, and care must be taken to avoid the influence of the 
conservation duration.  
Because of these constraints, as well as time and budget constraints, we have 
decided to focus on 3 categories of products, on the basis of the frequency of their 
consumption : soy isoflavones, St John Wort and Ginkgo biloba. For these 3 
categories of products, we have tested their active ingredients separately with our 
panel of in vitro tests, as pure standards. The complete study (in vitro testing of 
active ingredients separately, mixture of active ingredients and plant extract) has 
been performed only on Ginkgo biloba. We have not analyzed real samples at this 
stage, we rather preferred to analyze a reference material (from the National Institute 
of Standardization, NIST), with certified concentration of active ingredients of Ginkgo 
biloba. 
In order to work with plausible intestinal concentrations, we have applied the 
following dilution hypotheses to the estimated daily intake (EDI) of each selected 
compound:  
- [Maximal] (ppb or μg/L): 1L corporal fluid/meal, 1 meal/day 
 [Maximal] = EDI (μg/person/day) 
 
- [Minimal] (ppb or μg/L): 3L corporal fluid/meal, 3 equal meals/day 
 [Minimal] = [Maximal] / 9 
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The EDI may has been calculated either with values from literature or from 
packaging. For certain compounds, such as active ingredients from soy isoflavones, 
the EDI from the diet must be added to the EDI from food supplement consumption. 
This methodology provided us with an idea of plausible intestinal concentrations. 
These concentrations will be compared with dose-response curves obtained with in 
vitro models.  
2.5.2 Overview of the in vitro assays 
2.5.2.1 General toxicity of the active ingredients  
The toxicity of active ingredients was evaluated using bacteria (E.coli) and 
eukaryotic cells (HepG2 and Caco-2). For Caco-2 cells, two types of cytotoxicity 
assays were performed. First, inhibition of cell proliferation by active ingredients of 
food supplements was tested with the colorimetric MTS assay. Second, the release 
of lactate dehydrogenase (LDH) activity in the culture medium by necrotic cells was 
measured after incubation of 16-day post-confluent cells with active ingredients 
during 6h or 24h, before measuring CYP1A1 activity in cells (see below). The LDH 
assay constitutes a preliminary test, to ensure that concentrations of active 
ingredients used to measure CYP1A1 activity are not toxic for cells. 
2.5.2.2 Toxic mode of action  
Possible targets of active ingredients were identified by analyzing the effect on 
the expression of 14 genes involved in four different modes of action (oxidative 
damage, DNA damage, general cell lesions and membrane damage). They were 
performed with a bacterial reporter assay, carrying different stress promoters fused to 
the lac Z gene. The induction of the different stress genes was measured through the 
β-galactosidase activity. The index of the 14 genes and their function is shown in 
Table X (Dardenne et al., 2008). 
 
TABLE X: Stress gene promoters fused to the lacZ reporter gene and their major inducers.
 
Promoter Gene product/Function Responsive to
KatG Hydrogen peroxidase I Oxidative stress
MicF Antisense RNA to 5' OmpF Membrane integrity, osmotic stress
OsmY Periplasmic Protein Osmotic stress
UspA Universal stress protein Growth arrest
RecA General recombination and DNA repair SOS response
Zwf Glucose-6-phosphate dehydrogenase Oxidative stress
ClpB Proteolytic activation of ClpP Protein perturbation
UmuDC DNA repair Radiation and/or chemically induced DNA damage
MerR Regulation of the mercury resistance operon (mer) Heavy metals
Ada Adaptive response to alkylation DNA damage, mainly methyl adducts
DinD 
Unknown function within the DNA damage 
inducible response DNA damage
Soi28 Superoxide inducible gene Superoxide radical generating agents
Nfo Endonuclease IV 
Single-stranded and double-stranded DNA breaks, 
oxidative DNA damage
SfiA Inhibitor of cell  division SOS response
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2.5.2.3 Hormonal and dioxin-like activities  
Reporter gene assays were used to assess a broad spectrum of biological 
activities of food supplement‟s active ingredients, such as dioxin-like, anti-dioxin, 
steroid hormonal-like and anti-steroid hormonal activities. These biological assays 
are based on the use of reporter cells harboring an endogenous/exogenous “ligand-
dependent transcription factor” and a stable genetic construct consisting of a specific 
response sequence of DNA, a promoter and the firefly luciferase reporter gene. We 
used six reporter cell lines. Two are dioxin-sensitive cells and four are steroid 
hormonal-sensitive cells. The first group of cells test activation of the Aryl 
hydrocarbon receptor (AhR) and the second group responds to activation of the 
different specific steroid hormone receptors. The principle of reporter gene assays is 
shown in Figure 8.  
 
 
Figure 8: principle of reporter gene assays taking advantage of the AhR and steroid 
receptors pathways. R= receptor, PC= protein complex, XRE= Xenobiotic Responsive 
Element, HRE= Hormone responsive Element, P= promoter, Arnt= Aryl receptor nuclear 
translocator. Yellow triangle is the ligand. 
 
The AhR and the steroid hormone receptor pathways are very similar. Briefly, 
the inactive receptor is located in the cytoplasm within a protein complex. Upon 
binding of the ligand, the receptor crosses the nuclear membrane and 
homodimerizes, in the case of steroid hormone receptor, and heterodimerizes with 
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the Arnt protein, in the case of AhR. This dimer binds to a specific sequence of DNA 
(XRE or HRE, see figure 8). In normal cells, target genes are transcribed and 
different effects occur in the cells. In reporter cells, the product of the additional 
luciferase reporter gene produces a luminescence, after addition of substrates, which 
is directly correlated with the ligand concentration (Scippo et al., 2004; Van der 
Heiden, 2009, Willemsen et al., 2002, 2004 and 2005).  
The evaluation of the dioxin-like or anti-dioxin activity of active ingredients 
was performed by studying the capacity of the active ingredient to activate (agonistic 
effect) or to inhibit the activation (antagonistic effect) of the aryl hydrocarbon receptor 
(AhR). For this, we used the luciferase reporter cell lines H4IIE-XRE, which are 
derived from rat hepatoma cells and thus express the rat Ah receptor (rAhR), and 
HepG2-XRE, which are from human hepatoma cells and thus harbor the human Ah 
receptor (hAhR). These cells were exposed to one active ingredient (agonistic 
assays) or to a mixture of the reference AhR ligand and each active ingredient 
(antagonistic assays). 
Let‟s note that the rat cell line is more sensitive to dioxin than the human one. 
The concentration of half-maximal response (EC50) of TCDD for the rat and human 
hepatoma cell lines are 48 pM and 800 pM (24h) for H4IIE-XRE and HepG2-XRE, 
respectively, showing a lower sensitivity of HepG2-XRE cells towards TCDD, 
probably resulting from the different species origin of the Ah receptor. 
As the major target of the AhR transcription factor is the CYP1A1 
metabolization enzyme, an effect of a tested compound observed on activation or 
inhibition of the AhR will indicate that this compound probably also interacts with 
CYP1A1 expression in liver. 
To study the hormonal or anti-homonal activity of active ingredients, we used 
reporter cells derived from human mammary gland carcinoma, genetically modified to 
contain the firefly luciferase gene under a control of an inducible promoter. Four cell 
lines were used, sensitive to  
 Estrogen hormones (MCF-7 derived cells, containing mainly the human 
estrogen receptor alpha, hERalpha),  
 Androgen hormones (T47-D derived cells, containing the human androgen 
receptor, hAR), 
 Progestagen hormones (T47-D derived cells, containing the human 
progestagen receptor, hPR), 
 Glucocorticoid hormones (T47-D derived cells, containing the human 
glucocorticoid receptor, hPR). 
As most of the known endocrine disruptors display their effect by acting on a 
steroid receptor (mostly hER or hAR), an effect (activation or inhibition) on one or 
more steroid receptors of a tested compound indicates that the compound is a 
potential endocrine disruptor. 
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2.5.2.4 Effect on human cytochromes P450 (CYP) 1A1 and 3A4 activities in 
human colon adenocarcinoma cells (Caco-2 cells).  
In this study, we used the human colon adenocarcinoma cell line Caco-2 
(ATCC, Rockville, MD), a well-known in vitro model of the intestinal barrier. 
CYP1A1 brief definition: CYP1A1 is an inducible cytochrome P-450 present 
in intestinal cells and other tissues such as liver. Although most CYP oxidations are 
detoxification pathways, the chemistry of certain substrates leads to the production of 
reactive cytotoxic metabolites. For example, procarcinogens such as polycyclic 
aromatic hydrocarbons (PAHs), nitrosamines and food-derived aromatic amines may 
be activated to DNA-binding species by CYP1A1. Any compound able to increase 
the CYP1A1 activity is potentially dangerous for the organism.  
Different interactions were analyzed using the 7-ethoxyresorufin dealkylase 
(EROD) assay: 
- The inductive effect on CYP1A1 activity in presence of the active 
ingredients only. 
- The inhibitory effect on the induction of CYP1A1 activity by 
benzo[a]pyrene (B[a]P), a well-known CYP1A1 inducer in enterocytes 
and Caco-2 cells. 
 
CYP3A4 brief definition: Cytochrome P-450 3A4 (CYP3A4) is the 
predominant CYP isoform in the small intestine. It contributes to metabolism of 
approximately half the drugs in use today. Furthermore, it has also been proposed 
that small intestinal CYP3A4 could act in concert with P-glycoprotein to block 
systemic uptake of xenobiotics. Therefore, a modification in the CYP3A4 activity may 
modulate the bioavailability of some drugs, whith consequences more or less 
important for the patient.  
The activity of the CYP3A4 cytochrome can be induced or inhibited by a 
number of usual foods. As strange as it appears, the best documented one is 
grapefruit juice. A grapefruit juice-drug interaction was first accidentally reported in 
1991 (Bailey and Spence, 1991) when used as a flavor supplement to mask the taste 
of ethanol during a study of ethanol and felodipine interaction. A single glass of 
grapefruit juice caused a two- to three-fold increase in felodipine plasma levels 
compared to orange juice, which had no effect. It was observed that grapefruit juice 
inhibits the CYP3A4 activity, which leads to the increased blood level of the drug. 
Since then, many other drugs have been shown to have their bioavailability 
increased by grapefruit juice, such as cyclosporine, fenadine, midazolam and 
lovastatin. This excessive level of drug in the blood can lead to toxic levels, to the 
extent of causing an overdose. The onset of interaction can occur within 30 minutes 
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following intake of a single glass of grapefruit juice, and the inhibition can last up to 3 
days.  
Food supplements are well known to influence activity of the CYP3A4 protein. 
Because of the exponential increase of food supplement consumption, it is important 
to study their possible interactions with CYP3A4 activity in order to better understand 
the positive influence on cytochrome activity.  
Different interactions were analyzed by measuring the conversion of 
testosterone to 6β-(OH)-testosterone by the CYP3A4 isoform and detection of the 
metabolite by HPLC: 
- The inductive effect on CYP3A4 activity after a treatment of two weeks 
with the active ingredients. Cells are thereafter exposed to testosterone 
during 3h. 
- The inhibitory effect on CYP3A4 activity after pre-treatment with 1α,25-
dihydroxyvitamin D3 (1α,25-(OH)2-D3), a CYP3A4 inducer. Cells are 
thereafter exposed to both testosterone and the active ingredients 
during 3h.  
 More details on the three kinds of in vitro assays are available in the final report 
of phase I of the present project (Mormont et al, 2009). 
 This kind of approach, based on complementary in vitro techniques used as a 
“tool box”, is relevant to characterize the possible biological effects of a compound or 
a mixture of compounds (Ribonnet et al, 2011), but it is obvious that possible effects 
evidenced in vitro have to be confirmed in vivo, and, if possible of course, in humans. 
2.5.3 In vitro studies of active ingredients from Black radish 
Effects of active ingredients of Black radish on targeted stress genes 
The concentrations used in this study were calculated on the basis of growth 
inhibition experiments. The appropriate concentration ranges were selected. Results 
are shown on TABLE XI. 
The enantiomers of sulforaphane that were tested show clear and remarkable 
differences in especially the level of induction of MerR, 2.19 for DL-sulforaphane and 
72.1 for L-sulforaphane. MerR has a human analogue: MT. The high induction of 
MerR is in accordance with previous findings with human hepatoma cells (HepG2); 
after exposure to sulforaphane they observed elevated metallothionein (MT) 
expression, intracellular proteins that bind heavy metals with high affinity (Yeh et al., 
2005). The functions of MTs are uncertain, but they can detoxify heavy metals, 
provide a reserve of zinc and protect against oxidative stress.  On the other hand, the 
affinity of the methalothionein to some useful metals might reduce their bioavailability 
and thus provoke a deficiency. 
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At this point no conclusion can be given on whether or not the activation of a 
metallothionein is positive for health. Nevertheless, the Black radish food 
supplements are taken for their action on the intestinal tract (for example bile 
secretion), not a hypothetical heavy metal detoxification activity. Regarding this, the 
induction of the MerR gene expression by glucosinolates (which are also found in 
common food such as broccoli, Brussels sprouts and other cruciferous vegetables) 








2.5.4 In vitro studies of active ingredients from St John’ wort 
(Hypericum perforatum L.) 
Hypericin and hyperforin standards, the two major relevant ingredients of St 
John‟s wort, were used to perform different in vitro assays. The working 
concentrations have been calculated on the basis of the packaging information 
(concentration of standardized active ingredients and recommended daily intake) and 
the information from literature (measured concentration of non-standardized active 
ingredients), both converted in plausible concentration in the intestine (dilution 
hypothesis of the estimated daily intake in 1l of gastro-intestinal fluid). The plausible 
concentrations are:  
- Hypericin: 0,5ppm->5ppm 
- Hyperforin: 10ppm->100ppm 
 In our in vitro assays, these concentrations are plausible when Caco-2 cells 
(intestinal cells) are exposed to the compounds. For other cell systems (liver or 
mammary gland), it is not possible to calculate such plausible concentrations, but 
without other available information, these intestinal plausible concentrations were 
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used as reference concentrations for the other cell systems as well. This is true for all 
the active ingredients tested in this study. 
2.5.4.1 General toxicity of the active ingredients of St John’ wort 
The results of the general toxicity study of hyperforin and hypericin are 
presented in TABLE XII. 
 
TABLE XII: General toxicity and inhibition of cell proliferation by hypericin and hyperforin. 
IC50: concentration at which 50% of the growth is inhibited, LOEC: Lowest Observed Effect 
Concentration, LC50: Lethal Concentration at which 50% of the cells are dead. 
 
 
Results obtained using bacteria and eukaryotic cells are highly difficult to 
compare since the biological materials are different. There seems to be no link 
between the bacterial and the eukaryotic reactions to hypericin and hyperforin. 
Nevertheless, the LOEC value on human HepG2 cells for hypericin is ten times higher 
than for hyperforin, and also far higher than the plausible concentration in the intestine. 
This is also observed on human HepG2 for the LC50 (Lethal Dose at which 50% of the 
cells are dead). No harm would be expected thus from hypericin. In contrast, the much 
lower LOEC and LC50 concentrations observed for hyperforin are dramatically lower 
then its plausible concentrations, except for cytotoxicity in Caco-2 cells. This indicates 
that hyperforin is highly toxic for HepG2 cells and could provoke damages in the liver. In 
human Caco-2 cells, no LDH release (indicator of cell necrosis) was observed, but just 
the inhibition of cell proliferation.  
A possible explanation could be that the toxicity is provoked by some 
metabolites from hyperforin only secreted in liver cells and not in Caco-2 cell, but it is 
not well established if and how caco2 cells can metabolise certain compounds. These 
cell type specific effects could be further investigated. 
2.5.4.2 Effects of active ingredients of St John’ wort on targeted stress genes  
Neither hypericin nor hyperforin induced expression of any of the 14 screened 
stress reporter genes (data not shown). 
The known mode of action of St-John‟s wort - one of the most frequently 
studied medicinal plants - is mainly based on hyperforin. Its major pharmacological 
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activities affect unique eukaryotic systems such as neurotransmitter reuptake 
inhibition, CYP1A1 inhibition, anti-tumoral properties, thus all specific modes of 
action that cannot be evaluated using a bacterial system. 
2.5.4.3 Dioxin-like activity of the active ingredients of St John’ wort 
Agonistic assays 
The cells were exposed to each standard active ingredient during 6h and 24h 
to assess the dioxin-like activity (agonistic activity). No dioxin-like activity was 
observed, neither on rat nor on human hepatoma cells (results not shown). 
Antagonistic assays 
Antagonistic assays were carried out to measure a possible inhibition of the 
AhR pathway by standard active ingredients, when cells are co-exposed to AhR 
reference ligand, the TCDD (tetrachlorodibenzodioxin). Concentrations of TCDD 
were applied to the cells to induce 50% of the maximal inducible luciferase activity 
(EC50): 50 pM for H4IIE-XRE cells and 0.8 nM for HepG2-XRE. At the same time, 
increasing concentrations of standard active ingredients were added to the cells. The 
cells were exposed to those ingredients during 6h and 24h to assess the influence of 
the time exposure.  Results are presented on Table XIII. 
When rat hepatoma cells H4IIE-XRE are co-exposed, during 6h or 24h, to 
TCDD and hyperforin or to TCDD and hypericin, they generate a higher luciferase 
activity than when exposed to TCDD alone. Thus we observed a synergy between 
TCDD and hypericin (see also Figure 9 for hyperforin results), because no response 
was observed when these compounds were applied alone on the cells (see above). 
 
Table XIII: antagonistic activities of hyperforin and hypericin in dioxin-sensitive cells co-
exposed, during 6h or 24h, to TCDD and hyperforin or hyperici. 
 -: no activity; +: antagonistic activity (response < 75% of the TCDD half maximal response); 
Synergy: response > 100% of the TCDD half maximal response. Number in brackets : 
minimal concentration (ppm) showing an inhibition (corresponding to 75% of the TCDD half 
maximal response) of the Ah receptor. PC : plausible concentration. 
 
 
In contrast, in human hepatoma cells HepG2-XRE, both hyperforin and 
hypericin seemed to display antagonistic activities when exposed to the cells during 
6h or 24h (figure 10, illustrated for hyperforine). We observed some negative relative 
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responses for the highest tested concentration but MTT tests results indicated good 
cell viability (data not shown).  
 
 
Figure 9: Synergy between hyperforin and TCDD in rat hepatoma cells H4IIE-XRE exposed 
to a mixture of TCDD (50 pM) and increasing concentrations of hyperforin (exposure time of 
24h). 
 
Those results suggest that both hypericyn and hyperforin may modulate the 
cellular response to dioxin compounds and the AhR pathway. Interestingly, this 
modulation is different in rat (synergy) and human (inhibition) cells. 
As it is well known that the main target gene of the AhR is the CYP1A1, we 
can conclude that both hypericin and hypericin may modulate CYP1A1 activity in liver 
cells. 
 
Figure 10: Antagonistic activity of hyperforin in human hepatoma cells HepG2-XRE exposed 
to a mixture of TCDD (50 pM) and increasing concentrations of hyperforin (exposure time of 
24h).  
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2.5.4.4 Hormonal-like activity of the active ingredients of St John’ wort 
 
Agonistic assays 
Estrogen-sensitive cells were exposed during 24h to each standard active 
ingredient while the three other hormone-sensitive cells (cells sensitive to androgen, 
progestagen and glucocorticoids) were exposed during 48h, in order to assess the 
hormonal-like activities (agonistic activities) of hyperforine and hypericine in a range 
of concentrations including the plausible concentrations.  
No hormone-like activity was observed neither for hypericin nor for hyperforin 
(results not shown). 
 
Antagonistic assays 
Antagonistic assays were carried out to measure a possible inhibition of the 
steroid receptor pathways by hyperforin or hypericin when cells were co-exposed to 
the steroid receptor ligand (= inducer). Concentrations of inducer were applied to the 
cells to induce 50% of the maximal inducible luciferase activity (=EC50). The results 
were compared to the maximal response obtained with the reference ligand for each 
steroid receptor (hAR: 5 alpha-dehydrotestosterone, hPR: progesterone, hGR: 
dexamethasome and hER: 17beta-estradiol) and the outcomes of two independent 
experiments are shown in the Table XIV. 
 
Table XIV: antagonistic activities of hypericin and hyperforin in hormonal-sensitive cells co-
exposed to hypericin or hyperforin and the steroid receptor reference ligand (see above). 
 -: no activity; +:  antagonistic activity (response < 75% of the TCDD maximal response); /: 
not tested. Number in brackets : minimal concentration (ppm) showing an inhibition 
(corresponding to 75% of the reference ligand half maximal response) of the steroid receptor. 




In oestrogen sensitive cells, both hyperforin and hypericin seem to display 
hER antagonistic activities We observed some negative relative responses for 
hyperforin for the highest tested concentrations (4 and 7 µM) (Figure 11), but MTT 
test results indicated good cell viability (data not shown). In glucocorticoid sensitive 
cells, only hypericin exerted antagonistic activities (data not shown).  
These results show that both hypericin and hyperforin display anti-estrogenic 
activity in vitro, at the plausible intestinal concentrations taken here as references. 
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Figure 11: antagonistic activity of hyperforin in human breast tumour cells MCF7-ERE 
exposed to a mixture of 17beta-estradiol (12.5 pM) and increasing concentrations of 
hyperforin (exposure time of 24h). 
2.5.4.5 Interactions of the active ingredients of St John’ wort with the 
cytochrome CYP1A1 on Caco-2 cells 
Caco-2 cells have been exposed during 6h or 24h to active ingredients of St 
John‟ wort (hypericin or hyperforin), in presence or not of B[a]P, a well-known 
contaminant inducing CYP1A1 activity. 
Results are presented on TABLE XV, Figure 12 and Figure 13. 
 
Table XV: Impact of pure compounds as standards on CYP1A1 activity in presence or 
absence of B[a]P, in 16-day post-confluent Caco-2 cells. -: no effect. 
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Figure 12: Induction of CYP1A1 activity in Caco-2 cells after 6h (A) or 24h (B) exposure to 
different concentrations of hyperforin (Hf) or hypericin (Hc). Sixteen-day post-confluent cells 
seeded in 48-well plates (4.104 cells/cm2) were exposed to 0.01, 0.1, 1 or 10 ppm of Hf or Hc 
or to controls for 6h or 24h. The negative control consisted of FBS-free culture medium alone 
and the positive control in cells treated with B[a]P  (0.1 or 0.25 ppm). CYP1A1 activity was 
assessed through the measurement of the fluorescence produced by the conversion of 5 M 
7-ethoxyresorufin to resorufin. Results are expressed in pmol resorufin produced/min/mg 
protein. Values are means ± S.E.M. of three independent experiments performed in 
triplicates (n=9).* p<0.05, ** p<0.01, as compared to negative control. 
 
Figure 13: Decreasing effect of different concentrations of hyperforin (Hf) or hypericin (Hc) 
on B[a]P-induced CYP1A1 activity in Caco-2 cells. Sixteen-day post-confluent cells seeded 
in 48-well plates (4.104 cells/cm2) were exposed to 0.1 ppm of B[a]P alone or simultaneously 
with 0.01, 0.1, 1 or 10 ppm of Hf or Hc for 6h. The control  (Ctrl) consisted of FBS-free 
culture medium alone. CYP1A1 activity was assessed through the measurement of the 
fluorescence produced by the conversion of 5 M 7-ethoxyresorufin to resorufin. Results are 
expressed in pmol resorufin produced/min/mg protein and presented in % of B[a]P-induced 
CYP1A1 activity. Values are means ± S.E.M. of three independent experiments performed in 
triplicates (n=9).* p<0.05, ** p<0.01, *** p<0.005 as compared to negative control. 
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Only hypericin seems to increase CYP1A1 activity at a concentration of 10 
ppm. Nevertheless, this increase is weak compared to the activity induced by B[a]P. 
In vivo, the plausible concentrations of hypericin (from 0.5 ppm to 5 ppm) are slightly 
lower to those required to observe this reaction in the in vitro model, suggesting that 
the intake of plausible doses of St John‟s wort may slightly increase CYP1A1 activity.  
After co-exposure with hypericin, a slight decrease of B[a]P-induced CYP1A1 
activity was observed at all concentrations tested. At 10 ppm, hyperforin exerted a 
strong decreasing effect. This is quite interesting, as all tested concentrations are 
below the plausible concentration in the intestinal tract (10 ppm to 100 ppm for 
hyperforin). 
These results are consistent with the results obtained with reporter gene 
assays (see above) showing an inhibitory effet of both hypericin and hyperforin on 
the AhR activation by TCDD. 
The antagonistic effect of hypericin and hyperforin on CYP1A1 induction by 
B[a]P may be considered as positive regarding detoxification of living organisms 
submitted to PAHs. St John‟s wort could have a beneficial effect for the consumer by 
limiting the activation of co-occurring procarcinogenic molecules. Schwarz et al. 
previously observed the inhibition of recombinant CYP1A1 enzymatic activity by 
hypericin and hyperforin (Schwarz et al., 2003). In their study, based on a different 
biological model (microsomal systems), they suggest that inhibition by hyperforin 
results from competition with the substrate B[a]P for its binding site on the CYP1A1 
enzyme. On the other hand, hypericin, the other active ingredient, showed a 
noncompetitive inhibition of CYP1A1. 
The inhibitory effect of the active compounds on CYP1A1 activity in presence 
of B[a]P may be put in relationship with the  antagonist activity on the aryl 
hydrocarbon receptor (AhR), in human dioxin-sensitive cells (see above). In the 
scientific literature, B[a]P is known to bind with high specificity to the aryl 
hydrocarbon receptor (AhR), modifying the expression of CYP1A1. For example, it 
has been shown that B[a]P can significantly increase AhR and CYP1A1 expression 
in the human skin (Costa et al., 2010). Both induction and inhibition effects on 
CYP1A1 activity of the different active ingredients could occur through the AhR 
regulation pathway. Further investigations would be interesting. 
The inhibitory effect of the active ingredients taken independently has been 
enlarged to whole crude St. John‟s wort preparations. Schwarz & al. observed that 
St. John‟s wort extracts (from 3 commercial products) have the capacity to inhibit the 
diolepoxidation activity of CYP1A1 (Schwarz et al., 2003). For the observed inhibition 
of CYP1A1, it would be difficult to determine which constituent(s) is responsible for 
the CYP1A1 inhibition. Hypericin and hyperforin were found the most potent 
inhibitors. Thus, they are most likely responsible for the inhibition effect of the whole 
extract. However, besides the inhibitory potency, in the case of such a complex 
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mixture of constituents, the relative abundance of each compound in the preparation 
would also have an impact on the contribution of a distinct compound to inhibition, 
and other constituents of St. John‟s wort may contribute as well (Schwarz et al., 
2003). St. John‟s wort preparations are complex mixtures of a huge variety of 
compounds. The concentrations of the various constituents and their inhibitory 
potencies are different; therefore, it is difficult to single out the main inhibitor of 
CYP1A1 activity under in vitro conditions. The in vivo situation of CYP1A1 inhibition 
is even more complicated because pharmacokinetic properties (e.g., distribution, 
bioavailability, intracellular distribution, and clearance) must be taken into account 
(Schwarz et al., 2003).  
The modulation of the CYP1A1 activity by the active ingredients hypericin and 
hyperforin has thus been observed in this study, and is also documented on other 
biological models. This modulation doesn‟t take part in the reactions leading to their 
anti-depressant activity, thus could induce unknown actions on human health. 
2.5.4.6 Interactions with the cytochrome CYP3A4 on Caco-2 cells 
In this study, the same cell line Caco-2 has been used. The objective was to 
assess the influence of the active ingredients of St John‟s wort on the activity of the 
CYP3A4 cytochrome.  
No inhibitory effect on CYP3A4 activity by hypericin or hyperforin was 
observed (not shown). Regarding CYP3A4 induction, treatment of two weeks with 
hyperforin 1 ppm increased CYP3A4 activity, but was also cytotoxic, since the 
amount of protein at the end of the assay dramatically decreased (results not shown). 
The results of the study are therefore difficult to interprete.   
2.5.5 In vitro studies of active ingredients from soy isoflavones 
 
2.5.5.1 General toxicity of the active ingredients of soy isoflavones 
Genistein, daidzein and glycitein are the three major isoflavones that 
contribute for 40% of the soy extract. Their standards were used to perform different 
in vitro assays of toxicity and inhibition of proliferation. Results are present in TABLE 
XVI. 
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TABLE XVI: General toxicity and inhibition of proliferation assays for genistein, daidzein and 
glycitein. IC50: concentration at which 50% of the growth was inhibited, LOEC: Lowest 
Observed Effect Concentration, LC50: Lethal Dose at which 50% of the cells are dead. /: not 
tested, -: no effect. For Caco-2 cells, results are issued from graphical interpretation and not 
from statistical interpretation. 
 
 
Daidzein and genistein both displayed low toxicity on E.Coli, human HepG2 
cells, in the range of plausible intestinal concentrations. In Caco-2 cells, a dramatic 
decrease of cell viability was observed with 50 ppm genistein, which is in the range of 
realistic concentrations. A slight inhibition of the proliferation of Caco-2 cells has 
been observed for glycitein and daidzein. Genistein seems to have an antimicrobial 
effect (on E.Coli) and its first effects of cytotoxicity on human HepG2 cells occur in 
the range of plausible intestinal concentrations. 
In the scientific literature, genistein was already found to inhibit cell 
proliferation, to induce apoptotic cell death and differentiation in cancer cells, to exert 
antioxidant effects and to modulate cell cycle progression. At the cellular level, 
genistein was found to induce apoptosis and differentiation in cancer cells, inhibit cell 
proliferation, modulate the cell cycle, exert antioxidant effects, inhibit angiogenesis, 
and suppress osteoclast and lymphocyte functions. For the authors, these activities 
make genistein a promising agent in the treatment of cancer (Polkowski & Mazurek, 
2000). 
In the literature, it can be found that daidzein significantly inhibited cell 
proliferation in a dose- and time-dependent manner and resulted in significant cell 
cycle arrest after 72 h of treatment at concentrations over 5 and 10 µM (performed on 
breast cancer cells) (Choi & Kim, 2008). Those results match ours on Caco-2 human 
colon adenocarcinoma cells, where cell proliferation is inhibited from 1 ppm (4 µM), 
but not the liver HepG2 cancer cells. These differences can be explained by the 
specificity of the cells. Nevertheless, as for the genistein, daidzein could exert its 
anticancer effects in human colon cells. The putative anticancer properties are not 
well supported by data and need further investigations to be put forward. 
2.5.5.2 Effect of active ingredients of soy isoflavones on targeted stress genes 
A battery of genetically modified E.coli bacteria was used to gain insight in the stress-
related mode of action of genistein, daidzein and glycitein. Based on the toxicity data, 
appropriate concentration ranges were determined for the bacterial gene expression 
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assay. Four different modes of action classes were analyzed: oxidative damage, 
DNA damage, general cell lesions and membrane damage. Detailed bacterial strains 
are presented on TABLE XVII. 
 
 TABLE XVII: E.coli induced stress genes. In blue: significant induction, -: no induction 
  
 
In the literature, numerous in vitro eukaryotic cell culture studies have reported 
genistein to be clastogenic (chromosome breaking), DNA damaging and even 
mutagenic, in contrast to in vivo studies that generally have not showed genotoxicity 
results. Genistein would act to both induce oxidative DNA damage and to act as an 
antioxidant to potentially prevent such damage. The concentrations at which these 
opposing effects occur are difficult to reconcile (Klein & King, 2007). 
2.5.5.3 Dioxin-like activity of active ingredients of soy isoflavones 
Agonistic assays 
Dioxin sensitive cells were exposed to each isoflavone (in a range of concentrations 
from 2.5 to 80 M during 6h and 24h to assess the dioxin-like activity (agonistic 
activity)). The results are shown in TABLE XVIII. 
 
TABLE XVIII: Agonistic activities of isoflavones in dioxin-sensitive cells exposed during 6h or 
24h to active ingredients. rAhH: rat Ah receptor; hAhR: human Ah receptor; -: no activity; +: 
weak activity (<25% of the TCDD maximal response); ++: medium activity (25% <effect 
<75% of the TCDD maximal response); Number in brackets: minimal concentration showing 
an activation (corresponding to 15% of the maximal response obtained with TCDD). 
 
 
Isoflavones exerted a “medium” rAhR agonistic activity when cells are 
exposed during 6h, but no more after 24h (except a “residual” weak activity for 
daidzein). In contrast, no activity was measured in human hepatoma cells. These 
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results suggest that the isoflavones are able to induce the AhR pathway in rat but in 
a transient way. They are probably metabolized in these liver cells and are not 
present anymore after 24h. The discrepancy between rat and human cells could 
result from the difference of cell sensitivity towards dioxins.  
 
Antagonistic assays 
“Antagonistic assays” on rat hepatoma cells revealed that some “isoflavone + 
TCDD” mixtures exert an additive or synergistic activity in rat cells (TABLE XIX). 
Compared to exposure to isoflavone alone (Figure 14), a synergy was observed 
between “daidzein and TCDD” (6h). An equivalent synergy was also observed 
between “genistein and TCDD” (6h).  
 
TABLE XIX: antagonistic activities of isoflavones in dioxin-sensitive cells co-exposed (during 
6h or 24h) to TCDD and each active ingredients. rAhH: rat Ah receptor; hAhR: human Ah 
receptor; -: no activity; +:  antagonistic activity (response < 75% of the TCDD maximal 
response); synergy  : response >100 % of the TCDD maximal response. Number in brackets: 
minimal concentration showing an inhibition of the AhR (corresponding to 75% of the 
maximal response obtained with TCDD alone). 
 
 
In human hepatoma cells HepG2-XRE, only genistein (from 40 µM to 80 µM, 
exposure time of 6 and 24h) was able to decrease the maximal response induced by 
10nM of TCDD (antagonistic activity of genistein).  
This could be a positive result for human health. None of the major active 
ingredients has a dioxin-like activity on human hepatoma cells HepG2-XRE nor do 
they synergize with the dioxin TCDD. Even better, genistein seems to antagonize 
TCDD induction. However, interference with AhR activity could also be deleterious 
for the normal detoxification functions of its target genes, therefore any collateral 
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Figure 14: Comparison of mixtures “isoflavone + TCDD” and agonistic activities of 
isoflavones in rat hepatoma cells H4IIE-XRE. Above: exposure time of 6h. Below: exposure 
time of 24h. 
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2.5.5.4 Hormonal-like activities of active ingredients of soy isoflavones 
Agonistic assays 
Results of agonistic assays are shown in TABLE XX. 
 
 TABLE XX: agonistic activities of isoflavones in hormonal sensitive cells. 
 -: no activity; +++: strong activity (response > 75% of the reference ligand maximal 
response). Number in brackets: minimal concentration showing an activation of the steroid 
receptor (corresponding to 15% of the maximal response obtained with the reference ligand). 
 
We concluded that isoflavones display estradiol-like activities and thus should 
be classified as phytoestrogens, in agreement with the literature. The fact that soy 
isoflavones have an estrogen-like activity is the main argument for treating 
menopausal symptoms.  
Antagonistic assays 
The results of two independent experiments were compared to the maximal 
response obtained with the reference ligand of each steroid receptor (hAR: 
dehydrotestosterone, hPR: progesterone, hGR: dexamethasome and hER: 17beta-
estradiol) and are shown in TABLE XXI.  
 
TABLE XXI: antagonistic activities of isoflavones in hormonal-sensitive cells co-exposed to 
the receptor reference ligand (see above) and each active ingredient. -: no activity; +:  
antagonistic activity (response < 75% of the reference ligand maximal response); synergy : 
response > 100% of the reference ligand maximal response. Number in brackets: minimal 
concentration showing an inhibition of the steroid receptor (corresponding to 75% of the 
maximal response obtained with the reference ligand). 
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Results showed that the mixture “daidzein + dehydrotestosterone” and each 
mixture of “isoflavone + estradiol” produced a synergistic response (details not 
shown).  
For each isoflavone, an inhibition of the progestagen and the glucocorticoid 
pathways occurred. Progestagen controls the maintenance of pregnancy (a 
disruption can be responsible of abortion or early birth), bone metabolism, neuronal 
development, and reproductive system development. Inhibition of hPR by isoflavones 
could thus probably is a matter of concern. The glucocorticoid pathway 
(dexamethasone) controls glucose metabolism (equilibrium of the glucose 
concentration in blood) and inflammation. A chronic exposure to an excessive 
concentration of glucocorticoids is linked to obesity, type 2 diabetes and inflammation 
diseases.  
In estrogen-sensitive cells, the response was more than 100 % of the estradiol 
maximal response when each isoflavone was added to the cells (see TABLE XXI). 
The results obtained with mixtures with the reference ligand and the analysis of the 
different curves led us to conclude to a synergy between the three isoflavones and 
estradiol (details not shown). Considerations about the pro and cons of 
phytoestrogens are described in the chapter 2.6.2. 
 
2.5.5.5 Interactions of active ingredients of soy isoflavones with the 
cytochrome CYP1A1 on Caco-2 cells 
Caco-2 cells have been exposed during 6h or 24h to soy isoflavones 
(genistein, daidzein or glycitein), in presence or not of B[a]P, a well-known 
contaminant inducing CYP1A1 activity. 
Results are presented in TABLE XXII and Figure 15.  
 
TABLE XXII: Impact of pure compounds as standards on CYP1A1 activity in presence or 
absence of B[a]P, in 16-day post-confluent Caco-2 cells. -: no effect. For Caco-2 cells, 
results are issued from graphical interpretation and not from statistical interpretation. 
 
No induction of CYP1A1 activity in Caco-2 cells has been measured after 6h 
and 24h of exposure to genistein, daidzein or glycitein for the different concentrations 
tested. However, although not observed here, Sergent & al. observed previously that 
genistein presents a dose-dependant inducing effect (from 2.5 ppm) on CYP1A1 
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activity (Sergent, et al., 2009). Because genistein does not affect CYP1A1 mRNA 
expression, they suggest that it is not an aryl hydrocarbon receptor (AhR)-ligand in 
intestinal cells, but rather acts at a post-transcriptional level. This can also be related 




Figure 15: Decreasing effect of different concentrations of soy isoflavones on B[a]P-induced 
CYP1A1 activity in Caco-2 cells. Sixteen-day post-confluent cells seeded in 48-well plates 
(4.104 cells/cm2) were exposed to 0.1 ppm of B[a]P alone or simultaneously with 1, 12.5 or 
25 ppm of daidzein, genistein or glycitein for 6h. CYP1A1 activity was assessed through the 
measurement of the fluorescence produced by the conversion of 5 M 7-ethoxyresorufin to 
resorufin. Results are expressed in pmol resorufin produced/min/mg protein and presented in 
% of B[a]P-induced CYP1A1 activity. Values are means ± S.E.M. of three independent 
experiments performed in triplicates (n=9). 
In the antagonistic assays with B[a]P, co-exposure with any of the three 
polyphenols caused a decrease of B[a]P-induced CYP1A1 activity at all 
concentrations tested. At 12,5 ppm, the three isoflavones showed a marked 
antagonistic effect.   
Genistein and daidzein have already been reported to inhibit CYP1A1 activity 
or gene expression in different models (Gradin et al., 1994; Helsby et al., 1998; Kim 
et al., 2000; Hukkanen et al., 2000; Shon et al; 2006).  
The same conclusions can be given as for the active ingredients of St John‟s 
wort (see chapter 2.5.4.5): even if, in a way, they modulate the CYP1A1 activity in a 
potentially positive direction, these compounds are not consumed in food 
supplements for that purpose. Any collateral action of the active compounds should 
be completely known and controlled. 
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2.5.5.6 Interactions with the cytochrome CYP3A4 on Caco-2 cells 
No in vitro tests were performed in this project to study the interaction of 
genistein, daidzein and glycitein with the cytochrome CYP3A4. Nevertheless, it is 
interesting to notice that this has been done before with some flavonols, among 
which the genistein. Genistein was detected as significant inhibitor of the 1,25-
vitamin D3-induced CYP3A4 activity (Sergent, et al., 2009). In vivo, these effects 
could result in reduced activation of procarcinogens, such as aflatoxin B1, and/or in 
drug bioavailability modulation. Authors underline the importance of intestinal studies 
to assess food safety and health risks linked to the ingestion of flavonoid-enriched 
supplements or functional foods. 
2.5.6 In vitro studies of active ingredient and extract from Ginkgo 
biloba 
For Ginkgo biloba, pure active ingredients were tested separately and in 
mixtures as well as a Ginkgo biloba extract (GBE). The GBE used in the present 
study was provided by the U.S. National Institute of Standards and Technology 
(NIST, SRM 3247) (www.nist.gov/srm). 
 
TABLE XXIII: Certified concentration values (mg/g) for active ingredients in the standardized 
Ginkgo biloba extract (GBE, SRM 3247), as provided by the supplier (NIST), as well as 
calculated daily ingested dose (mg/day) and maximal realistic intestinal concentration 
(Cintestinal; g/ml) of the different active ingredients, taking into account that 100 mg of extract 
are ingested per day and are diluted in 1l of gastro-intestinal fluid (100 g/ml). 
 
Individual active ingredients have been tested at the concentration occurring in 
100 g of ginkgo NIST standardized extract/ml, which is considered as a plausible 
intestinal concentration. These intestinal concentrations are given in TABLE XXII as 
well as the certified concentration values in the NIST extract for each active 
ingredient considered in the present work and furnished by the supplier.  
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The active ingredients composition and concentration of the three different 
mixtures tested with our in vitro assays are indicated in TABLE XXIII as well (“mix 
terpenes”, “mix flavonols”, and “whole mix” including the 8 compounds). 
 
2.5.6.1 General toxicity of the active ingredients of Ginkgo biloba 
The results are presented in TABLE XXIV. 
Kaempferol, one of the three flavonols, is the most potent compound of the 
different active ingredients that were analyzed both with the bacterial and human in 
vitro assays. Improved risk assessment for kaempferol might be needed since it 
occurs in high concentrations and is the most potent compound. 
 
TABLE XXIV: General toxicity and inhibition of proliferation assays for the Ginkgo 
biloba active ingredients and mix of active ingredients. IC50: concentration at which 50% of 
the growth was inhibited, LOEC: Lowest Observed Effect Concentration, /: not tested; EDI: 
Estimated Daily Intake. For Caco-2 cells, results are issued from graphical interpretation and 
not from statistical interpretation.- : no effect. 
 
The ˝Mix 8 compounds˝ induce a growth inhibition on bacterial cells when 50% 
of the estimated daily intake (EDI) is reached. Because the investigated cells (E.coli) 
are the majority present in the digestive track, this could provoke a rupture in the 
bacterial equilibrium when high doses of Ginkgo biloba are taken. Nevertheless, the 
standard extract doesn‟t induce that antimicrobial effect. Further investigations on 
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2.5.6.2 Effect of active ingredients of Ginkgo biloba on targeted stress genes 
The results are shown in TABLE XV.  
As in the previous chapter, kaempferol induces a significant number of genes, 
related to various kinds of stresses. A negative impact of kaempferol on the intestinal 
and hepatic cells may be possible. The terpen ginkgolide A presented low impact 
compared to kaempferol. Improved risk assessment for kaempferol might be needed 
since it occurs in high concentrations and is the most potent compound. 
 
TABLE XXV : E.coli induced stress genes. In blue: significant induction, -: no induction. 
 
Nevertheless, it is important to notice that the beneficial effects of ginkgo 
leaves are the antioxidant properties. Antioxidants are substances that scavenge free 
radicals, which are damaging because they alter cell membranes, tamper with DNA, 
and even cause cell death. Free radicals occur naturally in the body, but 
environmental toxins (including ultraviolet light, radiation, cigarette smoking, and air 
pollution) can also increase the number of these damaging particles. Free radicals 
are believed to contribute to a number of health problems including heart disease 
and cancer as well as Alzheimer's disease and other forms of dementia. Antioxidants 
such as those found in ginkgo can neutralize free radicals and may reduce or even 
help prevent some of the damage they cause. As the used in vitro assay can only 
assess the presence of antioxidant inducing compounds, an interesting experiment 
would be to perform a mixture exposure to a typical oxidative stress inducing 
compound (ex. paraquat) and Ginkgo biloba to confirm the antioxidant properties. 
2.5.6.3 Dioxin-like activity of active ingredients of Ginkgo biloba 
Agonistic assays 
Table XXVI presents the results after 6 hours of cell exposure only, because 
no dioxin-like activity was observed after 24 hour. Only ginkgolide J exerted a 
medium agonistic activity in rat hepatoma cells. Bilobalide and quercetin had weak 
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agonistic activity when exposed to the human hepatoma cells.  These results suggest 
that the dioxin-like activities of some GBAI are rather weak and transient in these 
cells.  
TABLE XXVI: agonistic activities of Ginkgo biloba active ingredients and Ginkgo biloba 
extract in dioxin-sensitive cells. -: no activity; +: weak activity (response <25% of the TCDD 
maximal response); ++: medium activity (25% <response <75% of the TCDD maximal 
response). Number in brackets: minimal concentration (ppm) showing an activation 
(corresponding to 15% of the TCDD maximal response) of the Ah receptor. 
 
 
The mix of the flavonols has a weak dioxin-like activity when exposed to the 
human hepatoma cells. This effect is mainly due to quercetin, however a synergistic 
activity of the other flavonols in the mixture might also contribute. When mixed to the 
other terpens, the dioxin-like effect of ginkgolide J seems negligible because of its 
low concentration in the mix. For the mix of the eight compounds, a weaker dioxin-
like activity is observed compared to the one observed using the “Mix flavonols”, 
when exposed to the human hepatoma cells. These results suggest an inhibition of 
the flavonol effect by the terpens.  
The “GB extract” from an international reference displays a stronger dioxin-like 
activity than the mix 8 compounds, suggesting an additive effect of quercetin and 
bilobalide.  
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Our results are the demonstration that there are complex interactions between 
the eight active compounds, and that other components of the Ginkgo biloba extracts 
can also interfere with the activity of the food supplement. Considering the matrix (the 




Results are presented in TABLE XXVII. 
 
TABLE XXVII: antagonistic activities of Ginkgo biloba active ingredients and Ginkgo biloba 
extract in dioxin-sensitive cells co-exposed to TCDD and the tested compounds. -: no 
activity; +: antagonistic activity (response < 75% of the TCDD half maximal response); 
Number in brackets: minimal concentration showing an inhibition (corresponding to 75% of 




The flavonols independently seem to have an antagonistic activity. Because of 
their weak and transient dioxin-like activity, this could be considered as positive.  
Nevertheless, as for the agonistic assays, the variability of the results suggests the 
importance of the interactions between the different compounds of the Ginkgo biloba.  
For example, the “GB extract” shows an antagonistic activity when exposed to 
the human hepatoma cells. The effect is weaker than that obtained with the “Mix 8 
compounds”, despite the fact that the exposed concentrations are similar. We can 
conclude of an inhibiting effect of the GB extract. On the contrary, in rat hepatoma 
cells, agonistic activity was observed: the results showed that mixture of “GB extract 
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+ TCDD” produced a relative response higher than 100%. We concluded to a 
synergy. 
 Those results, even if obtained from standard active ingredients 
(independently and mixed), suggest that the Ginkgo biloba food supplements may 
modulate the response to dioxin compounds. This action is not part of the reactions 
leading to their therapeutic activities, thus could induce unknown impacts on human 
health. 
2.5.6.4 Hormonal-like activity of active ingredients of Ginkgo biloba 
Agonistic assays 
 
TABLE XXVIII: agonistic activities of Ginkgo biloba active ingredients and Ginkgo biloba 
extract in hormonal-sensitive cells. -: no activity; ++: medium activity (25% < response <75%) 
of the reference ligand maximal response; +++: strong activity (response > 75% of the 
reference ligand maximal response); Number in brackets: minimal concentration (ppm) 
showing an activation (corresponding to 15% of the maximal response obtained with the 




Results (TABLE XXVIII) showed that only flavonoids exerted estrogen-like 
activities. We concluded that flavonols, as observed for isoflavones (soy), have 
estradiol-like activities and thus could be classified as phytoestrogens.. 
The results obtained with the mixtures “Mix flavonols” and “Mix 8 compounds” 
indicate a synergy of the flavonols. In “Mix flavonols” and “Mix 8 compounds”, the 
maximum exposed concentrations of flavonols are lower but the agonistic effect is 
very strong. For “GB extract”, the effect is weaker than that obtained with the “Mix 
flavonols” and “Mix 8 compounds”, despite the fact that the exposed concentrations 
are higher. We thus conclude of an inhibiting effect from the other compounds of the 
GB extract, which has still an oestrogen-like activity.  
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Antagonistic assays 
Results are presented in TABLE XXIX. 
The group of flavonoids (kaempferol, quercetin and isorhamnetin) exerted 
antagonistic activities in progestagen-sensitive cells TM-Luc. Kaempferol and 
quercetin exerted activities in androgen-sensitive cells. On the other hand, only 
kaempferol exerted anti-glucocorticoid activity and a synergic activity with estradiol in 
estrogen-sensitive cells.  
 
TABLE XXIX: antagonistic activities of Ginkgo biloba active ingredients and Ginkgo biloba 
extract in hormonal-sensitive cells. -: no activity; +: antagonistic activity (response < 75% of 
the TCDD maximal response); /: not tested. *: visual cytotoxicity observed by microscopic 
examination of the cells. 
 
 
The “GB extract” showed antagonistic activity when exposed to the estradiol-
sensitive cells, which is in opposition with the “Mix flavonols” and “Mix 8 compounds”. 
We can conclude of an inhibiting effect from the GB extract. 
Because of the differences between the pure active ingredients, the different 
mix and the standard extract, it is predictable that each food supplement, with its own 
recipe, may have a specific action on hormonal sensitive cells. Further investigations 
should be performed. 
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2.5.6.5 Interactions of active ingredients of Ginkgo biloba with the cytochrome 
CYP1A1 on Caco-2 cells 
In this report, Caco-2 cells have been exposed during 6h or 24h first, to the 
NIST reference standardized extract of Ginkgo biloba and to the three commercial 
food supplements, then, to individual active ingredients of Ginkgo biloba, and finally 
to different mixtures of active ingredients, in order to assess CYP1A1 activity, in 
presence or not of B[a]P, a well-known contaminant inducing CYP1A1 activity.  
The results are presented in TABLE XXX and Figure 16 to Figure 19. Results 
observed with commercial food supplements of Ginkgo biloba (GBE1, 2 or 3) are 
hardly interpretable, since the right concentration of flavonols in the extract is not 
known, due to the lack of commercial standards for glycosidic forms. 
 
TABLE XXX: Effects on CYP1A1 activity after exposure of Caco-2 cells to major active 
compounds of Ginkgo biloba. GBE: Ginkgo biloba extracts from products presented as food 
supplements for the consumer. 
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Figure 16: Induction of CYP1A1 activity in Caco-2 cells after 6h or 24h exposure to different 
concentrations of Ginkgo biloba extract (GBE). Sixteen-day post-confluent cells seeded in 
48-well plates (4.104 cells/cm2) were exposed to 10, 20, 50, 100, 200 or 400 ppm of Ginkgo 
biloba extract or to vehicle control (0.5% DMSO) for 6h or 24h. CYP1A1 activity was 
assessed through the measurement of the fluorescence produced by the conversion of 5 M 
7-ethoxyresorufin to resorufin. Results are expressed in pmol resorufin produced/min/mg 
protein. Values are means ± S.E.M. of four independent experiments performed in triplicates 
(n=12).* p<0.05, ** p<0.01, *** p<0.005 as compared to vehicle control. 
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Figure 17: Induction of CYP1A1 activity in Caco-2 cells after 6h or 24h exposure to individual 
ingredients of Ginkgo biloba extract, alones (upper part) or in mixtures (lower part). Sixteen-
day post-confluent cells seeded in 48-well plates (4.104 cells/cm2) were exposed to each of 
the compounds listed in TABLE XXII, alone or in mixtures, at their assumed maximal realistic 
intestinal concentration or to controls for 6h or 24h. The negative control consisted in FBS-
free culture medium alone, the vehicle control in 0.5% DMSO and the positive control in cells 
treated with BaP (0.1 g/ml). CYP1A1 activity was assessed through the measurement of 
the fluorescence produced by the conversion of 5 M 7-ethoxyresorufin to resorufin. Results 
are expressed in pmol resorufin produced/min/mg protein. Values are means ± S.E.M. of 
four independent experiments performed in triplicates (n=12).* p<0.05, ** p<0.01, *** 
p<0.005 as compared to vehicle control. 
Project SD/AF/04 - Food interactions : effects on health, consumer perception and impact on agro-food industries - 
“FOODINTER” 
SSD-Science for a Sustainable Development – Agro-Food 94 
 
Figure 18: Decreasing effect of different concentrations of Ginkgo biloba extract (GBE) on B[a]P-





) were exposed to 0.1 ppm of B[a]P alone or simultaneously with 0, 10, 20, 50, 100, 
200 or 400 ppm of Ginkgo biloba extract for 6h. CYP1A1 activity was assessed through the 
measurement of the fluorescence produced by the conversion of 5 M 7-ethoxyresorufin to resorufin. 
Results are expressed in pmol resorufin produced/min/mg protein. Values are means ± S.E.M. of four 
independent experiments performed in triplicates (n=12). ).* p<0.05, ** p<0.01, *** p<0.005 as 
compared to B[a]P alone. 
 
We observed a dose-dependent induction of CYP1A1 activity in Caco-2 cells, 
stronger after 6h exposure than 24h exposure to an extract of Ginkgo biloba. This 
induction after 6h exposure is not explained by the active ingredients tested 
separately or even in mixtures. Therefore, this strong effect may be due to other 
occurring compounds of the complex extract (flavonol glycosides, proanthocyanidins, 
carboxylic acids,…) (van Beek & Montoro, 2009). However, no literature data 
suggest such an induction of CYP1A1 activity by these other compounds. The slight 
induction of CYP1A1 activity observed after 24h exposure may be explained by 
quercetin and/or kaempferol. 
In presence of B[a]P, the slight antagonistic effect on CYP1A1 activity 
observed with the extract of Ginkgo biloba may be explained by flavonols, which 
strongly decreased CYP1A1 activity in presence of B[a]P, when tested individually or 
even in mixtures, with or without terpens. 
In the literature, inhibition has also been reported with isorhamnetin, 
kaempferol and quercetin at the level of CYP1A1 catalytic activity and/or gene 
expression. In the present work, terpens seem to be less active than flavonols 
towards CYP1A1. 
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Figure 19: Decreasing effect of individual ingredients of Ginkgo biloba extract, alone (upper part) or 
in mixtures (lower part) on B[a]P-induced CYP1A1 activity in Caco-2 cells. Sixteen-day post-confluent 




) were exposed to 0.1 ppm of B[a]P alone or 
simultaneously with active ingredients listed in TABLE XXII alone or in mixtures, at their assumed 
maximal realistic intestinal concentration for 6h. The vehicle consisted in 0.6% DMSO. CYP1A1 
activity was assessed through the measurement of the fluorescence produced by the conversion of 5 
M 7-ethoxyresorufin to resorufin. Results are expressed in pmol resorufin produced/min/mg protein. 
Values are means ± S.E.M. of four independent experiments performed in triplicates (n=12). ).* 
p<0.05, ** p<0.01, *** p<0.005 as compared to B[a]P alone. 
A decreasing effect on CYP1A1 induction was observed after 6h exposure of 
Caco-2 cells simultaneously to B[a]P and GBE1, 2 or 3 at plausible intestinal 
concentration (not shown). Those results are similar to the ones above, but it is 
important to notice that the active ingredient concentrations in the raw extracts 
GBE1, 2 and 3 are unknown (100µg of each extract were used to perform the tests). 
As for the previous inhibitions of CYP1A1 activity by other active ingredients (from 
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soy and St John‟s wort) the inhibitory effect on the CYP1A1 activity could occur 
through the AhR regulation pathway.  
Similar to St John‟s wort, we see that the active compounds of Ginkgo biloba 
products, independently and in mixtures, as well as extracts, are able to modulate 
CYP1A1 activity in an in vitro model of the intestine, the first barrier encountered 
before entering systemic circulation. Since these herbal compounds reach intestinal 
cells at a possibly very high concentration in the same time as other chemicals such 
as drugs, food contaminants or other food constituents, the consequences of such 
interactions should be taken into account. Some compounds, inhibiting B[a]P-
induced CYP1A1 activity after co-exposure, could be considered as positive 
regarding detoxification of carcinogenic food contaminants such as PAHs. On the 
contrary, extracts inducing CYP1A1 activity could participate to the conversion of pro-
carcinogens to toxic DNA-binding metabolites, even if detoxification mainly occurred 
with most chemicals. 
The modulation of the CYP1A1 activity is not part of the reactions leading to 
the therapeutic effects of the Ginkgo biloba food supplements thus could induce 
unknown collateral impacts on human health. 
 
2.5.6.6 Interactions with the cytochrome CYP3A4 on Caco-2 cells 
No in vitro tests were performed in this project to study the interaction of the 
Ginkgo biloba active ingredients with the cytochrome CYP3A4. Nevertheless, it is 
interesting to note that this has been done in the past. 
Sergent & al. (2009) showed that quercetin inhibits the CYP3A4 constitutive 
activity, impairs the CYP3A4 induction by 1,25-vitD3 and inhibits the 1,25-vitD3- 
induced activity by direct enzyme interactions. As for grapefruit, the inhibition of the 
CYP3A4 activity may increase the plasma level of co-exposed drugs. The findings in 
humans are contradictory, and further studies are needed to elucidate the role of 
Ginkgo biloba in altered drug absorption due to CYP and P-gp inhibition. Three 
clinical studies excluded any effect of ginkgo on the CYP3A4 enzyme, but in two 
other studies ginkgo increased the plasma concentration of CYP3A4 probe drugs 
alprazolam and midazolam (Colalto, 2010).  
 
2.5.7 Recapitulative results of in vitro assays  
 
Recapitulative results obtained for the analysis of FS active ingredients using 
in vitro assays are summarized in the three following tables, as follow : 
1. Summary of cytotoxicity and induction of stress genes 
2. Summary of the effects on the AhR pathway and CYP1A1 
3. Summary of the effects on the steroid receptors pathway
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2.6 Review of the literature about in vitro and in vivo effects of 
active ingredients 
2.6.1 St John’s wort  
2.6.1.2 Activity on CYP3A4 
In vitro 
In vitro studies provide variable results. Two studies performed with 
recombinant microsomes have shown an inhibitory effect on the CYP3A4 activity for 
hypericin and hyperforin (Obach, 2000). Other studies observe a strong inductive 
effect of hyperforin on the CYP3A4 protein, for example in human hepatocytes 
(Komorosky, et al., 2004). Those contradictory results suggest that the hyperforin 




Different assays conducted with volunteers have shown significant induction of 
CYP3A4 activity after regular St John‟s wort consumption (Durr, et al., 2000; Wang et 
al. 2001; Markowitz, et al., 2003). This inductive effect has been attributed to 
hyperforin, as No clinically relevant CYP3A induction was observed after St. John's 
wort with low hyperforin content in healthy volunteers (Mueller et al, 2009). 
But taken as monotherapy, St. John‟s wort has an excellent safety profile (Izzo 
& Ernst, 2009). 
Izzo & Ernst (2009) present an overview of oral drugs that were shown to be 
influenced by St John‟s wort intake, mostly by lowering their therapeutic effect: 
- on immunosuppressants, such as cyclosporine, used on transplanted patients, 
- on cardiovascular drugs, for example warfarin, 
- on antiretrovirals drugs (causing treatment failure), 
- on anticancer drugs, which sometimes have a narrow therapeutic window, 
- on drugs acting on the central nervous system (such as antidepressants, 
anxiolitics, anti-epileptics and muscle relaxing agents),  
- on the gastrointestinal tract and respiratory system,  
- on hypoglycaemics, anti-inflammatories, antimicrobials and anti-migraine 
medicines,  
- clinical evidences also suggested that SJW may affect hormonal contraception. 
Numerous cases of women becoming pregnant while using oral contraceptives 
and SJW were described (Izzo & Ernst, 2009). 
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Numerous studies have confirmed the good tolerability of St. John‟s wort 
extract and the very low frequency of adverse effects in case of monotherapy. 
Nevertheless, a change in the metabolism of a drug by the co-administration of 
another substance like St John‟s wort food supplements may be clinically relevant. 
For example, women who take St John‟s wort concurrently with oral contraceptives 
should be advised to use other means of birth control or stop using SJW. 
2.6.1.3 St John’s wort and statins 
Statins are the most effective medications for the treatment of primary and 
secondary hypercholesterolemia. In Belgium, statistics for 2008 show that 8.3% of 
the Belgian population receives a daily statin treatment, which ranks them as the 
most prescribed drugs in Belgium (source: INAMI-RIZIV).  
 Several observations on patients under statin treatment (Gordon et al., 2009), 
and clinical trials (Sugimoto et al., 2001) show that some statins are significantly less 
effective when combined with St John‟s wort food supplements. For example, 
Sugimoto & al. (2001) observed that St John‟s wort treatment on healthy volunteers 
tended to lower plasma simvastatin, but had no influence on pravastatin 
concentration. Simvastatin is extensively metabolized by CYP3A4 in the intestinal 
wall and liver, which is induced by St John‟s wort. In contrast, CYP3A4 has a minor 
role in the metabolism of pravastatin (Sugimoto, et al., 2001). 
Inhibition of the statins efficacy can be critical for health. For example, a 59-
year-old man presented to his physician with hyperlipidemia. For his treatment, he 
received Rosuvastatin 10 mg/day and its total cholesterol blood level decreased to 
165 mg/dl. A routine lipid panel was performed 6 months later, and a marked 
increase of total cholesterol was noted (237 mg/dl). The patient confirmed that he 
was compliant with Rosuvastatin but had begun taking St. John‟s wort, 2 capsules 
per day. He was asked to stop taking the herbal supplement, and a repeat lipid panel 
4 months later showed a marked improvement of all parameters (Gordon et al., 
2009). 
2.6.1.4 St John’s wort and cataract 
Recent evidence suggests that the St John‟s wort component hypericin may 
be associated with cataractogenesis. This association has not been directly 
evaluated in humans, but a recent epidemiologic study revealed the relationship 
between self-reported St John‟s wort use and cataracts utilizing data from a large, 
population-based sample. The negative effect of hypericin can be explained because 
of its photosensitivity. It causes the production of oxygen radicals when exposed to 
visible or ultra-violet light, which bind to the lens crystalline proteins. However animal 
and human research indicated that photosensitization is not likely to occur at the 
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recommended dosage levels. Based upon experimental studies (animal and human) 
it would take approximately 30 to 50 times the recommended daily dose of the 
standardized extract to produce severe phototoxic effects in humans (Schulz et al. 
1998). The results of this study cannot be considered as univoque, but lend support 
to the hypothesis that St John‟s wort may indeed increase the risk of cataracts (Booth 
& McGwin Jr., 2009). It should be evaluated clinically in the future. 
2.6.1.5 Health concerns about St John’s wort based products: conclusions 
St John‟s wort products have been among the top-selling herbal preparations 
in developed countries in recent years. The reason for this success is the belief that it 
is more natural, safer and has fewer or no adverse effects compared to conventional 
antidepressants (Barnes, 2002). Numerous studies have confirmed the good 
tolerability of St. John‟s wort extract and the very low frequency of adverse events in 
case of monotherapy. 
St John‟s wort is well known for its capacity to interact with drugs. Our in vitro 
results showing that active ingredients of St John Wort are able to modulate the 
activity of CYP1A1, a xenobiotic metabolizing enzyme, as well as the activity of the 
Ah receptor, a transcription factor regulating the CYP1A1 gene expression, indicates 
also possible interactins with xenobiotics. Even if the decreasing effect on the 
cytochrome CYP1A1 activity by the St John‟s wort active ingredients in the presence 
of B[a]P could be considered as positive, this modulation does not take part in the 
reactions leading to their anti-depressant activity, thus it could induce unknown 
actions on human health. Moreover, the interactions with the CYP3A4 are dominant 
and concern an impressing number of drugs used every day by a large section of the 
population (statins, immunosuppressants, oral contraceptives,…).  
For precaution, patients under any drug treatment should not consider SJW as 
harmless, and thus should inform their physician. Moreover, pharmacists must also 
give appropriate information. They should be able to recognize the possible 
interactions and give advice and precautionary measures to the customers. Even 
when notified, this customized approach is unrealistic for products presented as food 
supplements for the consumer available in the supermarkets and on the internet. 
This is an issue, because as we have seen in the first part of the Foodinter project,  
48% of the interviewed consumers don't systematically read labels or leaflets ; 
among these 48%, 17% never read labels.   
2.6.2 Phytoestrogens 
As we have seen previously, soy isoflavones are endocrine disruptors able to 
play a hormonal role. Their estrogen-like activity is the one responsible for the 
therapeutic effects when treating menopausal symptoms. The three best 
characterized phytoestrogens are from soy: daidzein, genistein and glycitein.  
Project SD/AF/04 - Food interactions : effects on health, consumer perception and impact on agro-food industries - 
“FOODINTER” 
SSD-Science for a Sustainable Development – Agro-Food 103 
Ignored by most consumers, soy is found in more then 60% of processed 
food. In addition, other phytoestrogens are widely present in the normal human diet, 
for example in hop, spinach, clover, tea, coffee and rhubarb (AFSSA, 2005). They 
can also be found in other food supplements than the soy extracts, and have to be 
added to the phytoestrogens already ingested with normal food, in phytoestrogens 
risk assessment studies. 
The pro and cons of phytoestrogens have been deeply studied. 
The attitude of the general public and clinicians toward phytoestrogens 
(particularly soy phytoestrogens) is generally positive, in opposition to their synthetic 
counterparts, because of the vegetal origin of the molecules. Moreover, exposure to 
most synthetic EDs such as pesticides (e.g. DDT and methoxychlor), industrial 
lubricants (e.g. PCBs) and plasticizers (phtalates and bisphenol A) is frequently 
associated with alarming statistics regarding declining reproductive health and 
increasing rates of cancer and obesity (Crain, et al., 2008). Another example of 
confusion is that in Europe, soy formulations for non breastfeeding infants are 
available only by prescription and, consequently, the use of soy formulations is 
customarily lower in these countries. These types of advice are confusing for parents 
and have done little to quash the idea that soy formulation is a healthful alternative to 
breastfeeding (Patisaul & Jefferson, 2010). Phytoestrogens remain widely believed to 
provide an array of beneficial effects, including preventative or therapeutic actions in 
carcinogenesis, atherosclerosis, menopausal symptoms and osteoporosis.  
Studies concerning toxicology of a prolonged oral consumption of 
phytoestrogens have been conducted mainly in rodents, more rarely on dogs and 
apes. The results, scattered and contradictory, should thus be carefully considered 
(AFSSA, 2005). 
Nevertheless, it is well established that estrogens promote breast 
tumorigenesis, and that parameters which increase lifetime estrogen exposure (such 
as early menarche, short duration breastfeeding, and low parity) are associated with 
elevated breast cancer risk. Because they bind estrogen receptors with relatively 
high affinity, some researchers and clinicians are concerned that high phytoestrogen 
intake may increase the risk of carcinogenesis and put breast cancer survivors at risk 
for reoccurrence. Others have proposed that the opposite is true, citing traditionally 
low cancer rates in Asia as evidence (Patisaul & Jefferson, 2010). 
The AFSSA concluded in 2005 that studies concerning the cardio-vascular 
diseases and cancer did not find risks associated to the consumption of isoflavones 
as a substitute for hormonal treatment. Isoflavones seem associated neither to the 
benefits (climacteric comfort, osteoporosis) nor to the risks (cardiovascular disease, 
cancer). Nevertheless, the studies are not numerous, and indicate risks for certain 
population categories, in particular during pregnancy and early infancy (AFSSA, 
2005). 
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The question of whether or not phytoestrogens are beneficial or harmful to 
human health remains unsolved. The answer is likely complex and may depend on 
age, health status, life style and even the presence or absence of specific gut 
microflora (Patisaul & Jefferson, 2010). 
Each phytoestrogen has its own estrogenic potency, compared to the effect of 
the classical 17β-estradiol. The exact potency profile depends on the in vitro material 
and methods used. The classification is: oestradiol > coumestrol > 8-
prenylnaringenin > genistein, and equol > daidzein > glycitein. Data on the 
oestrogenic potency of mixtures of phytoestrogens are limited. Willard & Frawley 
(1998) demonstrated that co-treatment with equimolar concentrations of genistein, 
daidzein, formononetin and equol resulted in an additive oestrogenic response in a 
reporter gene assay relative to that observed for any individual phytoestrogen. 
However, Collins et al (1997) demonstrated that biochanin A and flavones inhibited 
the activity of oestradiol in a reporter gene assay, which is predictable for these weak 
partial agonists (FSA, 2003). 
A study performed on rats and measuring different histological parameters 
leads to the conclusion that most of the effects can be attributed to the estrogenic 
properties of genistein (McClain et al. 2005). From their data, experts of AFSSA 
concluded that soy isoflavone intake of up to 1 mg/kg bw/day does not raise safety 
concerns (AFSSA, march 2005). Genistein has been more thoroughly studied, it is 
estimated that the level of exposure of genistein for the citizens ranks from 0.016 to 
0.833 mg/kg bw/day, depending on their food habits (vegetarians have the highest 
levels). This is 0,16 % to 83,3% of the safe intake evaluated by the AFSSA. 
Nevertheless, genistein exposure from isoflavone-containing food supplements may 
reach 60 mg/day (the claimed benefits may be achieved with daily genistein intakes 
of 30 - 60 mg for an adult person, corresponding to 1 mg/kg bw/day). Considering a 
normal diet plus the food supplement intake, the safe daily intake can be widely 
exceeded. This is clearly a matter of concern. 
The Scientific committee of the Belgian Federal Agency for the Safety of the 
Food Chain (FAFSC) has recommended in 2009 to control the presence of 
phytoestrogens (more particularly genistein, daidzein and glycitein) in food, with a 
focus on novel food and food supplements (FASFC, 2009). 
Consumers should be aware that soy in food supplements contains endocrine 
disrupting compounds and make dietary choices accordingly. Consumers must be 
clearly informed through an adequate labelling. This labelling should mention at least 
the isoflavone content of the food supplements, the maximal advised intake, and the 
categories of population that should not consume this product (pregnant women, 
young children and vegetarians).  
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Health concerns about Soy isoflavone based products: conclusions 
The attitude of the general public and clinicians toward soy phytoestrogens is 
generally positive in opposition with their synthetic counterparts, because of the 
vegetal origin of the molecules. A litany of health benefits including a lower risk of 
osteoporosis, heart disease, breast cancer, and menopausal symptoms, are 
frequently attributed to phytoestrogens, but many are also considered as endocrine 
disruptors, indicating that they have the potential to cause adverse effects on health. 
It is widely documented in the literature, and our observations confirm it: soy 
isoflavones have an estrogen-like activity and shouldn‟t be given in high doses to 
some categories of the population.  
As we have seen in this study, the three main soy isoflavones don‟t induce 
any stress reaction from bacterial strains. It could be extrapolated to eukaryotic 
human cells. The decreasing effect of the cytochrome CYP1A1 activity by the three 
soy isoflavones in the presence of B[a]P could be considered as positive. 
Nevertheless, this modulation doesn‟t take part in the reactions leading to their 
therapeutic activity, thus could induce unknown actions on human health.  
The main health concern about the soy isoflavones is their known action as 
endocrine disruptors. The consumer must be clearly informed through an adequate 
labelling. This label should mention at least a warning concerning the categories of 
population that should not consume this kind of product. 
2.6.3 Ginkgo biloba 
Because the Ginkgo biloba is a platelet anti-aggregate, hemophiliacs and the 
people preparing for surgery should avoid taking it. The same advice is to be given 
for people taking anti-coagulants and anti-inflammatory.  
 
Heath concerns about Ginkgo biloba products: conclusions 
With an aging population seeking inexpensive solutions to troubles such as 
dementia and vasculopathy, Ginkgo biloba offers some benefits as a mild vasoactive 
and neuroprotective phytomedicine. Evidence indicates that it is effective in slowing 
Alzheimer‟s disease progression and ameliorating symptoms. The simplicity of the 
treatment, ease of access and low cost today make Ginkgo biloba extract one of the 
most popular food supplements. However, Ginkgo biloba is the second most 
common herb involved in drug interactions (after St John‟s wort). The number of 
reported cases of emerging Ginkgo-drug interactions is already on the rise, and the 
actual number of cases may in fact be higher due to under-reporting (cited in Abad et 
al., 2010). 
The estrogen-like activity of the flavonoids and the synergy of the mix with a 
standard activator of estrogen receptors suggest that they may act like isoflavones. 
Because of their hormonal activity, isoflavones are a matter of concern. 
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As seen in the previous in vitro assays, there is much probable interference 
between the Ginkgo biloba active compounds. It suggests that each food supplement 
could act differently on the intestinal cells, concerning both cytotoxicity, stress 
induction, hormonal equilibrium and herbal-drug interaction. The issue is still 
complicated by the possible presence of environmental contaminants such as heavy 
metals (founded in two products), and polycyclic aromatic hydrocarbons (excessive 
levels founded in one product).  
 
2.7 Risk assessment 
2.7.1  The sources of risks 
According to our observations based on the analyses of 61 products bought in 
Belgium from supermarkets, specialized shops and internet, and on in vitro analysis 
of active ingredients and mixtures of active ingredients, we have located sources of 
risks that could have directly and indirectly a negative impact on public health. The 
sources of risks identified during the Foodinter project can be classified into six major 
groups: toxicological issues, access to the market, consumer, manufacturing, 
uncertainties, labeling/advertisement. For each group, the source of risks was either 
clearly identified, or inspired by the experiences of other countries or from scientific 
literature. They are summarized here in a Fish Bone diagram (Figure 20). 
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Figure 20: Different sources of risks identified around the plant based Food Supplements 
consumption. 
2.7.2. Toxicological issues  
This family of risks refers to the sources of risks that could directly affect human 
health through its metabolism. The main part of the study concerned the presence of 
different environmental contaminants, as well as the action of active ingredients and 
their ability to interact with drugs. The sources can be sorted in three groups. They 
are: 
a. The environmental contaminants 
 Some trace elements, like the heavy metals cadmium and lead, were found in 
some products at concentrations that are too high (health concerns). 
 The polycyclic aromatic hydrocarbons (PAHs) were found in some products at 
high concentrations. St-John‟s wort and Ginkgo biloba extracts presented the 
most frequent contaminations and the highest average values for PAHs 
concentrations. 
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 Environmental contaminants such as mycotoxins, heavy metals, antifungals,  
PAHs, etc. : 
- may modulate the activity of the CYPs (proteins implicated in the 
metabolism of various drugs), 
- may modify the activity and the expression of efflux pumps, like the P-
glycoprotein (Pgp). Intestinal Pgp is a versatile multi-substrate pump, 
which can expel compounds out of the cells in order to bring them back 
to the luminal side of the intestinal barrier and maintain intracellular 
concentrations at low levels. The role of Pgp in drug interactions and 
bioavailability has been highlighted. 
b. The toxicity of the active ingredients 
 Possible related diseases are suspected to be provoked, like cataracts with St-
John‟s wort consumption,  
 Over dosage: some products are more concentrated in active ingredients than 
the legal limits (found in some St-John‟s wort products), 
 Poisoning: deaths through poisoning following consumption of such products 
is unprobable as consumption of food supplements is most often limited in 
amounts, 
 Each person has its own sensitivity to the ingredients ingested. The reasons 
are to be found in the genetic profile -this might explain the different responses 
to soy isoflavones between Caucasian and Asian people- and/or in the gut 
microflora -each individual's gut microbiota affects the bioavailability and 
response to orally administered drugs. 
c. The interactions due to the active ingredients 
 Interactions between drugs and some food supplements based on plants are 
well known by the scientific community. In our study, we have seen that some 
active ingredients modulate the activity of cytochromes, that are proteins that 
metabolize drugs, 
 There are possibilities of collateral effects of some FS and their active 
ingredients, for example through the modulation of the cytochromes CYP1A1 
activity, the interference with the dioxin pathway, and the endocrine disruptor 
effects. 
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2.7.3. Manufacturing 
Some results of our study suggest that the manufacturing could influence the 
quality of the products, in terms of environmental contaminants (such as PAHs or 
heavy metals) or active ingredients concentration : 
 Growing conditions, often widely different from the traditional conditions, can 
be at the origin of high variation in the chemical content, 
 Seasonal variations can also explain differences in the quality and 
concentrations of the active ingredients, 
 Misidentification of plants harvested from the wild is also a continuing problem, 
 The concentration of active ingredients depends on the organs of the plant, it 
is important to provide the exact plant part of the extract,  
 Post-harvest activities, like transport and storage of the raw material, can be at 
the origin of contamination (for example with lead and PAHs), and 
development of mycotoxins, 
 The manufacturing methods are sometimes different from the ones that were 
used traditionally. The concentration of non-desirable substances can thus 
increase. This has been observed for maca-based products, for which the 
traditional preparation would decrease the presence of some dangerous 
compounds, 
In conclusion, it is important to make autorities aware that controls must be 
ensured at batch level and to check if the manufacturing conditions are taken into 
consideration in the HACCP and autocontrol procedures of the producer. 
2.7.4. Access to the market 
 Notification is required for any food supplement that is meant to reach the 
Belgian shops (pharmacies, supermarkets, specialized shops…). 
Nevertheless, out of 25 products bought in the above mentioned places, 11 
were not authorized to be on the Belgian market at that moment. This means 
that some products pass the net and reach the market‟s stands. Controls were 
performed in 2007 by the FASFC on more than 5000 products; they had 
similar results, 
 There are sometimes notification failures; in our study two products showed 
deficiencies in labelling. It also happens that new (and illegal) health claims 
are written on the packages, which were not announced in the administrative 
file. The problem was worrying enough for the FASFC to perform specific 
actions on food supplements, 
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 The quantity of internet orders of food supplements is still not known, but it is 
obvious that it will grow during the following years. This market is totally out of 
control: only 4 of the products bought on the internet were notified (out of 36), 
 Products are free for sale in the supermarket, which is obviously criticized by 
the pharmacists who consider important to provide advice to the consumers. It 
can also be argued that, in the frame of this study, supermarkets have more 
frequently unauthorized products in their stands. 
2.7.5. Consumer’s behavior 
The consumer‟s behavior remains problematic in some aspects. 
 They feel unnecessary to warn the physician about their consumption, 
probably because it is free for sale in supermarkets, thus considered as a 
simple food, 
 Consumers mistrust the scientist‟s arguments, sometimes because they 
consider that scientists undergo lobbying, 
 Consumers share some unfunded beliefs, considering for example that the 
food supplements based on plants are de facto natural and safe. 18 to 45% 
consider the food supplements as perfectly safe. 
 Misinformation reigns in the mass-media society. The lack of criticism 
increases because of a “crowd effect”. 
2.7.6. Labeling/advertisement 
 Hidden advertisements, like “publi-reportages”, statements, or even journal 
articles, are spread in newspapers and magazines. 
 Misleading advertisements tend to overstate the effects of the product, for 
example with comforting pictures. It creates confusion in the consumer‟s mind.  
 Clear health claims appear on advertisements. “In December 2006 EU 
decision makers adopted a Regulation on the use of nutrition and health 
claims for foods which lays down harmonised EU-wide rules for the use of 
health or nutritional claims on foodstuffs based on nutrient profiles. …. One of 
the key objectives of this Regulation is to ensure that any claim made on a 
food label in the EU is clear and substantiated by scientific evidence » 
(statement on Nutrition and Health Claims from the EFSA website) , Of course 
we are still in a transition period during which the food supplement sector have 
to adapt their communication to the consumers There is also often insufficient 
information on the labels (like a phone number for consumer‟s), 
 Warnings are sometimes insufficient on the labels. 
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2.7.7. Uncertainties 
There will always be unknowns; it is clearly unfeasible to gain detailed 
knowledge about all the effects in a short time-span. However, the lack of a clear 
path forward cannot be an excuse for standing still. Each piece of scientific data is a 
part of a complex puzzle.  
Because each food supplement is a complex mixture of active ingredients, 
plant constituents and metabolites, it is obvious that they are completely different 
from the classical drugs sold in pharmacies. For a better understanding and control 
of their potential health impacts, it is pertinent to study the food supplements “from 
pure to sold”: first each potential active ingredient in a pure standard form with 
realistic intestinal concentrations, then mixtures of those active ingredients, then 
standard extracts (if available), and finally crude food supplements as they are sold. 
Since this will be in practice impossible to perform for each FS to be put on the 
market, there will always be uncertainties about potential effects related to the 
complex composition of the mixtures. 
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3 POLICY SUPPORT 
3.1 Recommendations based on the scientific observations 
3.1.1 Major health concerns 
The weight of each risk source depends on the probability for the occurrence 
of harmful effects on human health and the severity of that harm. Because the health 
issues are widely depending on the consumption behaviours, the assessment cannot 
consider only the scientific observations but also sociological information and 
labelling information. 
For public health, there are three major risks linked to the intake of plant 
based food supplements: the interactions with numerous drugs, which may modulate 
their efficiency, environmental contaminants such as heavy metals and polycyclic 
aromatic hydrocarbons, and finally biological effects of some active ingredients, 
acting as endocrine disruptors for example. There are several ways to decrease the 
negative impact of plant based food supplements. 
3.1.1.1 Interactions between food supplements and drugs  
To decrease the health concerns around the drugs-food supplements 
interactions, it is imperative to encourage all the health professionals (doctors, 
pharmacists) to alert their patients when prescribing drugs. Even in each variety of 
plant, depending on the manufacturing, there might be unexpected interactions. The 
precautionary principle should be encouraged. 
In parallel, everything must be done to increase the patient‟s awareness to 
inform their physician of their eventual consumption of food supplements. People 
should be aware that those products are not harmless and that natural products are 
not in any event safe. A recent survey performed by the Eurobarometer concerning 
the consumer‟s perceptions of food-related risks mentioned that the Belgians express 
a high level of confidence to their physician/doctor and health professionals (93%), 
significantly higher than any other information source (TNS Opinion & Social, 2010). 
Finally, new scientific studies should be encouraged in order to understand 
more precisely which are the modes of action of the food supplements and their 
active ingredients.     
These two issues (communication and scientific knowledge) have been 
addressed in this FOODINTER project, as illustrated in Figure 21. 
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Figure 21 : Recommendations regarding interactions between FS and drugs. 
 
 
3.1.1.2 Environmental contaminants and toxicity  
 
The struggle against contaminations should be already performed at the 
beginning of the production. Clear guidelines should be proposed to the producers in 
order to avoid contaminations. They should cover all the steps: from growing 
conditions to transport and conservation, following the HACCP (Hazard Analysis 
Critical Control Point) approach (which is mandatory according the European 
Regulation (CE) 852/2004) in order to detect and manage the critical points. For lead 
and PAHs, Codex alimentarius international codes of practice for the prevention and 
reduction of these contaminants should be followed 
(http://www.codexalimentarius.net/web/standard_list.do?lang=en). 
Environmental contaminants „heavy metals‟ and „polycyclic aromatic 
compounds‟ contents should be systematically verified prior to notification. 
Randomized controls have already proven their efficiency in terms of wild 
presence of not notified products on the market, of non-compliant labels, and of 
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some contaminations. During 2009 the FASFC performed a new control campaign 
similar to the one in 2007. Effective improvements were observed, thus the controls 
are efficient. Those controls should be developed in order to follow the exponential 
growth of this market.  
In parallel, targeted controls should be organized according to the specificity of 
the food supplement.  
- If the manufacturing requires specific drying steps, the focus should be 
on PAHs and lead content. 
- If the storage conditions are suspicious, a focus should be on 
mycotoxins content. 
- If the supplement is based on animal fat (e.g. omega 3 in fish oil), the 
focus should be on dioxin and PCB content. 
- If the geographical origin of the plant is suspicious, a complete battery 
of test should be envisaged. 
- According to the claimed health benefit, some specific tests should be 
envisaged in order to find eventual illegal drugs. 
The struggle against internet sales of uncontrolled products will probably be 
the next challenge for the public authorities. People should be informed that internet 
is not a safe source of food supplements. 
Several exotic plants, like the Maca root (Lepidium meyenii), generate debates 
around their efficiency and toxicity. The mode of action of Maca roots is unknown. 
Regarding the lack of knowledge on Maca root and its active ingredients, it could be 
envisaged to exclude this product from the Belgian market. The situation is unclear: 
Maca has substantial medicinal use in traditional herbal medicine by indigenous 
cultures, with a specific protocol to prepare it. The presence of alkaloids measured in 
this food supplement can be explained by the industrialization of the preparation of 
the products. Alkaloids are an indicator of a wrong process. Because they are known 
to be harmful, no residue of alkaloids is permitted in the food supplement. On the 
other side, those alkaloids are markers of authenticity, thus permit to diagnose false 
Maca extracts.  
Scientific in vitro tests suggest that Maca might lead to health concerns. The 
EFSA mentioned the maca in the list of “plants reported to contain toxic, additive, 
psychotropic, or other substances of concern”. The EFSA clarifies that this list does 
not imply that those plants are not safe for use in food supplement plants, but should 
be subjected to a more extensive safety assessment. A better understanding and 
characterization should be awaited before letting those products reach the Belgian 
market. 
As advised previously by a European scientific committee (EFSA, 2004), as 
purity specifications for all botanicals and botanical preparations are very difficult to 
define, the development of ad hoc manufacturing guidelines could be considered in 
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order to improve their characterization and safety. The EFSA published recently a 
guidance document for that purpose (EFSA, 2009). 




Figure 22 : Recommendations regarding the issues linked to the presence of contaminants 
in food supplements. 
3.1.1.2 Biological activities  
During this study, we have confirmed that some active ingredients may act as 
endocrine disruptors (in Soy isoflavones and Ginkgo biloba). More precisely, they 
have an estrogen-like activity and are thus called phyto-estrogens. This property is 
the reason for the claimed therapeutic effects of Soy isoflavones: reduction of 
menopausal symptoms. Nevertheless, phytoestrogens are known to be harmful for 
some categories of population that should be clearly informed (pregnant women, 
young children and vegetarians). Considering a normal diet plus the food supplement 
intake, the safe daily intake can be widely exceeded.  
Other biological effects are to be mentioned, such as possible side effects, 
overdoses, and individual susceptibilities. For all those problems, a good information 
campaign to the consumers should be planned in order to make people aware of the 
fact that food supplements are not harmless.  
Figure 23 summarizes the issues linked to the question of biological activities 
of food supplement active ingredients. 
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Figure 23 : Recommendations regarding the issues linked to the potential biological 
activities and/or toxicity of food supplements ingredients. 
3.1.2 The “Tradition-based claims”: a pervert argument ? 
When defending their products, it is frequently argued by the industrials that 
the traditional knowledge about the use and efficacy of botanical preparations should 
not be denied. Arguments cover the fact that knowledge and experience has been 
accumulated by mankind “over thousands of years” by carefully observing the 
properties, by optimizing their use, before the age of clinical trials and sophisticated 
methods. 
This opinion can not be shared in face of the observations of the Foodinter project: 
- Even if used for millenniums, the fact that direct side effects haven‟t been 
observed does not guarantee that there are no recorded health issues, which 
could not be directly related to the plant consumption. For example, as 
mentioned in this report, St-John‟s wort supplements are seriously suspected 
to induce cataracts. Many side effects of plant food supplements are probably 
still to be discovered. 
- The traditional manufacturing process is far from the mass production that we 
currently meet. As cited by the EFSA in 2009, botanicals and botanical 
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preparations might become hazardous as a result of deviations in the 
production process (e.g. misclassification, switching of species).  
- In opposition with the industrial process, the traditional manufacturing might 
also eliminate toxic compounds (the Maca root for example), and on the other 
side, the industrial manufacturing can induce their appearance. As the EFSA, 
we conclude that the safety of botanicals and botanical preparations should be 
ensured by following a Hazard Analysis and Critical Control Point (HACCP) 
approach. It must be applied with the necessary flexibility and adapted to each 
botanical preparation on a case-by-case basis. 
- Plant based food supplements are taken in concentrated doses (in opposition 
to traditional infusions (tisanes)), for example. The intake of active ingredients 
might be significantly higher that the estimated historical intake level. The 
impact of those high intake levels cannot be assessed only on the basis of the 
“historical experience”. 
 
3.2 Reflexions and recommendations for risk communication 
based on the sociological tasks 
  
3.2.1 Differentiate communication strategies according to the 
heterogeneity in consumer profiles and FS consumption 
patterns 
 
 When presenting the results of sociological tasks, we underlined the diversity 
one is to face when analyzing FS consumption and FS consumers. If one wants to 
diminish the risks associated with FS consumption, then it's thought that consumers 
have to be helped to put themselves or their consumption in perspective, and to 
wonder whether FS are a solution to the “problems” they face. In order to do that, we 
have to admit that it requires to touch consumers at the centre of their practices and 
framings, at the centre of what they consider a problem, a risk or a lack in their 
lifestyle, that justifies their consumption. Therefore, the rhetoric at work behind the 
assessment by consumers themselves that they “have a problem” (or could avoid 
some) should also be addressed ; not the product itself, but the discourses and 
societal evolutions that give them a grip on consumers : “I could be stronger” ; “I 
could be less stressed” ; “I could reinforce my immune system” ; and so on.  
 We underlined that it would be very difficult to address FS consumers in their 
globalism (moreover regarding the often very specific and contextual nature of risks 
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related to FS and FF), and that a multifaceted, tailored risk communication and risk 
management strategy would be a more suitable answer. This would be much more 
talkative to consumers, and would suit their framings of these diverse “patterns” or 
“models” we identified in part 2.1.3. of this report, by reinserting in its “context” (or 
with shared references) the message that is to be heard (and analyzed) by 
consumers. This message should take into account the fact that there are indeed a 
lot of objectives that consumers pursue through FS consumption, each having to be 
addressed in its specificity. 
 For instance, consumers using FS on the “preventive” mode (that is more 
rooted in familial references and “traditional” categories) seem “educated” to reason 
in terms of purpose, and are not familiar at all with categories of legal status or of 
active substances ; this would expose them to too much complexity and blur their 
knowledge-building process. We could give another example of a sportsman, that 
consumes FS in order to boost some of his performances, and that has undertaken a 
lot of research to manage to understand the working principles of products, their 
composition, their long term effect, etc., for whom a more “expert” communication 
could be suited, or a communication that would be relayed by its sport trainer (or 
sport center), or sport-FS retailer.  
 This also raises the need for the communication strategy to be tailored to the 
various networks of advice that appeared from the focus groups and surveys 
(corresponding to the “profiles” discussed in the results) : these can be informal 
channels (friends, family, web sites, sport trainers, advertising and articles in reviews, 
…), as well as formal channels (practitioners, pharmacists, “alternative therapists” 
(whose status should be clarified), …). No hierarchy or dismiss should be done 
between them, as consumers don't do hierarchy between those channels neither, 
except on the basis of trust. This is why they can give more weigh to trusted 
relatives, or their self-judgment and feelings, than to the advice of practitioners, even 
if they don't have the competence.  
 
3.2.2. Internet-based risk communication, risk deliberation, and risk  
governance platform 
 It was discussed with consumers about the idea of a web site that could give 
them “good information” on FS products and associated risks.  We imagined a multi-
level communication tool or “multi-purpose platform”, with different parts accessible 
according to consumers‟ or other actors‟ demands or needs. Some parts or features 
could also be restricted to certain specialists or health professionals, as we will 
discuss further. 
 The first level of information could be a traditional form of risk communication, 
where consumers could find good practice rules (tips and recommendations, like 
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“don't buy this brand/product”, “don't buy on this website”, “don‟t use this FS wit this 
food”, ...), or general assessed information classified by products, and designed to 
suit their framings or “profiles”. We can also imagine presenting precise examples of 
the risks that are warned against, which are generally very striking to consumers. 
 The need for “good information” was strongly underlined by consumers, who 
get often drown into the ocean of (mainly unverified) information they can find. 
“Good” information was defined as clear, independent/impartial/unbiased, complete 
or making its limits explicit. This leads to the importance of the second level of 
information that should be developed on the web site : more than only tips or advice, 
we think that this tool could be of major interest in order to allow consumers' 
empowerment, that is giving them the keys : (1) to distinguish between product 
categories in the mess of “alternative health products” ; (2) to identify and understand 
the risks associated with FS and FF (and extensively with other assimilated 
products), as well as the way they are managed, and the place or roles consumers 
could have in face of these risks. Accordingly, consumers should be given neutral, 
realist information and helped to make their own opinion and judge if they should 
adapt their consumption practices. If one wants consumers to take their responsibility 
in face of risks associated with a consumption they chose, then they should be given 
the means, knowledge and critical distance to take this responsibility ! 
 A third dimension of this web site should allow discussion with consumers. We 
already mentioned that it's important to consider the variation in consumers' profiles 
and patterns of consumption (so not targeting only one, “mean” target, but different 
ones ; also, communication should be done on various level of complexity, to adapt 
to the various expectancies and capacities of understanding of consumers), what is a 
first step towards a two-way communication process. But the idea of implementing a 
discussion platform (an Internet “forum”) would go beyond this and be a much more 
radical step towards real dialogic governance, allowing consumers to become actors 
in different ways and not only receptors or targets whose behaviour is to be changed. 
Moreover, this would be an initiative that would respond to consumers' expectancies, 
as existing forums are very popular (but on which the quality and independence of 
information is a huge problem. 
 This forum could be subdivided in different parts :  
 one where consumers could discuss with other consumers or consumers 
associations (like it happens on the majority of Internet forums, like for 
instance “Doctissimo”) ; but the forum we imagine should be different that the 
one we can find presently, as we plead for its explicit moderation by scientists, 
therapists and risk or products experts. This would be great importance, as 
aiming at preventing from giving unproven or partial advice. However, the idea 
would be that experts shouldn't need to answer in person to each question, as 
other members of the forum (consumers) could give suited answers too ; 
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these would only have to be monitored and verified or balanced. These 
discussions, like what happens on forums, could become references for other 
consumers having similar questionings 
 one where consumers could ask questions directly to specialists (from the 
discipline they look for : formal medical disciplines, “alternative medicines”, risk 
experts, regulation or management experts, …) 
 one where consumers could formulate remarks or recommendations on 
products and risks management, as well as on risk communication (what they 
don't understand, what they don't agree with, …) ; this could be very helpful for 
the designers of communication or management strategies, assuming that 
every remark couldn't be taken into account but that the designers (experts) 
should be open to the idea that “simple” citizen directly voice out concerns to 
them...and of course have the will to listen and give answers to these 
concerns. 
 
 A fourth part of the website would detail and explain the basis of the risk 
management system, in a way that makes explicit the presuppositions and limits of 
this system (namely uncertainty (i.e. long term effects of products), complexity (due 
to huge number of products, high pace of evolution, and large scope of risks 
(depending on potentially unlimited factors and interactions). This would allow 
consumers to increase their knowledge on the reality of risk management, and put 
back the “myths” or ideals behind risk management in perspective. To sum, this 
would increase the reflexivity of consumers and allow them to better understand what 
are the real challenges in risk management and which behavior they have to adopt in 
face of them.  
 A fifth part could allow discussion and sharing of knowledge on risks, between 
scientists/experts and between health professionals on (on the mode of scientific 
reviews, but also on a “simplified” mode, giving summaries or analyzing controversial 
issues). This would be a platform for the state of knowledge on risks associated with 
FS consumption substances, environmental contaminants, interactions, …).  We can 
also imagine a kind of “forum” dedicated to risk experts, scientists and health 
professionals, where they could ask questions or share ideas and knowledge on FS. 
 In addition, it could give precious information to those experts and health 
professionals on consumers' practices or opinions, perceptions of risks, reactions to 
or incomprehension of risk communication 
 At least (but not at last, as this tool should be open and in constant evolution), 
a sixth part would be dedicated to social sciences research on risk communication 
and risk management. Indeed, the totality of information published by the members 
of the forums (consumers or experts) would be precious material to analyze, in order 
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to help increase the reflexivity of the whole risk governance system, that has to be 
adaptive !  
Briefly, we then identified some limits of this Internet tool :  
 every consumer may not have Internet, or may not know about the website ; 
accordingly, other media should be used, such as folders to let in “hot spots” 
(drugstores, at therapists', in sport centers, …), publication of articles in 
popular reviews, of advertisements, TV spots (on the mode of documentaries 
rather than only (too) short spots, even if both would have advantages and 
disadvantages), … 
Accordingly, the second level of information we identified should also aim the media 
and resources (reviews, web sites, advertisements, ...) that presently touches 
consumers, that they can be using to guide their FS consumption  
 this website would have to become popular, which would take time and 
implication from public actors as well as from the experts that should 
participate in the web site management ; it won't become a widely shared 
reference in one year 
 if it becomes popular (but the means should be allowed so that this happens 
to be), however, it will certainly become subject to attacks from interest groups 
and lobbies, for whom reflexivity, critic and consumer empowerment is seldom 
encouraged 
3.2.3. Recommendations concerning health professionals (and 
more generally the healthcare system) 
 
 Consumers pointed out the lack of knowledge from general practitioners on 
nutrition and “alternative health products” or “alternative therapies”, as well as 
interactions between all those compounds.  
 This lack of knowledge from practitioners could also be a lack of will or interest 
in alternative therapies, or even a strategy of defence of professional interests, as 
these alternatives to conventional medicine are often dismissed by doctors. 
 But this could also be a lack of time or capacities, as we can't expect from 
practitioners to know everything on every products or interactions. Moreover, the 
conventional form of medical consultation, driving the approach of practitioners, is 
rooted in a “problem-solution” approach, often simplified or routinized, to which 
should correspond a specific drug. When patients would want to analyze complex 
interactions, then practitioners show generally a lack of will or knowledge to inquire 
complex interactions, and send them back to specialists'. This sends to another 
problem, which is that consumers can't always afford these specialists, and will 
assuredly often prefer cheap self-research and auto-medication in this case. 
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 This underlines the need to improve the basic training and formation of 
practitioners (but also of herbalists or other therapists or advisers) on nutritional 
aspects, on “alternative health products” and on interaction risks. All these have 
become a widespread reality they can't ignore nor dismiss anymore. 
 
 They have to be pushed to study complexity in its depth (and ask a large 
amount of questions, on food, FS consumption, habits, …), to take time to formulate 
precise, tailored advice, without necessarily being sent to specialists (or else 
consultation of specialists should be partly refunded by the healthcare system).  
3.2.4. Increase the quantity and quality of the information displayed 
by producers 
 
 This call for more and better information aimed at better labels (more 
information on contents, concentrations, origin of compounds, …) and obligation of 
notices of use (detailing interaction risks, but also the testings having been 
conducted and their limits), certification schemes passed (and what they assess), … 
 For certification, a clear sign should be displayed on the label so that the 
product could be quickly identified by consumers when buying the product 
somewhere else than in drugstores. We could also imagine a training to be followed 
and passed by producers on risks associated with FS ; like for certification, a picture 
could easily assess that these formations have been passed. 
 
 NAREDI, the association of food supplements producers, as a stakeholder in 
the National Food and Health Plan 
(http://www.health.belgium.be/eportal/Myhealth/Healthylife/Food/FoodandHealthPlan/
index.htm?fodnlang=fr) recommended already in 2008 the concerned Working Group 
headed by Professor Jean Nève to create a brochure explaining Food Supplements 
to the Belgian population.  This initiative should be encouraged by the authorities and 
finalized as soon as possible. 
3.2.5. Improve the clarity and efficiency of food supplements (risk) 
management and procedures, defined through European and 
Belgian regulations and administration 
 
 As risk management procedures were not well understood by consumers, they 
formulated a call for clarification of these :  
 What does “notification” assess ? (Does it include controls of compounds ? 
Additional testings ?) ; Why not making systematic testings of every products, 
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if we want this procedure to be really safe and not only a “procedure for the 
pleasure of procedure” ? 
 What cover the various categories of products created by law correspond 
(“MP”, NP”, “NNP”, “herbal products/plants”, “other products”, …) ? What do 
they mean, what are the differences between them, and to what does it 
correspond in the whole health products range ? Is it not a way to make 
different constraints on producers or networks of retailing (especially the 
concern of herbal products, which are about to be banished from herbalists') ?  
 Is the control efficient and trustful, as only very few people work on it at the 
federal agency and are supposed to control every product on the market ? 
 
 Moreover than being criticized as unclear and insufficient risk management, it 
was criticized by consumers that some non-notified products could be easily be 
found on the Belgian market, raising the important question of the efficacy of the 
procedures, and the consequent (lack of) trust consumers have in them.  
But more than solely “adding more control” – a model whose limits are obvious in 
our era of complexity and uncertainty, combined with high expectancies from the 
public –, shouldn't we also find new paradigms and procedures to both define and 
manage risks and the (still) unknown ? Those procedures and their design should be 
more opened up to discussion and co-elaboration with the public and professionals, 
as well as be more adaptive and reflexive...what is especially challenging in a context 
of high industrial or professional lobbying. 
 
Nevertheless, it must be recognized that Belgium has a leading role in the 
European Union in the field of food supplements. The FASFC organized during the 
Belgian presidency a symposium on our Belgian self-checking systems. Among 
these systems, the guide G-011 for the FS sector is an officially approved self-
checking guide as reference tool for the manufacture of food supplements in 
Belgium. 
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4 DISSEMINATION AND VALORISATION 
 
A workshop has been organized on 23 March 2011 afternoon, in Tervuren, open to 
the scientific community and the representatives of Belgian authorities, as well as to 
representative of food supplements producers (see program in annex 4). 
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